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The Role Of Midbrain Chloride Ion Dysregulation In Escalated Alcohol
Consumption
Abstract
Alcohol use is a prominent contributor to global disease burden and a leading cause of preventable
mortality. Long-term severe problem drinking is clinically diagnosed as alcohol use disorder (AUD), one of
the most prevalent neuropsychiatric diseases worldwide. Despite the persistent public health concern
posed by alcohol abuse, treatments targeting specific brain mechanisms impacted by and driving
pathological alcohol use are lacking.
Behavioral animal models have revealed that the mesolimbic dopamine reward pathway is a critical
mediator of alcohol’s reinforcing effects. The ventral tegmental area (VTA) is a central hub of this reward
circuitry and subversion of alcohol-induced neuronal activity in the VTA has been linked to increased
alcohol consumption. Among its many effects in the brain, alcohol enhances release of the inhibitory
neurotransmitter GABA in the VTA. This acute effect of alcohol is exacerbated by prior alcohol, drug, or
stress exposure, which are all risk factors for subsequent alcohol abuse. For these reasons, the central
hypothesis of this dissertation was that disruptions in alcohol-induced inhibitory GABA signaling in the
VTA contribute to escalated alcohol consumption.
To delineate the mechanisms of disturbed VTA inhibitory transmission that may lead to increased alcohol
consumption, electrophysiological recordings, in vivo pharmacological manipulations, and alcohol selfadministration paradigms were performed in rodents. The second and third chapters provide evidence
that an acute stressor in adulthood or chronic nicotine exposure in adolescence promote subsequent
alcohol self-administration behavior via chloride ion (Cl-) dysregulation in VTA GABA neurons.
Normalizing Cl- homeostasis by intra-VTA pharmacological upregulation of the potassium-Clcotransporter KCC2 prevented the increased alcohol drinking phenotype observed after stress or nicotine.
In the fourth and fifth chapters, rescue of disrupted Cl- homeostasis via serotonin 2A receptor (5-HT2AR)
activation is demonstrated ex vivo and correlated with 5-HT2AR agonist-mediated reduction in heavy
alcohol consumption.
Collectively, this body of work suggests that dysregulation of VTA Cl- transport, dictated largely by KCC2
function, increases risk for alcohol abuse. Targeting this form of inhibitory plasticity represents a novel
interventional approach for AUD. Therefore, future work is needed to identify clinically safe and
efficacious pharmacotherapies to reverse disturbances in midbrain Cl- homeostasis in alcohol-dependent
individuals.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Neuroscience

First Advisor
John A. Dani

Keywords
5-HT2A receptor, Ethanol, GABA, KCC2, Stress, VTA

Subject Categories
Biology | Neuroscience and Neurobiology

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/4023

THE ROLE OF MIDBRAIN CHLORIDE ION DYSREGULATION IN ESCALATED
ALCOHOL CONSUMPTION
Blake A. Kimmey
A DISSERTATION
in
Neuroscience
Presented to the Faculties of the University of Pennsylvania
in
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2020

Supervisor of Dissertation
_________________________
John A. Dani, Ph.D.
Professor of Neuroscience

Graduate Group Chairperson
_________________________
Joshua I. Gold, Ph.D.
Professor of Neuroscience

Dissertation Committee
Heath D. Schmidt, Ph.D., Associate Professor of Nursing and Psychiatry (Chair)
Michael P. Nusbaum, Ph.D., Professor of Neuroscience
Marc V. Fuccillo, M.D., Ph.D., Assistant Professor of Neuroscience
Minghong Ma, Ph.D., Professor of Neuroscience

ACKNOWLEDGMENT
“If I have seen further, it is by standing on the shoulders of giants.”
Isaac Newton

It is with great pleasure and honor that I acknowledge the individuals that have supported
and made possible my dissertation work. My advisor Dr. John Dani has had a consistently
positive influence on my development as a scientist. Dr. Dani provided me with the
resources and intellectual freedom to pursue a challenging thesis project and explore my
academic interests. He taught me that science is a process and at each stage I must set
aside preconceived notions to find the truth in nature. The enthusiasm and dedication that
Dr. Dani brings to scientific research motivates me to work hard and appreciate the beauty
in discovery. For these reasons, I am especially grateful for his mentorship and I will strive
to emulate his great example as I continue my scientific training.
Within Dr. Dani’s lab, I was most fortunate to work closely with Dr. Alexey Ostroumov.
Since joining the lab, Dr. Ostroumov was my regular collaborator and mentor on numerous
projects. Among his many contributions to my development as a scientist, Dr. Ostroumov
helped me gain independence as a patch-clamp electrophysiologist, one of my proudest
achievements as a doctoral student. Our frequent discussions on the scientific principles
of our work and his openness to my inquiries and hypotheses enhanced my intellectual
growth. His focus, energy, and rigorous approach to science have positively shaped my
own practices. I look forward to our future scientific relationship and seeing the discoveries
he will make as an independent investigator at Georgetown University.

ii

I have also had the privilege of working with Dr. William Doyon and Dr. David Connor, as
well as a number of doctoral students, and undergraduates during my time in Dr. Dani’s
lab. Drs. Doyon and Connor have extensive experience in the alcohol field and behavioral
neuroscience, respectively, and helped shape my understanding of the rodent models
used in alcohol research. Dr. Alyse Thomas, a former doctoral student, was a constant
source of intellectual support for me and a fantastic example of successful scientific
training. Of equal import, the aims of my research endeavors were brought to fruition with
the help of Ruthie Wittenberg, a current doctoral student in Dr. Dani’s lab, as well as
Alexandra Croicu and Nikita Shadani, who received their undergraduate degrees in 2019.
Throughout my journey in science I have benefitted from the faculty and research
environment at the University of Pennsylvania. I am filled with gratitude for the guidance
that my former mentors, past rotation advisors, and thesis committee members have
provided for me. The experience I gained, in addition to the thoughtful, insightful, and
critical feedback from my committee have been instrumental to my success. As a student
in the Neuroscience Graduate Group, I have had wonderful opportunities to expand my
individual development and become engaged with the community to disseminate our
knowledge of the brain. In this way, I have gained invaluable friendships with truly
inspirational people.
The road to completing my thesis work has been exacting at times, both personally and
academically. I am indebted to my friends and family for bolstering my confidence in myself
and helping me persevere to see this path to its end. To all of my colleagues, friends, and
family I say thank you, you are my giants.

iii

ABSTRACT
THE ROLE OF MIDBRAIN CHLORIDE ION DYSREGULATION IN ESCALATED
ALCOHOL CONSUMPTION
Blake A. Kimmey
John A. Dani, Ph.D.

Alcohol use is a prominent contributor to global disease burden and a leading cause of
preventable mortality. Long-term severe problem drinking is clinically diagnosed as
alcohol use disorder (AUD), one of the most prevalent neuropsychiatric diseases
worldwide. Despite the persistent public health concern posed by alcohol abuse,
treatments

targeting

specific

brain

mechanisms

impacted

by

and

driving

pathological alcohol use are lacking.
Behavioral animal models have revealed that the mesolimbic dopamine reward pathway
is a critical mediator of alcohol’s reinforcing effects. The ventral tegmental area (VTA) is
a central hub of this reward circuitry and subversion of alcohol-induced neuronal activity
in the VTA has been linked to increased alcohol consumption. Among its many effects in
the brain, alcohol enhances release of the inhibitory neurotransmitter GABA in the VTA.
This acute effect of alcohol is exacerbated by prior alcohol, drug, or stress exposure,
which are all risk factors for subsequent alcohol abuse. For these reasons, the central
hypothesis of this dissertation was that disruptions in alcohol-induced inhibitory GABA
signaling in the VTA contribute to escalated alcohol consumption.
To delineate the mechanisms of disturbed VTA inhibitory transmission that may lead to
increased alcohol consumption, electrophysiological recordings, in vivo pharmacological
iv

manipulations, and alcohol self-administration paradigms were performed in rodents. The
second and third chapters provide evidence that an acute stressor in adulthood or chronic
nicotine exposure in adolescence promote subsequent alcohol self-administration
behavior via chloride ion (Cl-) dysregulation in VTA GABA neurons. Normalizing Clhomeostasis

by

intra-VTA

pharmacological

upregulation

of

the

potassium-Cl-

cotransporter KCC2 prevented the increased alcohol drinking phenotype observed after
stress or nicotine. In the fourth and fifth chapters, rescue of disrupted Cl- homeostasis via
serotonin 2A receptor (5-HT2AR) activation is demonstrated ex vivo and correlated with 5HT2AR agonist-mediated reduction in heavy alcohol consumption.
Collectively, this body of work suggests that dysregulation of VTA Cl- transport, dictated
largely by KCC2 function, increases risk for alcohol abuse. Targeting this form of inhibitory
plasticity represents a novel interventional approach for AUD. Therefore, future work is
needed to identify clinically safe and efficacious pharmacotherapies to reverse
disturbances in midbrain Cl- homeostasis in alcohol-dependent individuals.
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CHAPTER 1
Alcohol Abuse and Underlying Neurocircuitry: A General Introduction
Blake A. Kimmey

The Burden of Alcohol Use and Abuse
Humans have consumed alcohol for thousands of years for the intoxicating and
pleasurable effects of the drug. Whether for celebration, socializing, or relaxation, alcohol
drinking is engrained in society. Cultural and governmental factors, such as social or
religious acceptance, economic prosperity, as well as availability and regulation, all
contribute to rates of alcohol drinking (WHO, 2018). Today, nearly one-third of the global
population, or 2.4 billion people, are current drinkers (Collaborators, 2018). By volume,
yearly total per capita consumption of pure alcohol continues to rise, from 6.4 liters at
present to an estimated 7.0 liters by 2025 worldwide (WHO, 2018). In the United States,
alcohol use is even more prevalent. In 2016, more than 140 million people aged 18 and
older were current alcohol users (Bose, 2018), consuming nearly 9 liters of pure alcohol
per capita each year (Peacock et al., 2018).
Despite the apparent popularity of drinking, alcohol overconsumption is a risk factor for a
number of short- and long-term negative health consequences that contribute to global
disease burden. Indeed, alcohol misuse is a leading cause of preventable disability and
morbidity as more than 200 health conditions have been linked to harmful alcohol drinking,
including liver and pancreatic disease, cardiovascular disease, diabetes, and cancer
(Rehm, 2011; Peacock et al., 2018; WHO, 2018). It follows that harmful alcohol use is a
1

leading cause of mortality around the globe, responsible for an estimated three million
deaths, or 5.3% of all deaths annually (WHO, 2018). Of this number, approximately 88,000
alcohol-attributable deaths occurred in the United States, claiming as many as 2.5 million
years of potential life (Gonzales et al., 2014). Economically, alcohol misuse cost the United
States nearly 250 billion dollars as recently as 2010 (Sacks et al., 2015), further
compounding the societal burden imposed by excessive alcohol drinking.
Binge drinking is the most common form of harmful alcohol use, classified as consumption
of four drinks for women or five drinks for men on the same occasion (Bose, 2018). This
pattern of drinking elevates the blood alcohol concentration to 0.08 g/dL or higher, the
legal limit to operate a motor vehicle in the United States. Blood alcohol concentrations in
this range are associated with motor impairment, confusion, compromised decision
making, memory problems, as well as risk for injury to self or others. Consequently, bingedrinking accounts for approximately 77 percent of costs (191 billion dollars) related to
alcohol misuse annually, including work-related productivity loss and illness, automobile
accidents, criminal justice, and health care (Sacks et al., 2015).
Nevertheless, over 17% of the adult population in the United States report binge drinking
behavior, consuming approximately 17.5 billion total binge drinks annually (Kanny et al.,
2018). Repeated episodes of binge drinking within a month (5 or more days) is termed
heavy alcohol use (Bose, 2018). Approximately 1 in 4 adult binge drinkers in the United
States engage in heavy drinking, defined as 5 or more binge episodes in a month (Bose,
2018). Binge drinking and heavy alcohol use are risk factors for the development of severe
problem drinking, classified as alcohol use disorder (AUD). AUD is a chronic relapsing
brain disease characterized by compulsive alcohol seeking and drinking, loss of control in
limiting one’s intake, and the emergence of a negative motivational state when not using
2

alcohol (Koob, 2014). AUD is one of the most prevalent neuropsychiatric conditions
worldwide (Collins et al., 2011), affecting an estimated 237 million men and 46 million
women (WHO, 2018). In the United States, the prevalence of lifetime AUD among adults
was nearly 30% as defined by the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) (APA, 2013; Gonzales et al., 2014). AUD may be accompanied by other
psychiatric disorders (e.g. major depressive disorder) and by somatic and psychosocial
problems (e.g. violence or suicidal ideation) (Grant et al., 2015; Kranzler & Soyka, 2018).
Alcohol drinking remains an important aspect of society. However, alcohol intoxication is
directly linked to a broad range of health problems as well as social and economic costs.
Recurrent alcohol abuse can precipitate a lifelong struggle with AUD. For these reasons,
continuing research efforts are focused on mitigating the harm posed by excessive alcohol
drinking and AUD. Moreover, preclinical work aimed at identifying factors and neural
mechanisms that promote alcohol abuse are of crucial importance; four such studies will
be described in subsequent chapters.
Environmental Factors Influencing Alcohol Abuse
There is no single known cause for AUD. However, the transition from moderate alcohol
consumption (1-2 drinks per day) to excessive drinking and alcohol use disorder has been
linked to a number of different genetic, physiological, and psychosocial risk factors (APA,
2013). Individual predispositions include, but are not limited to, a family history of
alcoholism (Dawson & Grant, 1998), weak response to alcohol (Schuckit, 1994), and male
sex (Grant et al., 2015). More commonly, environmental factors such as stress (Koob &
Le Moal, 1997) and prior drug use (e.g. alcohol, nicotine) (Barrett et al., 2006) trigger
pathological alcohol use, and are highlighted below.
3

Stress Exposure
Stress is generally defined as any stimulus that disrupts or threatens the body’s internal
homeostatic balance (Chrousos, 2009). Stressors, therefore, are perceived harms that
typically elicit the expectation of a negative impact or outcome (Sinha, 2001; 2008). In
this way, stressors vary across several dimensions, including severity, expectedness,
duration, type of threat, and mental health status (Keyes et al., 2011).
Population-based epidemiological studies reveal a consistent, positive relationship
between stressor severity and frequency with heavy alcohol drinking (Dawson et al.,
2005). For example, the National Epidemiologic Survey on Alcohol and Related
Conditions (NESARC) reported that drinkers who experienced six or more stressful events
in the 12 months prior to interview consumed three times more alcohol on a daily basis
than those drinkers with no stressful events in the preceding year (Dawson et al., 2005).
A variety of life stressors are associated with uncontrolled alcohol use (Stephens & Wand,
2012), such as demanding work environments, familial discord, legal trouble, low income,
as well as health and psychological burdens (Armeli et al., 2000; San Jose et al., 2000;
Perreira & Sloan, 2001).
However, not all populations demonstrate equal vulnerability to stress-induced alcohol
misuse. Multiple factors influence the association between stress and heightened alcohol
use including sex, race, age, socioeconomic status, and individual coping mechanisms.
For example, both men and women tend to drink more after a stressful experience
(Kilpatrick et al., 1997; Keyes et al., 2012). However, men report heavier drinking after
stressful experiences than women (San Jose et al., 2000; Dawson et al., 2005). Among
those experiencing six or more stressful incidents in the past year, the percentage of men
4

binge drinking is approximately 1.5 times greater that of women (Keyes et al., 2012).
Across sexes, racial and ethnic minority stress associated with discrimination correlates
with more severe patterns of alcohol consumption (McCabe et al., 2010; McLaughlin et
al., 2010; Yoo et al., 2010).
Stress experienced across the lifespan can have differential effects on drinking behavior.
Early life is a period of particular vulnerability. Stressors that occur during childhood and
adolescence often produce long-lasting psychological damage, accounting for a large
proportion of adult neuropsychiatric pathology (Green et al., 2010). Correspondingly,
individuals with a history of childhood abuse or neglect demonstrate greater alcohol use
and this risk for harmful alcohol drinking carries into middle adulthood (Widom et al., 2007).
Following both early life and adult stress exposures, people who report drinking to cope
with distress or psychological harm typically engage in solitary, abusive intake over social
drinking (Abbey et al., 1993; Moos et al., 2010; Keyes et al., 2012). In the most severe
case, post-traumatic stress disorder promotes subsequent alcohol abuse as a means to
achieve symptom relief, and is particularly prevalent among combat veterans and victims
of childhood abuse (Helzer et al., 1987; Dube et al., 2002; Schumm & Chard, 2012). In
marked contrast, stressful incidents occurring in old age are not correlated with increased
alcohol drinking, likely due to the overall decrease in alcohol consumption among the
elderly (Skaff et al., 1999).
Stress is commonly cited as a reason for initiation and escalation of alcohol use in
response to the physical or psychological effects of the stress experience (Uhart & Wand,
2009; Keyes et al., 2012). The pervasiveness of stress-alcohol interactions is revealed by
this epidemiology. Individually, psychological and personal stressors can render a drinker
more vulnerable to alcohol abuse. However, the interplay between stress and subsequent
5

alcohol drinking is complex, making targeted intervention difficult. Therefore, mechanistic
studies identifying physiological or pharmacological effects of alcohol that are subverted
by stress exposure are needed. Efforts to achieve this goal are highlighted in the
preclinical studies described in Chapters 2 and 4.
Nicotine Use
Like alcohol, nicotine is one of the most commonly abused legal substances. Smoking
tobacco-containing products and e-cigarettes is addictive, mediated by the reinforcing
effects of nicotine. Smoking poses numerous health consequences including heart and
lung disease, and cancer (National Center for Chronic Disease et al., 2014). In addition,
nicotine use at any age increases the risk for harmful alcohol use (Grucza & Bierut, 2006).
Among those diagnosed with AUD, smoking prevalence is two- to three-fold higher than
in the general population (Dawson, 2000; Grant et al., 2004; Falk et al., 2006). This
comorbidity of alcohol and nicotine abuse is highly prevalent and may exacerbate the
health risk associated with either drug alone (Adams, 2017).
Epidemiological studies have consistently demonstrated that high rates of nicotine use
positively correlate with excessive alcohol consumption (Carmody et al., 1985; Batel et
al., 1995; Barrett et al., 2006). Smoking of nicotine-containing cigarettes versus
denicotinized cigarettes has been shown to promote alcohol drinking (Barrett et al., 2006).
Indeed, smokers drink nearly twice as much alcohol as nonsmokers (Carmody et al.,
1985) and individuals who are nicotine dependent are as much as four times more likely
to have AUD than the general population (Grant et al., 2004).
This interaction between nicotine and alcohol use is complex and can be altered by
numerous factors including genetic background, drug accessibility, social and cultural
6

dynamics, income, and age at first exposure (Schorling et al., 1994; Bobo & Husten, 2000;
Weitzman & Chen, 2005; Acheson et al., 2006; McKee et al., 2007). Strikingly, over 80%
of smokers experiment with cigarettes before the age of 18 (Yuan et al., 2015; Richter et
al., 2017). This early life smoking experience increases the likelihood of heavy drinking
throughout adolescence and adulthood (Harrison & McKee, 2008). Understanding the
neurobiological mechanisms underlying increased alcohol consumption precipitated by
adolescent nicotine exposure is the focus of Chapter 3.
Preclinical Models of Alcohol Consumption
While epidemiological studies are important for determining behavioral correlations in
humans, they fail to elucidate causal relationships between risk factors and alcohol abuse.
Reinforced drug-seeking behavior and intoxication resulting from alcohol exposure is a
conserved phenomenon across a breadth of species, from rodent to human (Sullivan &
Hagen, 2002). This homology in behavioral response to the drug provides multiple levels
of interrogation into the neurobiological mechanisms underlying alcohol abuse.
Preclinical studies conducted in laboratory animals offer rigorous control over
experimental conditions to directly link environmental exposure (e.g. stress, nicotine, or
alcohol) with the development of heavy alcohol use. Rodents (i.e. mice and rats) can
voluntarily consume large quantities of alcohol to reach a state of intoxication in a manner
that parallels human drinking (Ron & Barak, 2016). Thus, rodent models offer excellent
face validity (Spanagel, 2017) and are used to probe the neural mechanisms underlying
different aspects of the human drinking condition through both operant and non-operant
forms of alcohol consumption. Moreover, the parallels in alcohol intake between rodents
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and humans suggests that the brain substrates involved in alcohol taking and seeking
across species is similar (Sanchis-Segura & Spanagel, 2006; Vengeliene et al., 2008)
Operant Alcohol Self-Administration
Procedurally, operant alcohol self-administration requires animals to perform a behavioral
response (e.g. press a lever) to gain limited access to an aqueous solution of alcohol for
oral consumption of the drug. Operant alcohol self-administration typically results in blood
alcohol concentrations that range from 0.02 to 0.08 mg/dL, and is therefore considered a
model of moderate alcohol consumption (Carnicella et al., 2014; Ron & Barak, 2016).
However, higher intake levels are achievable under certain experimental conditions
(Carnicella et al., 2014). This form of alcohol reinforcement draws upon the associative
learning mechanisms inherent to operant conditioning (Panlilio & Goldberg, 2007) by
pairing a learned motor action with delivery of the reward, alcohol (Everitt & Robbins, 2005;
Sanchis-Segura & Spanagel, 2006). The ability of the animal to acquire and maintain the
behavior is reflected in the operant responses and amount of alcohol consumed. Thus,
operant alcohol self-administration offers controlled, quantitative measures of alcohol
drinking behavior.
Establishing operant alcohol self-administration in rodents generally involves two phases
of behavior, acquisition and maintenance (Lynch et al., 2010). During acquisition, the
response requirement for obtaining a small, defined quantity of alcohol is routinely set to
a fixed ratio (FR) schedule of reinforcement. Thus, under a FR1 schedule, the animal must
make one operant response to receive access to alcohol. This operant schedule allows
researchers to assess potential differences in the abuse liability of alcohol following prior
environmental exposure (e.g. stress or nicotine) (Spanagel, 2017). After FR responding is
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maintained, rodents can be transitioned to a progressive ratio (PR) schedule, under which
the response requirement for successive alcohol reinforcements is increased
exponentially. The highest response rate an animal performs to obtain a single alcohol
reinforcer is defined as the break point. In this way, the effort or motivation to seek and
take alcohol can be assessed quantitatively and has been investigated following various
environmental exposures in both rodents and humans (Barrett et al., 2006; Vendruscolo
et al., 2012)
To minimize the potentially aversive stimulus properties of alcohol (e.g. palatability), a
sweetened alcohol solution is often introduced at the outset of alcohol self-administration,
typically using the non-caloric sweetener saccharin (Samson, 1986; Boyle et al., 1994).
By gradually increasing the concentration of alcohol in solution (i.e. fading in), animals
adjust their intake to the taste and sensory cues of the drinking solution allowing for the
operant behavior to be rapidly acquired and the alcohol-reward association to stabilize
and be maintained for the duration of the experiment. Importantly, saccharin can be faded
out and removed from the alcohol solution to allow for the maintenance of alcohol
reinforcement to be examined in the absence of alternative reward cues (e.g. sweet taste).
Finally, following a period of maintenance, operant alcohol self-administration behavior
can be extinguished, by withholding receipt of alcohol reinforcement when the animal
makes a response (i.e. to model abstinence), and reinstated (i.e. to model relapse) (Le et
al., 2000b; Bossert et al., 2013; Funk et al., 2014).
Non-Operant Alcohol Self-Administration
Oral alcohol self-administration that does not require performance of a learned motor
response is the most common behavioral strategy for rodent alcohol consumption in
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laboratory studies. A variety of non-operant models have been developed, including
continuous, intermittent, and limited schedules of access to alcohol that result in moderate
to heavy levels of alcohol ingestion in rodents (Becker & Ron, 2014; Ron & Barak, 2016;
Spanagel, 2017). Generally, non-operant alcohol self-administration occurs in the home
cage of single-housed rodents where animals are given access to two bottles: one
containing a solution of alcohol and the other containing water. Under these conditions,
two-bottle choice drinking allows for quantitative analysis of total volitional alcohol intake
and preference. The inbred mouse line C57BL/6 is frequently used for home-cage drinking
experiments, as this mouse line was found to consume larger doses of alcohol relative to
other mouse strains, with or without the addition of saccharin (Rhodes et al., 2007;
Yoneyama et al., 2008; Rosenwasser et al., 2013).
Moderate or excessive volitional alcohol drinking phenotypes are observed using a
continuous access, two-bottle choice paradigm in rodents. To achieve moderate levels of
consumption, animals typically drink from a 10% (vol/vol) solution of alcohol with no
intervening periods of abstinence (i.e. 24-hour, daily drinking). During continuous access,
rodents do not demonstrate escalation in alcohol drinking behavior over the course of the
experiment and blood alcohol concentrations do not exceed 0.05 g/dL (i.e. 1-5 g/kg/24hr)
(Ron & Barak, 2016). In contrast, continuous access to an increasing progression of doses
of alcohol in solution, ramping from 3% to 20% over several days, results in heavy alcohol
consumption. Animals will increase their total alcohol intake over 24 hours as the dose of
alcohol is increased, reaching levels as high as 15 g/kg/24hr (Ozburn et al., 2013).
Intermittent and limited access models of alcohol drinking were developed to drive
heightened levels of alcohol intake in rodents. Intermittent drinking refers to the schedule
of alcohol delivery: rodents are given 24 hours of access in the home cage, followed by
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24 hours of deprivation (i.e. no alcohol availability) (Hwa et al., 2011). During the first two
weeks of drinking the alcohol dose is increased from 3% to 20%, at which point animals
are maintained on the 20% alcohol solution. Alternating bouts of alcohol drinking and
abstinence, coupled with an increasing alcohol percentage in solution, results in an
escalation in alcohol intake and preference over time, typically peaking in excess of 15
g/kg/24hr (or 0.1 g/dL) in C57BL/6 mice (Hwa et al., 2011; Carnicella et al., 2014; Griffin,
2014). Compulsive alcohol drinking in the face of negative consequences can also be
measured using the intermittent two-bottle choice paradigm. After achieving stable
consumption of alcohol, a bitter tasting compound (i.e. quinine), which is an aversive
stimulus to rodents, is gradually added to the alcohol solution over the course of several
drinking days (Ron & Barak, 2016; Warnault et al., 2016). The emergence of a
perseverative, aversion-resistant drinking phenotype resembles alcohol consumption
patterns of individuals with AUD (Koob & Le Moal, 1997; APA, 2013).
When given access to a single bottle of 20% alcohol solution for limited periods of time,
rodents exhibit elevated, binge-like drinking. Models, such as ‘drinking in the dark’
(Rhodes et al., 2005; Thiele et al., 2014) capitalize on the increased consummatory
behavior of mice during wakefulness (i.e. the dark phase of the 24 hour light cycle), and
thereby achieve blood alcohol concentrations as high as 0.16 g/dL, or twice the legal limit
in humans, in a two to four hour drinking session (Thiele & Navarro, 2014).
Collectively, preclinical models of alcohol consumption were developed to recapitulate
various aspects of human alcohol drinking and AUD. Both moderate and excessive
alcohol self-administration models are crucial in identifying cellular and molecular neural
substrates of vulnerability for AUD. Alcohol self-administration paradigms based on
operant and non-operant responses differ in procedural characteristics, as described
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above. Moreover, these models are differentially sensitive to environmental exposures
(e.g. stress or nicotine) that precede alcohol drinking or manipulation of specific neural
circuits implicated in alcohol drinking behavior (Spanagel, 2017).
Stress and Nicotine Effects on Alcohol Self-Administration
The physiological processes that underlie the stress response in humans are conserved
in rodents. Among these, appropriate secretion of glucocorticoids (i.e. cortisol in humans
and corticosterone in rodents) into the bloodstream is critical to adaptive responses to the
stressor (Herman & Cullinan, 1997). Although epidemiological studies indicate a strong
relationship between stress and excessive alcohol consumption, preclinical studies
examining the impact of stress on alcohol self-administration show mixed results.
Therefore, like stress-induced excessive alcohol drinking observed in humans, animal
models reveal that alcohol consumption may be differentially influenced by stress in
different populations and under different conditions (Spanagel et al., 2014).
Experiments that fail to observe stress-induced increased alcohol consumption are likely
due to procedural differences, heterogeneous stress responses, and limited insight into
variables influencing stress-induced alcohol intake (Becker et al., 2011; Noori et al., 2014).
For example, the timing of stress exposure relative to alcohol presentation can have
dramatically different effects if given proximal to or distant from the start of alcohol selfadministration. Experiments that align better with the temporal dynamics of acute stressinduced glucocorticoid signaling (i.e. on the order of hours) typically observe increased
alcohol self-administration (Noori et al., 2014). For these reasons, experiments should be
designed to minimize variability across and within subjects in order to increase
reproducibility and strengthen the construct validity of stress-induced drinking studies.
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This is accomplished through careful consideration of the type of stressor (Pfau & Russo,
2015), timing of the stressor relative to an alcohol self-administration session (Noori et al.,
2014), mitigation of home cage or environmental stress (e.g. single housing or
homeostatic disturbances) (Edwards et al., 2013), and rodent strain (e.g. high or low
consuming; stress resilient or susceptible) (Golden et al., 2011) used in each study.
To examine the effects of nicotine on alcohol consumption in rodents, animals are either
passively exposed via peripheral injection or subcutaneous mini-pump or actively selfadminister nicotine (e.g. intravenously). Non-contingent, passive administration offers
increased precision with drug dosing and timing of exposure whereas active selfadministration offers greater insight into individual preference and vulnerability (Matta et
al., 2007). Under either administration paradigm, rodent models generally agree with the
human literature and demonstrate that nicotine exposure can increase subsequent alcohol
self-administration (Le et al., 2000a; Le et al., 2003; Bito-Onon et al., 2011; Doyon et al.,
2013a; Leao et al., 2015), with some exceptions (Nadal & Samson, 1999; Sharpe &
Samson, 2002). As with stress-alcohol studies, procedural differences exist across
experiments such as route of nicotine administration, duration of exposure (e.g. acute or
chronic), animal age, and the phase of alcohol drinking under consideration.
Early life nicotine exposure has longer-lasting influences on subsequent alcohol selfadministration (Kemppainen et al., 2009; Lárraga et al., 2017). Adolescent rats exposed
to nicotine or nicotine with alcohol demonstrated significantly higher alcohol consumption
in adulthood (Lárraga et al., 2017). Behavioral studies examining nicotine-alcohol
interactions thus provide evidence in favor of nicotine exposure, particularly during
adolescence, influencing subsequent responses to alcohol (Doyon et al., 2013a;
Ostroumov & Dani, 2018a).
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Although the underlying neurocircuits and molecular mechanisms mediating the
interactions between stress or nicotine and subsequent alcohol abuse remain largely
obscure, revealing how the pharmacological effects of alcohol are altered by prior
environmental exposure may lead to novel therapeutic interventions for AUD.
Midbrain Reward Neurocircuitry Underlying the Behavioral Effects of Alcohol
The Mesolimbic Dopamine Pathway
Alcohol has diverse effects throughout the body when consumed. However, the behavioral
reinforcement that is experienced following alcohol ingestion arises from the cellular and
molecular actions of alcohol in the brain’s reward circuitry (You et al., 2018), which also
regulates mood, emotional responses, and incentive-based behavior (Fields et al., 2007;
Grace et al., 2007; Schultz, 2007).
Engagement of the reward neurocircuitry, also referred to here as the mesolimbic
dopamine (DA) pathway, has been shown to be crucial for identifying rewards in the
environment and initiating actions to consume or exploit those rewards (Koob & Le Moal,
2008). Consequently, the acquisition of operant alcohol self-administration involves the
mesolimbic DA pathway (Rassnick et al., 1992; Ikemoto et al., 1997; Koob & Volkow,
2010; Lammel et al., 2014) and pharmacological manipulation of DA signaling disrupts
alcohol drinking (Pfeffer & Samson, 1988). Moreover, this brain reward circuitry is a
substrate for stress hormones and nicotine (Koob & Le Moal, 2001; Laviolette & van der
Kooy, 2004b), both of which modulate alcohol self-administration, as previously
discussed. For example, alcohol directly activates stress pathways (e.g. the hypothalamicpituitary-adrenal axis) to elicit glucocorticoid release and the development of compulsive
alcohol consumption involves activation of glucocorticoid receptors in the mesolimbic DA
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pathway (Ellis, 1966; Vendruscolo et al., 2012). Moreover, nicotine exposure increases
glucocorticoid signaling in the brain (Fu et al., 1997) and thereby alters subsequent
DAergic responses to alcohol in a manner that facilitates alcohol self-administration
(Doyon et al., 2013a).
Because dysregulation of mesolimbic circuitry and DA signaling is a characteristic feature
of drug addiction (Volkow et al., 1996; Volkow et al., 2007; Luscher & Malenka, 2011),
experience-related adaptations in alcohol-induced signaling in the mesolimbic DA system
may be an important mediator of the behavioral interaction between environmental
exposures and subsequent excessive alcohol consumption (Piazza et al., 1993; Gonzales
et al., 2004). The primary source of DA within the brain reward circuitry is the ventral
tegmental area (VTA) (You et al., 2018).
The Ventral Tegmental Area: A Hub for Alcohol Reward Processing
The mesolimbic DA pathway is the best characterized reward circuit composed of DAreleasing neurons in the midbrain ventral tegmental area (VTA), the primary source of DA
within the circuit, that project to the nucleus accumbens (NAc) situated in the ventral
striatum of the forebrain (Russo & Nestler, 2013). VTA release of DA in the NAc is involved
in the initial reinforcement of alcohol drinking, as NAc lesions prevent acquisition of alcohol
self-administration behavior (Ikemoto et al., 1997).
The VTA is composed primarily of DA and GABA neurons, accounting for approximately
65% and 30% of all VTA neurons, respectively, as well as a minor population of glutamate
neurons (<5%) (Hnasko et al., 2012; Morales & Margolis, 2017; Bouarab et al., 2019).
Subsets of these neuron types co-release other neurotransmitters (e.g. DA-glutamate
neurons) (Hnasko et al., 2010; Stuber et al., 2010; Root et al., 2018). DA and GABA
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neurons in the VTA have been extensively implicated in alcohol-related reward and may
contribute to the reinforcing properties of alcohol in a subregion-specific manner.
Topographically, the VTA is divided into five subregions: rostral linear nucleus of the
raphe, interfascicular nucleus, caudal linear nucleus, paranigral nucleus, and
parabrachial pigmented nucleus (Oades & Halliday, 1987). The exact percentage of
neuron types as well as the ratios of DA to GABA neurons varies between VTA subregion
(Swanson, 1982; Nair-Roberts et al., 2008; Yamaguchi et al., 2011; Mazei-Robison &
Nestler, 2012). The ventro-caudal aspects of the VTA (i.e. in the posterior paranigral
and parainterfascicular nuclei) contain nearly equal numbers of DA and GABA neurons,
while dorsally (e.g. in the parabrachial nucleus) and rostrally, DA neurons far outnumber
GABA neurons. Behaviorally, this caudal to rostral distribution is important for alcohol
reinforcement as rats will directly self-administer alcohol into caudal, but not rostral
subregions of VTA (Rodd et al., 2005).
Within this anatomical framework, DA and non-DA neurons demonstrate differential
forebrain targeting (Beckstead et al., 1979; Phillipson & Griffiths, 1985; Brog et al., 1993;
Hasue & Shammah-Lagnado, 2002; Lammel et al., 2008). For example, the medial shell
subregion of the NAc receives robust DA input from the caudo-medial VTA, while rostromedial and lateral VTA DA efferents more prominently project to the lateral shell of the
NAc (Ikemoto, 2007; Lammel et al., 2008). In addition, non-DA neurons (e.g. glutamate
neurons) and GABA neurons form local synapses with other VTA neurons and project to
diverse forebrain areas such as the NAc, ventral pallidum, lateral hypothalamus, lateral
habenula, and prefrontal cortex (PFC) (Van Bockstaele & Pickel, 1995; Carr & Sesack,
2000; Dobi et al., 2010; Yamaguchi et al., 2011; van Zessen et al., 2012; Taylor et al.,
2014; Bouarab et al., 2019).
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Numerous afferent inputs to the VTA modulate the activity of DA and GABA neurons and
have been implicated in a range of motivated behaviors from drug or food seeking to
regulation of aversion (Jhou et al., 2009b; Nieh et al., 2016; Oliva & Wanat, 2016). Major
excitatory, glutamatergic inputs arise from the laterodorsal and pendunculopontine
tegmentum, lateral hypothalamus, bed nucleus of the stria terminalis, and prefrontal cortex
(Carr & Sesack, 2000; Omelchenko & Sesack, 2005; Massi et al., 2008; Watabe-Uchida
et al., 2012; Kallo et al., 2015). Additionally, serotonergic (5-HT) neurons of the dorsal
raphe nucleus transmit mainly excitatory, metabotropic signals to VTA neurons (Herve et
al., 1987; Esposito, 2006). Prominent inhibitory, GABAergic innervation of the VTA is
provided by the rostromedial tegmental nucleus, ventral pallidum, laterodorsal
tegmentum, bed nucleus of the stria terminalis, lateral hypothalamus, lateral habenula,
amygdala, and the NAc (Rahman & McBride, 2000; Geisler & Zahm, 2005; Jhou et al.,
2009a; Xia et al., 2011; Janak & Tye, 2015; Kallo et al., 2015).
VTA afferents demonstrate some selectivity with respect to post-synaptic target, which
contributes to their behavioral roles. For example, the excitatory inputs from the
laterodorsal tegmentum mainly innervate VTA DA neurons (Omelchenko & Sesack, 2005;
Lammel et al., 2012). The ventral pallidum provides inhibitory input to both DA and nonDA neurons in the VTA (Hjelmstad et al., 2013). The bed nucleus of the stria terminalis,
which plays a role in responding to both fear and stress, modulates both GABA and DA
neurons via direct glutamatergic innervation of GABA neurons and indirect inhibition of DA
neurons (Kudo et al., 2012). Similarly, glutamate and GABA afferents arising from the
lateral hypothalamus innervate DA and GABA neurons respectively (Poller et al., 2013;
Nieh et al., 2016). Inhibitory GABAergic inputs from the rostromedial tegmental nucleus
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target primarily DA neurons (Lecca et al., 2012) and those from the NAc target both DA
and GABA neurons (Xia et al., 2011; Edwards et al., 2017; Yang et al., 2018).
Modulation of VTA Signaling by Alcohol
Dopamine
DA neurons are the most well studied class of cells in the VTA and express heterogeneous
electrophysiological properties across subregions (Lammel et al., 2008). Conventional DA
neurons, found primarily in the lateral VTA, are distinguished by the presence of a
prominent h-current in addition to displaying various modes of firing activity in vivo that
include tonic and phasic patterns (Grace & Bunney, 1984; Hyland et al., 2002; Zhang et
al., 2010). Tonic activity involves slow irregular or pacemaker patterns of action potential
firing (i.e. < 5 Hz ex vivo, <10 Hz in vivo), whereas phasic activity involves short-latency
bursts of action potentials (typically 2–4 action potentials, each separated by less than 80
ms). DA neurons in brain slices do not generally display phasic activity (Fig. 1.1A, B)
(Grace & Onn, 1989), indicating that burst firing depends on afferent synaptic inputs that
are likely disrupted in slice preparations. The transition from tonic to phasic firing in vivo
is hypothesized to be a key mechanism for transmitting behaviorally relevant information
related to drug reinforcement (e.g. cues signaling reward availability) (Schultz, 1998;
Montague et al., 2004; Grace et al., 2007).
Alcohol stimulates release of DA in the NAc, but not through local actions of alcohol in the
NAc itself (Imperato & Di Chiara, 1986; Yoshimoto et al., 1992; Samson & Hodge, 1993),
suggesting that the rewarding effects of alcohol occur within the VTA, the source of NAc
DA. Indeed, alcohol excites DA neuron tonic action potential firing and bursting in the VTA
as observed experimentally both in vivo and ex vivo (Gessa et al., 1985; Brodie et al.,
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1990; Diana et al., 1992; Brodie & Appel, 1998; Foddai et al., 2004; Morikawa & Morrisett,
2010). However, this effect is modulated by prior experience. For example, reduced tonic
DA concentrations in the NAc have been observed after withdrawal from protracted
alcohol exposure (Schindler et al., 2016). In contrast, phasic VTA DA neuron signaling is
enhanced by prior alcohol experience (Spoelder et al., 2015).
There is also subregion variability in alcohol-induced DA neuron activation. Medial and
caudal DA neurons in the VTA (e.g. in the rostral linear and interfascicular nuclei) respond
more robustly, and in a concentration-dependent manner to alcohol, than DA neurons
elsewhere in the VTA (Brodie et al., 1990; Mrejeru et al., 2015). Furthermore, caudomedial DA neurons showed lower threshold increases in action potential firing in the
presence of alcohol. Higher doses of alcohol (>20 mM) were required to elicit increased
firing rates in lateral VTA DA neurons (e.g. in the parabrachial pigmented and paranigral
nuclei) (Mrejeru et al., 2015).
Presently, a single, specific target responsible for alcohol-induced excitation of VTA DA
neurons has not been identified (You et al., 2018). However, multiple synaptic and nonsynaptic influences of alcohol have been implicated in the overall excitatory effect of
alcohol on DA neurons (Morikawa & Morrisett, 2010). For example, mild to moderate
levels of alcohol (5-50 mM) potentiate GABAergic and suppress glutamatergic synaptic
transmission onto DA neurons (Theile et al., 2008; Dopico & Lovinger, 2009; Theile et al.,
2011). In contrast, alcohol enhances the function of numerous ion channels that promote
DA neuron excitability, including L-type calcium channels, hyperpolarization-activated
cation channels, and G protein-coupled inwardly-rectifying potassium channels, as well as
nicotinic acetylcholine receptors (Luscher & Ungless, 2006; McDaid et al., 2008; Herman
et al., 2015). In fact, increased DA neuron firing in response to alcohol is likely mediated
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by an alteration in an intrinsic property, as this effect is not diminished when DA neurons
are isolated from synaptic inputs (Brodie et al., 1999; Nimitvilai et al., 2016).
GABA
Substantial evidence implicates a role of VTA GABA signaling mechanisms in alcohol selfadministration behavior (Boyle et al., 1993; Chester & Cunningham, 2002; Kumar et al.,
2009). GABAA receptors (GABAARs) are a target of alcohol’s in vivo effects as alcohol
binds to specific amino acid residues on GABAARs that results in enhanced anion
conductance through the receptor channel (Harris, 1999; Glykys et al., 2007). In ex vivo
slice preparations, alcohol increases presynaptic GABA release onto DA neurons (Theile
et al., 2008) This enhancement in presynaptic GABA release is thought to involve 5-HT
receptor or stress signaling pathways (Nie et al., 2004; Theile et al., 2008).
A principal source of inhibitory input onto VTA DA neurons arises from local GABA
neurons (van Zessen et al., 2012), suggesting that changes in alcohol-induced inhibitory
transmission onto DA neurons could be mediated, at least in part, by adaptations in VTA
GABA neurons. In general, VTA GABA neurons display distinct electrophysiological,
morphological, and molecular characteristics from conventional lateral VTA DA neurons
(Fig. 1.1C, D). Notably, VTA GABA neurons lack prominent h-current and demonstrate
higher action potential firing rates than DA neurons (>7 Hz ex vivo, >10 Hz in vivo) with
a relatively short action potential duration (Steffensen et al., 1998; Korotkova et al., 2006;
Zhang et al., 2010; Li et al., 2012; Liu et al., 2012).
In vivo electrophysiological recordings from putative VTA GABA neurons indicate that
GABAergic responses to alcohol can vary as a result of prior alcohol, stress, or drug
exposures. For example, GABA neurons can show transient inhibition and excitation
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during a single recording (Gallegos et al., 1999). This biphasic response of GABA neurons
likely arises from the dose of alcohol and the timing between injections (Gallegos et al.,
1999; Steffensen et al., 2009).
Plasticity in VTA GABA Signaling as a Mechanistic Target for Alcohol Abuse Intervention
Alcohol exposure induces a long lasting (> 1 week) potentiation of inhibitory signaling in
the VTA when administered in vivo (Melis et al., 2002). This prolonged enhancement in
GABA transmission arising from acute alcohol injection corresponds with an increase in
subsequent alcohol drinking behavior in mice (Melis et al., 2002). Repeated or chronic
alcohol exposure has similar effects as protracted withdrawal from alcohol drinking in
adolescent rats enhanced the frequency of GABA release onto VTA DA neurons
(Schindler et al., 2016). One plausible source of this enhanced inhibitory drive onto DA
neurons are local VTA GABA neurons.
During withdrawal from acute or repeated alcohol exposure, VTA GABA neurons display
impaired GABAAR function manifested as GABA neuron action potential firing that is
resistant to GABAAR agonist treatment (Nelson et al., 2018). Likewise, following chronic
alcohol exposure (i.e. peripheral injection or inhalation), VTA GABA neurons demonstrate
no change in action potential firing, or tolerance, to the acute inhibitory effect of alcohol
administered in vivo (Gallegos et al., 1999). However, this effect can vary based on
experimental protocols (e.g. anesthetized versus awake) (Ludlow et al., 2009).
Plasticity in VTA GABA neuron activity in response to alcohol may arise from the complex
relationship of stress hormones with inhibitory signaling mechanisms. Accumulating
evidence suggests that midbrain GABAAR function, a prominent pharmacological target of
alcohol, may be enhanced by stress hormones or prior drug experience (e.g. nicotine
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promoting glucocorticoid release) as observed after alcohol exposure itself. Such plasticity
may occur via changes in GABA synthesis, release mechanics, expression of specific
GABAAR subunits, or disruptions in the inhibitory chloride ion (Cl-) gradient in VTA GABA
neurons (Laviolette & van der Kooy, 2001; 2004a; Ting et al., 2009; Doyon et al., 2013a;
Ting et al., 2013; Maguire, 2014). Increased inhibitory signaling is hypothesized to
contribute to blunted mesolimbic DA signaling that facilitates drug seeking behavior (Melis
et al., 2005). Correspondingly, systemic blockade of glucocorticoid receptors prior to
nicotine exposure or local inhibition of GABAARs in the VTA decreases alcohol selfadministration (Nowak et al., 1998; Doyon et al., 2013a).
Ultimately, the precise mechanisms by which alcohol-induced GABA neuron activity is
altered by prior experience (e.g. stress or drug exposure) and the role of the underlying
neuroadaptations in driving escalated alcohol consumption is presently unknown.
Therefore, studies focusing on GABA plasticity mechanisms in the VTA and their
relationship to drug seeking behavior provide inroads for the development of novel
pharmacotherapies (Ostroumov & Dani, 2018b) and is the approach taken with the
experimental work presented in this dissertation.
Summary
Alcohol use is pervasive. The reward experienced when consuming alcohol promotes
excessive intake, despite the clear negative health consequences of such behavior for the
individual and society. Certain life events or exposures can facilitate harmful alcohol
drinking, such as stress or nicotine use, yet the neurobiological substrates responsible for
this transition to escalated alcohol consumption remain obscure. Therefore, animal
models of alcohol self-administration are used to probe the neurocircuitry that is common
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to alcohol, stress, and nicotine. This work reveals the importance of the mesolimbic DA
pathway in experiencing alcohol-related reinforcement and its potential role as a locus for
interactions with prior environmental exposures. In particular, the VTA, the principal
source of DA in this reward circuitry, demonstrates alterations in DA and GABA neuron
activity that is paralleled by enhanced inhibitory GABA drive onto DA neurons and
increased alcohol self-administration behavior.
Identifying the underpinnings of this plasticity and reverting those mechanisms to the basal
state may offer novel therapeutic options for alcohol abuse. To this end, the ensuing work
presented in this dissertation identifies a previously unidentified form of inhibitory plasticity
in the VTA that promotes subsequent alcohol consumption. A neuromodulatory pathway
is then revealed and targeted to correct dysregulated inhibitory signaling in the VTA and
reduce escalated alcohol drinking.
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Figures

Figure 1.1. VTA neuron identification ex vivo.
(A) Using the cell-attached and whole-cell patch configurations, VTA GABA neurons in the lateral
VTA were electrophysiologically identified followed by immunohistochemical confirmation at the
end of experiments. Lateral VTA GABA neurons demonstrate fast, spontaneous action potential
firing rates (> 7Hz, left panel) and lack a prominent h current (Ih, center panel). Neurobiotin backfill
labeling revealed that neurons with these electrophysiological properties are not immunoreactive
for tyrosine hydroxylase (TH), consistent with a non-DAergic phenotype, which is consistent with
GABA neurons in this area. (B) To confirm the identification criteria outlined above, a VGAT-Cre
mouse received bilateral intra-VTA infusions of an adeno-associated virus (AAV) expressing eYFPtagged channelrhodopsin (ChR2, left panel). A representative recording from an eYFP-positive
neuron (right panel), displaying electrophysiological properties described above, demonstrated
blue light-induced increased firing, matching the stimulation frequency (20Hz). (C) VTA DA neurons
in the lateral VTA are electrophysiologically and immunohistochemically distinct from GABA (or
non-DAergic) neurons. DA neurons demonstrate slower, spontaneous pace-maker firing (1-5Hz,
left panel), and a prominent Ih (center panel). Neurobiotin-labeled DA neurons were
immunoreactive for TH, consistent with a DAergic phenotype. (D) In parallel with the experiment
performed in (B), an eYFP-negative VTA DA neuron with the above electrophysiological
characteristics was patched in a VGAT-Cre mouse expressing eYFP-tagged ChR2 (left panel). A
representative DA neuron recording revealed blue light-induced suppression of action potential
firing (right panel).
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Abstract
Stress is a well-known risk factor for subsequent alcohol abuse, but the neural
mechanisms underlying interactions between stress and alcohol remain largely unknown.
We demonstrate in rodents that pre-exposure to stress attenuates alcohol-induced
dopamine responses and increases alcohol self-administration. The blunted dopamine
signaling resulted from ethanol-induced excitation of GABA neurons in the ventral
tegmental area. Excitation of GABA neurons was mediated by GABAA receptor activation
and involved stress-induced functional downregulation of the K+-Cl- cotransporter, KCC2.
Blocking stress hormone receptors or enhancing KCC2 function prevented the attenuated
alcohol-induced dopamine response and prevented the increased alcohol selfadministration. These results demonstrate that stress alters the neural and behavioral
responses to alcohol through a neuroendocrine signal that shifts inhibitory GABA
transmission toward excitation.
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Introduction
Excessive alcohol use is among the leading causes of preventable death worldwide
(WHO, 2014). While many variables contribute to the development of alcohol use disorder
(AUD), exposure to stressful life events represents a significant risk factor (Keyes et al.,
2012). Stress increases alcohol consumption in alcohol-dependent and non-dependent
populations (Ayer et al., 2011; Thomas et al., 2011; Tamers et al., 2014), and stress is
thought to underlie a transition to pathological drug (Koob & Le Moal, 2005).
Stress-induced changes in alcohol use likely arise from an interaction between the stress
and reward systems of the brain (Uhart & Wand, 2009; Spanagel et al., 2014). At the
cellular level, both stress hormones and ethanol influence the DA system by direct actions
on DA neurons or indirectly via changes in excitatory and inhibitory synaptic inputs (Saal
et al., 2003; Niehaus et al., 2010). Stress hormone signaling also may alter midbrain
GABAA receptor signaling, but the molecular mechanism underlying this adaptation has
not been identified and may arise from changes in GABA synthesis, in release, or in
expression of specific GABAA receptor subunits (Maguire, 2014). Alternatively, acute
stress exposure has been shown to induce a paradoxical shift toward excitatory GABAA
receptor signaling within the HPA axis by altering the intracellular anion homeostasis
(Hewitt et al., 2009; Sarkar et al., 2011). Given that the GABAA receptor is a target of
ethanol, we postulated that alterations in GABAA receptor transmission could contribute
to an interaction between stress and ethanol self-administration.
To examine the interaction between stress and ethanol, we exposed drug-naive rats to
stress and then measured their subsequent ethanol intake. Concomitant with increases in
ethanol self-administration, we show that acute stress attenuates ethanol-induced VTA
DA neuron firing. These glucocorticoid receptor-dependent effects on DA signaling were
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mediated by an increase in VTA GABAergic inhibition onto DA neurons. Stress induced
the functional downregulation of KCC2 in VTA GABA neurons, shifting GABAA receptor
signaling from inhibition towards excitation. Pharmacological activation of KCC2 restored
the GABAergic circuitry and DA neuron signaling and prevented the escalation in ethanol
self-administration induced by stress. These results indicate that a shift toward excitatory
GABA signaling within the mesolimbic system is associated with increased drinking after
exposure to stress.
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Methods and Materials
Animals
Male Long-Evans rats (Harlan-Sprague) weighing 300-500 g were used for in vivo studies.
All animals were handled at least 5 days prior to the onset of surgery/behavioral testing
and were singly housed in a quiet, temperature- and humidity-controlled satellite facility
under at 12-hour light/dark cycle. Rats had food and water available ad libitum in their
home cage and were rewarded with sweetened cereal when handled. All procedures were
carried out in compliance with guidelines specified by the Institutional Animal Care and
Use Committee at University of Pennsylvania.
Drugs and Experimental Design
Unless otherwise noted, all drugs were obtained from Sigma Aldrich and were dissolved
in sterile saline. CLP 290 was a generous gift from Drs. Y. De Koninck and A. Castonguay
(Laval University, Quebec, Canada). CLP 290 is a carbamate prodrug of CLP257 (Gagnon
et al., 2013). Driven by the findings of carboxylesterase expression in the brain (Yamada
et al., 1994; Yamada et al., 1995; Holmes et al., 2009; Jones et al., 2013) and by the
knowledge that carbamate bonds can be broken even in brain extracts (Fernandez et al.,
2000; Fernandez et al., 2003), we hypothesized that CLP290 would be effective even
when applied locally in the VTA. Before injecting CLP290 into the VTA, we showed that
incubation of VTA brain slices with CLP290 recovered the chloride ion (Cl-) homeostasis
after stress.
RU486 (40 mg/kg) was dissolved in DMSO and administered intraperitoneally (i.p.) 15 min
before stress (Saal et al., 2003). All VTA microinfusions were administered at a flow rate
of 0.5 µL/min for a duration of 2 min. The injector was removed after an additional 1-2
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minutes to permit diffusion away from the injection site. For VTA microinfusion
experiments, RU486 was first dissolved in DMSO (2 mg/ml) then diluted in ACSF to a final
concentration of 2 µg/ml in 10% DMSO. CLP290 was first dissolved in DMSO (1 mM) then
dissolved in ACSF to a final concentration of 40-50 µM in 5% DMSO. Intra-VTA
microinfusions of CLP290 occurred 15-30 min before ethanol self-administration. Upon
experiment completion, infusions sites were identified postmortem by the location of the
injectors in the tissue. Infusions outside the VTA were used for comparison as a negative
control. Chicago Sky Blue was infused into the VTA to estimate spatial diffusion of the
drugs.
Stressed animals were subjected to a 1 hour of immobilization in a clear cylindrical
Broome-style restrainer. Immobilization potently activates the stress hormone systems
(Pitman et al., 1988). Behavioral responses to prolonged immobilization include increased
vocalization, dander release, defecation, and urination (DeTurck & Vogel, 1982). Animals
that did not show defecation were excluded from the study. Restraint stress typically
occurred between 5-8 P.M., towards to the beginning of the animals’ dark cycle and 1520 hours prior to ethanol exposure or testing. The 15-hour timeframe between the stress
and the ethanol exposure was chosen to examine the long-term effects of acute stress on
alcohol responses and to allow the animals to recover from any physical discomfort
experienced during the restraint.
Operant Ethanol Self-Administration
Standard operant chambers (Med Associates Inc., St. Albans, VT, USA) were used for the
self-administration experiments. Illumination of interior chamber light and presentation of
lever accompanied the start of each session. Depression of the lever triggered 15 sec of
access to a retractable drinking spout (a fixed ratio-1 reinforcement schedule). Three rats
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in the stress treatment group responded for ethanol on a single fixed ratio-4 schedule.
Ethanol intake in these rats was not significantly different from other rats in the same
group. Each drinking session lasted 60 min/day and occurred daily in most cases, with an
occasional day off. Spout licks were recorded by a lickometer.
Animals were initially water-restricted overnight and trained to lever press for a saccharin
solution (0.125%, w/v). Once trained, the animals were no longer water restricted and their
baseline saccharin intake was monitored for at least 3 days until intake was stable (less
than 20% variation in the 2 days preceding ethanol exposure). Importantly, to reduce
variability within and between groups, animals were excluded if their saccharin intake was
below 5 ml or above 15 ml on average per session. If the animals underwent surgery,
saccharin intake was re-established. The effects of stress on acquisition of ethanol selfadministration were then measured. Ethanol was introduced into the saccharin drinking
solution in the following way: 2% ethanol on day 1 and 4% ethanol for all subsequent days
(Fig 1). Consumption was monitored by measuring the volume of liquid in the drinking
bottle before and after the session. Lever presses, lickometer responses, and body weight
were also measured daily. To achieve consistent behavioral results with this protocol, it is
imperative to maintain a quiet, stress-free environment for the animals. Importantly, noise
in the animal facility should be kept to a minimum and the animals should be calm and at
ease with their handlers.
To assess whether the effect of stress was specific to ethanol and not related to the
saccharin in the drinking solution, we included a separate control group that responded
for saccharin alone (no ethanol) (n = 8). This saccharin control group did not consume
significantly more fluid after stress exposure compared to their pre-stress baseline: 10.7
± 1.3 ml/session before stress, 11.6 ± 1.1 ml/session after stress (p > 0.05). Moreover,
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saccharin intake after stress was not statistically different from intake in the non-stressed
ethanol control group over a comparable number of days. As an additional saccharin
control experiment, we faded saccharin out of the ethanol solution over a period of 5 days.
After fading out the saccharin completely, a difference in ethanol intake between control
and stress groups was still present. For the analysis of blood-ethanol levels, blood
samples were taken immediately following the completion of the 60-min self-administration
session (within 10 min) and stored in a sealed vial. Blood samples were analyzed on the
same day by gas chromatography-mass spectrometry (Atlantic Diagnostic Laboratories,
Bensalem, PA).
Surgical procedures
Cannulation surgeries were performed for self-administration experiments as described
previously (Doyon et al., 2013a). For behavioral studies, animals were implanted with
bilateral cannulae (30G, Plastics One) targeting the VTA (mm from Bregma: AP -5.8, ML
±0.8, DV -6.5). Recovery from surgery took approximately 3-5 days and was accompanied
by daily handling and stable increases in body weight.
Histology
The rats were deeply anesthetized with a combination of Ketamine and Xylazine (0.1
mL/100 g bodyweight). Saline was then perfused through the heart, followed by 10%
formalin (v/v). The brains were removed and immersed in 10% formalin for at least 2 days.
The brains were cut into 75-μm coronal sections on a vibratome (Leica Microsystems Inc.,
Buffalo Grove, IL, USA) and stained with cresyl violet to determine the anatomical
placements of the microinfusion injectors.
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In Vivo Electrophysiology
Rats were anesthetized with isoflurane and implanted with a catheter in jugular vein.
Animals were positioned on a stereotaxic apparatus and an incision in the middle was
made to expose the skull. A burr holes were drilled to accommodate recording and ground
electrodes. Rat body temperature was maintained throughout experiment at 37 ºC using
isothermal pad (Braintree Scientific, MA, USA).
Electrodes were pulled on a horizontal puller (Sutter Instrument, CA, USA) from filamentcontaining borosilicate glass (0.68 mm ID, 1.2 mm OD; WPI). Electrodes were backfilled
with 0.5M Na+-acetate and 2% Chicago Sky Blue (5 - 15 MΩ). Electrodes were slowly
lowered with a micromanipulator and positioned in the lateral VTA (coordinates 5.3 – 6.0
mm posterior from bregma, 0.8 – 1.4 lateral to midline and 7.5 – 8.5 ventral to brain
surface). Electrical signals were recorded using AM Systems Model 1700 amplifier (WA,
USA), filtered at 0.3 – 5 kHz and monitored using pClamp 8.0 (Molecular Devices, CA,
USA) and audiomonitor (Grass Instruments).
DA neurons were recorded in the lateral VTA and identified based on their
electrophysiological and pharmacological properties. Putative DA neurons exhibited low
frequency spontaneous firing (< 10 Hz, irregular or bursting), broad action potential
waveform (> 3 ms) and sensitivity to D2 receptor ligands (Ungless & Grace, 2012; Eddine
et al., 2015).
After 6-20 min of stable neuronal recording (basal activity), 0.3 g/kg dose of ethanol was
injected i.v. every 3 minutes, so that the last administered dose was equal to the sum of
the drug already received, and the cell activity was recorded. Only one cell was recorded
per rat. Drug-induced modifications of the basal activity were calculated in percentage for
34

the 3 minute period following each administration and compared with the pre-drug
baseline. Following ethanol administration quinpirole and eticlopride were injected i.v.
(0.25 mg/kg) for pharmacological identification of VTA neurons.
After recording, cell location was labeled by application of Chicago sky blue dye. The dye
was injected via administering positive pressure (1-2 min) through the suction port in
microelectrode holder. At the end of experiment brains were kept in 10% formalin for at
least a day. The brains were cut into 75-μm coronal sections on a vibratome (Leica
Microsystems Inc., Buffalo Grove, IL, USA) and stained with cresyl violet to verify
recording site by light microscopy.
Midbrain Slices and Electrophysiology
Horizontal slices (230 μm) containing the VTA were cut on a vibratome (Leica
Microsystems) from Long-Evans rats (21–30 days old) in ice-cold, oxygenated (95%
O2/5% CO2) high-sucrose ACSF (in mM): 205.0 sucrose, 2.5 KCl, 21.4 NaHCO3, 1.2
NaH2PO4, 0.5 CaCl2, 7.5 MgCl2, 11.1 dextrose. Immediately after cutting, slices were
transferred to normal ACSF buffer (in mM): 120.0 NaCl, 3.3 KCl, 25.0 NaHCO3, 1.2
NaH2PO4, 2.0 CaCl2, 1.0 MgCl2, and 10.0 dextrose, 20.0 sucrose. The slices were
constantly oxygenated (95% O2/5% CO2) and maintained at 32°C in ACSF for 40 min,
then at room temperature for at least 60 min. For incubation experiments, slices were
bathed in corticosterone (1 μM), RU486 (10 μM) or CLP290 (10 μM) for an additional hour
(Pitman et al., 1988; Gagnon et al., 2013; Yoshiya et al., 2013). To perform
electrophysiological recordings, slices were transferred to a holding chamber and
perfused with normal ACSF at a constant rate of 2-3 ml/min at 32°C. Patch electrodes
made of thin-walled borosilicate glass (1.12mm ID, 1.5 mm OD; WPI) had resistances of
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1.0–2.0 MΩ when filled with the internal solution (in mM): 135.0 KCl, 12.0 NaCl, 2.0 MgATP, 0.5 EGTA, 10.0 HEPES, and 0.3 Tris-GTP, pH 7.2–7.3.
DA neurons were identified in the lateral VTA by their morphology (> 20 μm soma size),
low firing frequency (1–5 Hz), and the presence of a large Ih current, which together
correlate (> 94%, 34 of 36) with tyrosine hydroxylase (TH)-positive cells (Chen et al., 2008;
Zhang et al., 2010). In contrast, VTA GABA neurons were identified by the combination of
factors including small somata size, high firing rate (> 7 Hz), and the lack of Ih current.
Cells with these properties were consistently TH-negative (> 95%, 47 of 49) (Klink et al.,
2001; Korotkova et al., 2006; Margolis et al., 2006).
The firing rates of VTA DA and VTA GABA neurons were recorded in cell-attached
configuration in passive voltage-follower mode. Contributions of ionotropic glutamatergic
or GABAergic synaptic inputs to ethanol (50 mM) induced alterations in firing rate were
assessed with the AMPA and NMDA-type glutamate receptor antagonists 6,7dinitroquinoxaline-2,3-dione (DNQX, 20 μM) and DL-2-amino-5-phosphonopentanoic acid
(AP5, 50 μM; Tocris Bioscience) and the GABAA-receptor antagonist, picrotoxin (50-100
μM). After each cell-attached experiment, recordings were converted to the whole-cell
configuration and Ih current was measured. Some cells were also backfilled with
neurobiotin for immuno-identification. For repetitive synaptic stimulation recordings in cellattached configuration, a bipolar tungsten stimulating electrode (World Precision
Instruments, Inc) was placed 100–150 μm away from the recording electrode. Trains of
constant-current pulses (20 Hz frequency, 1 s duration, 200 μA amplitude) were applied
with an inter-stimulus interval of not less than 1 minute. At least 3 stimulation trains were
conducted for each cell and the responses were averaged. Synaptic GABAA receptor
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stimulation was isolated using AMPA, NMDA and GABAB receptor antagonists (DNQX,
20 μM; AP5, 50 μM, and CGP55845 1 μM respectively).
In whole-cell configuration, spontaneous inhibitory post-synaptic currents (sIPSCs) were
recorded in voltage clamp mode while holding VTA DA neurons at −60 mV. To isolate
sIPSCs, ionotropic glutamatergic synaptic transmission was inhibited by AP5 and DNQX
in the perfused ACSF. Ethanol (50 mM) was added to the perfused ACSF to assess
ethanol-induced alterations in sIPSCs. sIPSCs were blocked by picrotoxin. To measure
activity dependent depression of evoked IPSCs, recordings were performed in whole cell
mode and the internal solution contained: (in mM): 123.0 K+-gluconate, 8.0 NaCl, 2.0 MgATP, 0.2 EGTA, 10.0 HEPES, and 0.3 Tris-GTP, pH 7.2–7.3. Synaptic GABAA input was
isolated using DNQX, AP5 and CGP55845. The liquid junction potential between the bath
and the pipette solutions was corrected before either recordings or data analysis.
For EGABA recordings gramicidin was first dissolved in methanol to a concentration of 10
mg/ml and then diluted in a pipette solution to a final concentration of 150 μg/ml. To
determine EGABA evoked IPSCs were measured under voltage clamping at different
holding potentials. Amplitudes of eIPSCs were plotted against voltage to estimate the
reversal potential. After each perforated-patch experiment, recordings were converted to
the whole-cell configuration and Ih current was measured. Recordings were performed in
the presence of DNQX, AP5, CGP55845 and tetrodotoxin (0.5 μM).
Recordings were made using an Axopatch 200B amplifier (Molecular Devices), filtered at
10 kHz, digitized at 20 kHz using pClamp 9.2 (Digidata Interface, Molecular Devices), and
analyzed off-line using Clampfit 9.2.
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Immunohistochemistry
To validate the identification of VTA DA and VTA GABA neurons, neurobiotin backfills and
TH double labeling were used. The recording pipette contained 0.3% neurobiotin (Vector
Laboratories). Slices were fixed with 10% neutral formalin phosphate buffer for 12–24
hours, incubated in a blocking solution containing 3% normal goat serum solution and
0.3% triton X-100 for 2 hours, and then incubated overnight with primary anti-TH (1:100;
Millipore, #AB152) at 4 °C. The slices were then rinsed with PBS and treated with the
secondary antibody Cy3- conjugated anti-rabbit IgG (1:200) and AMCA-conjugated
streptavidin (1:1000; both from Jackson ImmunoResearch).
Western Blots
The VTA was harvested in horizontal brain slices from adult animals (VTA slices were
prepared as described in Midbrain slices and electrophysiology section). Membrane
fractions were prepared using the Mem-PER Plus Membrane Protein Extraction Kit (Model
89842; Thermo Scientific, Rockford, IL). Samples (30 µg of protein) in 2.5% 2mercaptoethanol were run through a 4-15% Precast Protein Gel (4561083; Bio-Rad). The
sample was transferred to nitrocellulose membrane (Bio-Rad). Primary antibodies used
were rabbit anti-KCC2 antibody at 1:400 (07-432; Millipore, Temecula, CA), rabbit antiPhospho-Ser940 KCC2 antibody (p1551-940; PhosphoSolutions, Aurora, CO) at 1:1000,
and mouse anti-GAPDH (glyceraldehyde 3-phosphate dehydrogenase) antibody
(MAB374; Millipore) at 1:400. Secondary anti-bodies used were goat anti-rabbit IgG
secondary antibody (T2191; Applied Biosystems, AB Foster City, CA) or goat anti-mouse
IgG/IgM (T2192, Applied Biosystems). All antibodies were diluted in SignalBoost solution
(407207; EMD Millipore Corp., Billerica, MA). Membranes were developed using Tropix
CDP-Star solution (T2218; Applied Biosystems) for 5 minutes, then scanned using the
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Protein Simple FluorChem R chemiluminescence detector, and analyzed using AlphaView
SA software. The optical densities of KCC2- and Phospho-Ser940 KCC2-specific bands
were measured and normalized to the GAPDH values.
Statistical Analyses
Analysis of variance (ANOVA) with repeated measures (in SPSS for Windows) was used
to analyze daily ethanol self-administration as well as the DA and GABA neuron firing
rates. For analysis of action potential firing, the raw data (in Hz) were converted into a
percentage of basal, and the last three bins (2-min each) before bath application of ethanol
were used as the baseline. For analysis of repetitive synaptic stimulation, the last ten bins
(0.5-s each) before the stimulus were used as the baseline. Exponential fittings were
compared by F-test. A two-tail t-test assuming equal variance was used to assess
differences between the mean sIPSC frequency, the mean firing rates, as well as the mean
ethanol intake levels. For western blot analysis, a paired t-test was used to compare
protein levels from control and stress littermates that were run on the same gel.
Significance for all analyses was determined by p < 0.05.
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Results
Stress Increases Ethanol Self-Administration via Activation of Glucocorticoid Receptors
We first examined how a single episode of restraint stress alters subsequent ethanol
intake measured during daily operant self-administration sessions (Fig. 2.1A). Stable lever
pressing for saccharin (0.125%, w/v) was first established followed by the introduction of
ethanol (2%–4%) into the drinking solution (Doyon et al., 2013a). Animals were subjected
to restraint stress (1 hr) approximately 15 hr prior to the first ethanol self-administration
session. The 15 hr separation between the stress and ethanol self-administration was
chosen to examine the lasting impact on neural circuits, not the immediate proximal
influence of the stressor itself (Noori et al., 2014).
Pre-exposure to stress caused a significant and long-lasting increase in ethanol selfadministration compared to the non-stressed control group (Fig. 2.1A): group: F(1,21) =
19.32, p < 0.01. Blood-ethanol levels were measured in a subset of animals and were
correlated with ethanol intake (Fig. 2.1B). Stressed rats showed significantly higher bloodethanol levels (120.8 ± 13.6 mg/dL, n = 5) than non-stressed rats (61.3 ± 4.3 mg/dL, n =
10, p < 0.01). Elevated drinking after stress was also observed at higher ethanol
concentrations (7%–10%) over a 3-week period (Fig. 2.1C). Mean intake of ethanol over
the first 7 days was 0.74 ± 0.03 g/kg for the control group (n = 19) and 0.95 ± 0.03 g/kg
for the stressed group (n = 16, p < 0.01) (Fig. 2.1D, black and red bars). Therefore, acute
restraint stress induced robust changes in the acquisition and maintenance of ethanoldrinking behavior.
Restraint stress is known to increase circulating glucocorticoid levels (Pitman et al., 1988).
To determine whether the effect of stress on drinking was mediated by stress hormone
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signaling, a separate group of rats was pretreated with RU486 (a glucocorticoid receptor
antagonist) prior to stress. Pretreatment with systemic RU486 prevented the stress from
increasing subsequent ethanol self-administration (Fig. 2.1D, dark blue bar; 0.67 ± 0.07
g/kg). To determine whether stress hormone signaling acted locally within the DA system
(Uhart & Wand, 2009; Spanagel et al., 2014), RU486 or vehicle was microinfused
bilaterally into the VTA prior to stress exposure (Fig. 2.1E). Intra-VTA administration of
RU486 prevented stress from increasing subsequent ethanol self-administration (Fig.
2.1D, light blue bar; 0.55 ± 0.05 g/kg), revealing that the effect of stress requires
glucocorticoid receptor activation within the VTA. In non-stressed control rats, RU486 did
not significantly influence ethanol intake when administered systemically or by local
microinfusion (Fig. 2.1D, gray bar on the right; 0.67 ± 0.04 g/kg), demonstrating a selective
effect of RU486 on stress-induced drinking. Additional control experiments with saccharin
and palatable food suggest that the effect of stress was specific to ethanol selfadministration.
Stress Attenuates Ethanol-Induced DA Neuron Activity In Vivo
Ethanol self-administration involves DA signaling in the nucleus accumbens (NAc)
(Gonzales et al., 2004). Ethanol stimulates DA release in the NAc by increasing the firing
rate of VTA DA neurons (Foddai et al., 2004). To determine whether restraint stress
altered DA neuron firing rate in vivo, we conducted single-unit recordings of VTA DA
neurons in anesthetized rats 15 hr after stress (Fig. 2.2A). DA neurons were recorded in
the lateral VTA (Fig. 2.2E) and were identified based on their electrophysiological and
pharmacological properties (Fig. 2.2B). The spontaneous firing rate of VTA DA neurons
was measured before and after intravenous infusion of ethanol (0.6–1.5 g/kg). Ethanol
administration induced an increase in the spontaneous firing rate of VTA DA neurons in
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control animals (128.6% ± 7.6%). In contrast, stressed animals failed to demonstrate a
significant firing-rate increase upon ethanol administration (102.3% ± 3.1%) (Fig. 2.2C and
D; n = 8–13, p < 0.01).
Stress Attenuates Ethanol-Induced DA Neuron Firing Rates via Enhanced GABA Release
Ex Vivo
To examine the cellular mechanisms of the blunted DA signaling after stress, we
measured the ex vivo responses of VTA DA neurons to ethanol. Midbrain horizontal slices
containing the VTA were cut 15 hr after restraint stress, and patch-clamp recordings were
performed on DA neurons. Putative DA neurons were recorded from the lateral VTA and
were identified based on established anatomical and electrophysiological criteria (Fig.
2.3A). In 34 of 36 cells displaying these electrophysiological properties, the DA phenotype
was confirmed by tyrosine hydroxylase staining (Fig. 2.3B). During cell-attached
recordings, bath application of 50-mM ethanol increased the spontaneous firing rate of DA
neurons from unstressed control rats (Fig. 2.3C and D, black data), but DA cells from
stressed animals failed to show significant increases in firing rate upon ethanol application
(Fig. 2.3C and D, red data): group x time: F(10,200) = 3.55, p < 0.01.
Reduced DA activity after stress could be mediated through decreased excitation or
increased inhibition of DA neurons. To probe the relative contribution of excitatory
neurotransmission, we recorded ethanol-induced DA activity during inhibition of ionotropic
glutamate receptors with DNQX (20 mM) and AP5 (50 mM), which inhibit AMPA and
NMDA receptors, respectively. When comparing control and stressed groups, the basal
firing rate of DA neurons was not significantly altered by bath application of DNQX and
AP5. Upon ethanol application, DA neurons from stressed animals again showed reduced
DA activity compared to controls (Fig. 2.3E): group 3 time: F(10,130) = 6, p < 0.01,
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indicating that this effect of stress was not mediated via changes in glutamatergic
neurotransmission.
Next, we tested the contribution of GABAergic signaling by comparing ethanol-induced
VTA DA neuron firing between control and stress groups in the presence of picrotoxin, a
GABAA receptor antagonist. Picrotoxin (50 mM) did not significantly alter the basal firing
rate between the control and stress groups. However, upon application of ethanol, the
presence of picrotoxin prevented the blunted DA responses to ethanol observed after
stress (Fig. 2.3F, red trace). This finding suggests that stress reduced DA responses to
ethanol via changes in GABAergic neurotransmission.
Altered inhibitory control of DA neurons after stress could be mediated through changes
in presynaptic neurotransmitter release or postsynaptic receptor responses. To determine
the site of adaptation for GABAergic neurotransmission, we performed whole-cell patchclamp recordings of VTA DA neurons and we measured spontaneous inhibitory
postsynaptic currents (sIPSC) in the presence of ethanol (Fig. 2.4A). In control animals,
bath-applied ethanol produced a small increase in sIPSC frequency (116.1% ± 5.0%). In
contrast, DA neurons from stressed animals showed significantly greater ethanol-induced
potentiation of sIPSC frequency compared to the control response (171.5% ± 7.2%) (Fig.
2.4B and C, black and red data; n = 8–10, p < 0.01). Systemic injection of RU486 prior to
stress prevented the stress-mediated increase in sIPSC frequency observed after ethanol
application (Fig. 2.4C, gray bar): 110.6% ± 4.5%, n = 8.
To demonstrate the direct action of glucocorticoids in mediating the effects of stress, brain
slices from control rats were incubated in corticosterone (1 μM) for 1 hr (Pitman et al.,
1988). DA neurons from control animals treated with corticosterone showed a potentiation
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of ethanol-induced sIPSC frequency that was indistinguishable from stressed animals
(Fig. 2.4C, dark blue bar): 182.7% ± 10.7%, n = 8. Importantly, incubation with RU486
prevented this corticosterone-mediated increase in sIPSC frequency (Fig. 2.4C, light blue
bar): 114.5% ± 5.5%, n = 6. Increased frequency, but not amplitude, of sIPSCs suggests
that the change caused by stress and corticosterone resides with the presynaptic neuron
(i.e., the GABA neuron) not with the postsynaptic neuron (i.e., the DA neuron).
Stress Increases Ethanol-Induced VTA GABA Neuron Firing Rate Ex Vivo and In Vivo
Patch-clamp recordings indicated that stress induced long-term alterations in GABAergic
inputs onto VTA DA neurons. Local VTA GABA neurons can modulate VTA DA neuron
activity (Creed et al., 2014). To examine whether stress altered the effects of ethanol on
local VTA GABA neurons, we performed electrophysiological recordings of these cells ex
vivo (Fig. 2.5A). Putative VTA GABA neurons in slices were recorded in the lateral VTA
and identified by a combination of factors including small somata size (<20 mm), high
pacemaker-like firing rate (>7 Hz), and the lack of Ih-current (Fig. 2.5B) (Korotkova et al.,
2006; Margolis et al., 2006). Importantly, 47 of 49 VTA neurons with these properties were
not immunoreactive for TH (Fig. 2.5C). We measured ethanol’s effect on VTA GABA
neuron spontaneous firing rate in a cell-attached configuration. Bath-application of ethanol
on VTA slices from control animals produced a marginal increase of GABA neuron firing
rate (Fig. 2.5D, black trace). A significantly higher ethanol-induced increase in GABA
neuron firing rate was observed following stress, compared to non-stressed controls (Fig.
2.5D, red trace): group x time: F(10,160) = 5.89, p < 0.01.
As was previously examined in VTA DA neurons (Fig. 2.3E and F), we probed for changes
in excitatory and inhibitory input onto VTA GABA neurons ex vivo. After application of
ethanol, inhibition of ionotropic glutamate receptors with DNQX and AP5 did not prevent
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the enhanced GABA cell firing rate observed after stress, indicating that this effect was
not mediated via changes in glutamatergic neurotransmission (Fig. 2.5E): group x time:
F(10,110) = 11.19, p < 0.01. However, blocking GABAA receptors with picrotoxin
prevented the enhanced firing rate of VTA GABA neurons observed after stress (Fig. 2.5F,
red trace). This result suggests that, in stressed animals, ethanol increased VTA GABA
neuron firing rate via GABAA receptors.
Stress Promotes Excitatory GABA Input onto VTA GABA Neurons Ex Vivo
Based on our findings in Figure 2.5F, we hypothesized that GABA inputs onto VTA GABA
neurons produced excitatory responses. To test this, we measured VTA GABA neuron
firing rates in response to repetitive stimulation of synaptic GABAA receptor inputs with
ionotropic glutamate receptors inhibited (Fig. 2.6A). Upon electrical stimulation (20 Hz for
1 s), GABA neurons from control animals showed decreased firing (Fig. 2.6B and C, black
data), indicative of GABAergic inhibition of the recorded GABA neuron. In marked
contrast, slices from stressed animals showed increased GABA neuron firing after GABAA
receptor stimulation (Fig. 2.6B and C, red data). This finding directly demonstrates
excitation mediated by high-frequency stimulation of GABAA receptors. Importantly, this
effect was blocked by picrotoxin (Fig. 2.6C, Stress + picrotoxin), providing further
confirmation that the observed excitation of VTA GABA neurons following stress was
mediated by GABAA receptors. In control animals, similar GABAA receptor-mediated
excitation was also observed following 1 hr incubation of brain slices in corticosterone
(Fig. 2.6C, blue bar, Cort), suggesting that prolonged exposure to corticosteroids is
sufficient to promote excitatory GABAA transmission onto VTA GABA neurons.
It has been reported (Staley et al., 1995) that GABAA receptor-mediated excitation can be
prevented by application of acetazolamide, an inhibitor of carbonic anhydrase. Based on
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these findings, we postulated that acetazolamide would prevent the transition from GABAA
receptor-mediated inhibition to excitation of GABA neurons observed after stress. Bath
application of acetazolamide (10 μM) did not change basal GABA neuron firing rate
between control and stress groups, nor did it change control responses to repetitive
stimulation. However, repetitive stimulation in the presence of acetazolamide blocked the
increase in GABA neuron firing after stress (Fig. 2.6C, Stress + ACTZ).
Stress Alters Anion Homeostasis in VTA GABA Neurons Ex Vivo
We next investigated the causes underlying the increased GABA cell excitation by alcohol.
The transition in GABAA receptor signaling (Fig. 2.6B and C) suggests a depolarizing shift
in the GABAA reversal potential (EGABA) in VTA GABA neurons (Hewitt et al., 2009). EGABA
is the membrane potential at which evoked IPSCs change their direction from inward to
outward. To determine EGABA in VTA GABA neurons, we performed gramicidin perforated
patch-clamp recordings to preserve the intracellular anion concentrations, and we
measured GABAA IPSCs at different membrane potentials (Fig. 2.7A). VTA GABA
neurons from stressed animals showed a significantly more depolarized EGABA value
compared to controls (Fig. 2.7B and C): -63.4 ± 3.1 mV after stress (red data) versus 88.2 ± 3.3 mV in controls (black data), n = 10, p < 0.01.
A depolarizing shift in EGABA reflects a higher intracellular chloride ion (Cl-) concentration,
which in adult neurons is often mediated by a decrease in Cl- extrusion capacity. During
prolonged GABAA receptor stimulation, decreased Cl- extrusion capacity leads to
intracellular Cl- accumulation, culminating in the collapse of the Cl- gradient and decreased
synaptic GABAA receptor inhibition. To test whether exposure to stress weakens Clextrusion in VTA GABA neurons, we applied repetitive GABAA receptor stimulation and
measured activity-dependent depression of the IPSCs (Hewitt et al., 2009). The rate of
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decrease in IPSC amplitude at the conditions that favor Cl- influx (0 mV) depends on Claccumulation and activity-dependent synaptic depression. In contrast, GABAA receptor
stimulation at the conditions of Cl- efflux (-90 mV) only depends on activity-dependent
synaptic depression. The decrease of IPSC amplitude at 0 mV occurred significantly faster
after stress (Fig. 2.7D and E): F = 39.9, p < 0.01. Upon electrical stimulation at 20 Hz at a
holding potential of -90 mV, stress did not affect the rate of synaptic depression in VTA
GABA neurons (Fig. 2.8A and B). The differential effect of stress at -90 mV versus 0 mV
indicates that stress increased Cl- accumulation, suggesting a reduced capacity for Clextrusion in VTA GABA neurons.
Stress and Glucocorticoids Induce Dephosphorylation of KCC2 at Serine 940
Stress-induced reductions in Cl- extrusion capacity have been associated with
dephosphorylation of the K+, Cl- cotransporter, KCC2, at serine 940 (S940) (Sarkar et al.,
2011; Kahle et al., 2013). To examine stress-induced alterations in KCC2 protein
expression and its phosphorylation in the VTA, we performed western blot analysis using
an antibody against total KCC2 protein, as well as a phospho-specific antibody against
the KCC2 phosphorylation site S940 (Sarkar et al., 2011). Immunoblots revealed two
prominent bands (approximately 140 and 270 kDa) for both total and S940 KCC2
antibodies, indicating the presence of monomeric and dimeric structures of KCC2 protein
(Fig. 2.7F) (Hewitt et al., 2009). The ratio of phosphorylated-S940 KCC2 to total KCC2
protein after stress was significantly lower compared to control (Fig. 2.7G): 78.3% ± 5.5%
for monomer, 79.6% ± 4.7% for dimer.
To determine whether glucocorticoids mediate the effect of stress on KCC2, VTA slices
from control animals were incubated for 1 hr in corticosterone. Similar to in vivo exposure
to stress, the ratio of phosphorylated- S940 KCC2 to total KCC2 protein was significantly
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lower after corticosterone incubation (Fig. 2.7H): 75.5% ± 7.6% for monomer, 78.6% ±
9.4% for dimer.
No significant differences in the expression of total KCC2 protein between control and
stressed groups were observed (Figure 2.8C, red data) or in controls tissue incubated with
corticosterone ex vivo (Figure 2.8C, blue data). Importantly, immunolabeling analysis in
the VTA suggests that KCC2 protein is expressed exclusively on non-DA neurons (Taylor
et al., 2016), which is consistent with the presence of another Cl- extrusion mechanism in
DA neurons (Gulacsi et al., 2003). Taken together, these results suggest that stress or
corticosterone leads to dephosphorylation of KCC2 protein at S940, which decreases
KCC2 function and alters anion homeostasis.
Enhanced Cl- Extrusion Restores Anion Homeostasis in VTA GABA Neurons and
Prevents Stress and Ethanol Interactions Ex Vivo and In Vivo
Based on our findings in Figure 2.7, we hypothesized that enhancement of Cl- extrusion
would restore normal alcohol self-administration in stressed animals. To enhance Clextrusion specifically, we used recently developed activators of KCC2, CLP257 and
CLP290 (Gagnon et al., 2013). First, we confirmed that CLP257 and CLP290 were
effective in VTA GABA neurons by measuring activity-dependent depression of IPSCs (as
in Fig. 2.9). After incubation of VTA slices with CLP257 (>1 hr, 5 mM) or CLP290 (>1 hr,
10 mM) the rates of decrease in IPSC amplitude at 0 and -90 mV were similar between
control and stressed groups (Fig. 2.9A-D). Given that CLP257 was shown to be rapidly
metabolized in vivo, we further testedCLP290,whichwasdemonstrated to have longer bioavailability (Gagnon et al., 2013).
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Next, we studied the effect of CLP290 on the stress-induced depolarizing shift in EGABA
and conditional GABAA receptor-mediated excitation of GABA neurons observed after
stress (as in Figures 2.7B and 2.6B, respectively). Using synaptic GABAA receptor
stimulation during recordings from VTA GABA neurons (Fig. 2.10A), we found that
correcting the Cl- gradient with CLP290 in slices from stressed animals returned EGABA
back to the control value (Fig. 2.10B) and blocked the stimulation-induced increase in
GABA neuron firing (Fig. 2.10C).
Given that stress altered anion homeostasis in VTA GABA neurons, we next determined
whether this phenomenon mediated stress-induced alterations in alcohol’s actions on VTA
DA neurons (Fig. 2.10D). In slices from stressed animals, boosting Cl- extrusion with the
KCC2 activator, CLP290, returned the alcohol-induced firing rate of DA neurons to the
control value (Fig. 2.10E).
Finally, we locally microinfused CLP290 bilaterally into the VTA prior to the first ethanol
self-administration session and measured ethanol intake over 7 days (Fig. 2.10F). IntraVTA infusion of CLP290 significantly decreased the average daily ethanol intake in the
stressed group back to control levels (0.79 ± 0.05 g/kg) compared to the stressed group
that received intra-VTA infusions of vehicle (1.00 ± 0.08 g/kg) (Fig. 2.10G; n = 12–13, p <
0.05). These data were indistinguishable from the non-stressed control group (dotted
horizontal line). VTA infusions of CLP290 did not alter ethanol consumption in control
animals (0.84 ± 0.05 g/kg, data not shown). Locations of intra-VTA infusions of CLP290
are shown for reference (Fig. 2.10H).
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Discussion
While epidemiological studies consistently report associations between stress and ethanol
consumption (Keyes et al., 2012), the underlying neuronal effects have not been well
delineated. We found that alterations in GABAA receptor responses on GABAergic
neurons of the VTA correlate with an increase in ethanol self-administration induced by
temporally distant, acute stress. After stress, we detected enhanced VTA GABAergic
inhibition of DA neurons in response to ethanol. Blunted DA signaling was mediated by a
transition toward excitatory GABAA receptor signaling in the VTA and was associated with
decreased functional expression of KCC2. Stress-induced adaptations were prevented by
acetazolamide (Staley et al., 1995) or by CLP290 (Gagnon et al., 2013). The effect of
stress on GABA transmission was recapitulated in vitro by corticosterone exposure and
was prevented by pharmacological blockade of glucocorticoid receptors (Cadepond et al.,
1997). Most importantly, when CLP290 or RU486 were locally infused in the VTA in vivo,
stress no longer increased ethanol self-administration.
The decreased DA response to ethanol was correlated to the stress event and to the
excitatory GABA signaling. Although the DA response was not directly examined as a
cause of the increased self-administration, others have reported that enhancing DA
signaling exogenously attenuates voluntary drinking in rats (Bass et al., 2013).
Furthermore, a correlation between decreased ethanol-induced DA release and increased
self-administration has been previously reported in rodent studies (Brodie & Appel, 2000;
Ramachandra et al., 2007; Doyon et al., 2013a).
The shift toward excitatory GABAA receptor signaling was correlated to the stress event
and was required for the stress to cause increased ethanol self-administration (Figure 2.8).
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Although GABAA receptor signaling normally mediates inhibitory synaptic transmission in
the adult mammalian nervous system, it can shift toward excitation under certain
pathological conditions, including epilepsy, neuropathic pain, and neuronal trauma (De
Koninck, 2007). The shift arises from the decreased function of the chloride ion (Cl-)
extrusion pump, KCC2 (Kaila et al., 2014). Upon strong GABAA receptor stimulation,
diminished function of KCC2 leads to the accumulation of Cl- inside the cell and
subsequent loss of the Cl- gradient. Activity-dependent loss of the hyperpolarizing Clgradient unmasks an outward flux of bicarbonate ions through GABAA receptors, resulting
in neuronal depolarization/excitation (Staley et al., 1995). Consistent with this model, we
found that the GABAergic circuitry responds as expected in the basal condition. However,
when GABAA receptors are highly engaged by strong stimulation (Figure 2.7) or by ethanol
(Figures 2.8A), a compromised extrusion capacity leads to a collapse in the Cl- gradient,
excitation of VTA GABAergic neurons, and blunted dopamine responses are detected.
This shift toward excitatory GABA may occur elsewhere in the brain after stress, but the
increased ethanol self-administration was prevented if this shift was blocked in the VTA.
Although an excitatory shift in GABA transmission in the adult brain is usually associated
with pathological conditions, similar transitions were found in the HPA axis following stress
and in the VTA following chronic exposure to opiates (Laviolette et al., 2004; Hewitt et al.,
2009; Sarkar et al., 2011). When our results are taken with the accumulation of evidence
in the literature, it suggests that the shift toward excitatory GABA signaling may be a more
common phenomenon than is presently appreciated (Chung, 2012; Astorga et al., 2015).
Here we demonstrated that glucocorticoid receptor signaling within the VTA was
necessary to increase ethanol self-administration after stress. Moreover, prolonged
exposure to corticosterone in vitro (in midbrain slices) was sufficient to induce
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neuroadaptations associated with in vivo stress. These findings highlight the importance
of glucocorticoid signaling within the VTA, but we do not rule out the participation of other
stress signaling molecules or hormones, such as CRF, in mediating stress-induced
adaptations (Ungless et al., 2003; Hwa et al., 2016). Furthermore, the effect of
glucocorticoids on VTA GABA neurons may involve the activity of noradrenaline,
glutamate, and glial cells (Coull et al., 2003; Hewitt et al., 2009; Lee et al., 2011; Taylor et
al., 2016).
Although animal studies generally support the hypothesis that stress increases ethanol
consumption, some results have shown that stress decreases intake or has no effect
(Becker et al., 2011). These differences arise from a combination of factors, including the
type of stressor used, the duration or timing of the stressor, as well as the type of drinking
paradigm employed (Noori et al., 2014). An important parameter in our experimental
design is that the stress exposure was well-separated (15–20 hr) from the ethanol selfadministration, which allowed us to examine the lasting neural circuit consequences of the
treatment not the proximal effect of stress itself. In our study, we kept the ethanol content
of the drinking solutions relatively low during the acquisition phase, which likely resulted
in less variability in self-administration. The rats experienced less of the aversive stimulus
cues of ethanol while still achieving significant blood-ethanol levels. In addition, some
animals show resilience to the effects of stress (Pfau & Russo, 2015), so it is essential to
verify that there is a physiological response to the stressor and to exclude animals that do
not show that response.
In summary, we showed that acute stress exposure decreases the sensitivity of the DA
system to ethanol and increases subsequent ethanol self-administration. These effects
required a shift toward excitatory GABAA signaling in the VTA and were associated with
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decreased Cl- extrusion capacity in VTA GABA neurons. The temporally distant, acute,
intense stress experience produced long-lasting neuroadaptations within the mesolimbic
systems of the brain that were expressed upon exposure to ethanol. This overall process
represents one mechanistic pathway linking life stress experiences to increased alcohol
use. However, future work should determine whether similar mechanisms also contribute
to the effects of stress during chronic alcohol use and relapse.
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Figures

Figure 2.1 Stress Increases Ethanol Self-Administration.
(A) Rats self-administered saccharin prior to fading ethanol into the drinking solution. Rats were
subjected to a single restraint stress 15–20 hr before the first ethanol exposure (red arrow). Daily
fluid intake was measured in control and stressed rats. Stressed rats showed greater ethanol intake
compared to unstressed control rats. **Significantly different from the control group by ANOVA with
repeated measures, p < 0.01, n = 16–19 rats/group. (B) Ethanol intake (g/kg) versus blood ethanol
levels (mg/dL). Blood ethanol was measured immediately after the self-administration session in
control (black) and stressed (red) animals. A regression analysis showed a significant and positive
correlation between ethanol intake and blood ethanol levels, F(1,13) = 162.7, p < 0.01. (C) Mean
daily intake for 4%, 7% and 10% ethanol are plotted. Significance of difference between control
and stressed groups for each ethanol concentration was determined by t-test (*p < 0.05; **p <
0.05), n = 5-7 rats/group. (D) Mean daily ethanol intake over the first seven self-administration
sessions. Stressed rats (red bar) consumed significantly more ethanol (g/kg) compared to control
rats (black bar). Blockade of glucocorticoid receptors with RU486 systemically (dark blue, 40 mg/kg,
i.p.) or locally in the VTA (light blue, 40 ng/1 mL) prior to stress prevented increases in ethanol
intake, n = 10, 14. RU486 administered systemically or intra-VTA to control animals did not alter
ethanol intake, n = 9, gray bar. **Significantly different from all groups by t test, p < 0.01. (E)
Following self-administration experiments, the microinfusion sites of RU486 were determined. The
distribution of injection sites in the VTA was similar between control (gray circle) and stressed
animals (light blue circle) and distributed across coronal sections 5.3-6.0 mm posterior from
bregma.
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Figure 2.2. Stress Attenuates Ethanol-Induced VTA DA Neuron Firing In Vivo.
(A) The spontaneous firing rate of VTA DA neurons was measured in vivo using single-unit
recordings in anesthetized animals. (B) Upper panel: In vivo single-unit recordings of VTA DA
neurons in anesthetized rats. Example traces for putative dopamine neurons showing low
frequency spontaneous firing (<10 Hz) and broad triphasic action potential (>3 ms). DA neurons
often display burst firing (right). Lower panel: putative DA neurons were inhibited by the D2-type
receptor agonist quinpirole (0.25 g/kg). This effect was then reversed following the D2-type receptor
antagonist eticlopride (0.25 g/kg). Pharmacological confirmation of DA neuron identity was
performed at the completion of each recording. (C) Representative recordings from putative DA
neurons before and after ethanol administration (0.6–1.5 g/kg) in the control (black) and stressed
(red) groups. No significant differences in the mean basal firing rate were detected between control
and stressed groups: 6.3 ± 0.7 Hz in control versus 8.0 ± 1.0 Hz after stress, n = 8–13, p > 0.05.
(D) In the control group (black), ethanol increased the firing rate of putative DA neurons. In the
stressed group (red), ethanol failed to increase the firing rate of putative DA neurons. **Significantly
different from the control group by t test, p < 0.01, n = 8–13 rats/group. (E) Putative DA neuron
recording sites in the VTA for control (black) and stressed animals (red).
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Figure 2.3. Stress Attenuates Ethanol-Induced DA Neuron Firing via Altered GABAergic
Signaling Ex Vivo.
(A) Left panel: Ex vivo patch clamp recordings of DA neurons from the lateral VTA. The lateral VTA
was identified as medial to the medial terminal nucleus of the accessory optic tract (mt) and lateral
and rostral to the crest of medial lemniscus (ml). Abbreviations: VTA = ventral tegmental area, SNc
= substantia nigra pars compacta, SNr = substantia nigra pars reticulate, ml = medial lemniscus,
mt = medial terminal nucleus of accessory optic tract. Center panel: VTA DA neurons displayed
low spontaneous firing frequency (< 5 HZ). The firing rates of VTA DA neurons were recorded in
cell-attached configuration in passive voltage-follower mode. Right panel: VTA DA neurons
possessed large Ih (> 150 pA) current. Ih was recorded in whole-cell configuration using voltage
step protocol (-40 mV to -110mV in 10 mV steps, 1.5 s duration, traces on (E) displayed for steps
from -80 to -110). All calculations of the peak Ih amplitude were taken from a -60 mV to -110 mV
hyperpolarizing step. (B) Neurobiotin-labeled putative DA neurons were immuno-positive for
tyrosine hydroxylase (TH, red stain). (C) Left: Spontaneous firing rate of VTA DA neurons was
measured using the cell-attached configuration. Right: Representative recordings from DA neurons
before and after bath ethanol administration in the control and stressed (red) groups. No significant
differences in mean basal firing rate were detected before ethanol: 2.3 ± 0.2 Hz in control versus
2.0 ± 0.2 Hz after stress, n = 10–12. (D) Normalized spontaneous firing rates of VTA DA neurons
following ethanol (gray horizontal bar) in unstressed control group (black) and in rats exposed to
stress 15 hr prior to cutting the slice (red). **Significantly different from the control by ANOVA with
repeated measures, p < 0.01, n = 10–12 cells/group. (E) Glutamatergic receptor antagonists
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(DNQX and AP5) did not prevent ethanol-induced attenuation of DA cell firing after exposure to
stress (red) and showed a lower firing rate than unstressed controls (black). **Significantly different
from the control by ANOVA with repeated measures, p < 0.01, n = 7–8 cells/group. (F) The GABAA
receptor antagonist, picrotoxin, prevented ethanol’s attenuation of VTA DA neuron firing rates after
stress (red) and showed a response similar to the unstressed controls (black), n = 9–15 cells/group.
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Figure 2.4. Stress and Corticosterone Increase GABA Release onto DA Neurons Ex Vivo.
(A) Spontaneous inhibitory postsynaptic currents (sIPSCs) onto VTA DA neurons were recorded
using the whole-cell patch-clamp configuration. No significant differences were detected in the
mean basal sIPSC frequency or amplitude between stressed and control groups before ethanol:
frequency, 2.4 ± 0.6 Hz in control versus 2.3 ± 0.3 Hz after stress; amplitude, 26.2 ± 4.0 pA in
control versus 30.8 ± 3.6 pA after stress, p > 0.05, n = 8–10. (B) Representative recordings of
sIPSCs before and after ethanol administration in the control (black) and stressed (red) groups. (C)
Mean changes in the sIPSC frequency after ethanol application in VTA DA neurons. DA neurons
from stressed animals (red) demonstrated a significantly increased ethanol-mediated sIPSC
frequency compared to neurons from unstressed controls (black). Systemic inhibition of
glucocorticoid receptors with RU486 (40 mg/kg) prior to stress prevented elevated sIPSC frequency
(gray). Incubation of VTA slices from control animals with corticosterone increased ethanolmediated sIPSC frequency in DA neurons up to stress levels (dark blue). Co-incubation with RU486
prevented this increase (light blue). Incubation of brain slices with RU486 and/or corticosterone did
not alter basal parameters of sIPSCs (data not shown). Across all groups, ethanol application did
not produce significant changes in the sIPSC amplitudes (data not shown, n = 6–10, p > 0.05).
**Significantly different from control and RU486-treated groups by t test, p < 0.01, n = 6–10
cells/group.
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Figure 2.5. Stress Increases Ethanol-Induced GABA Neuron Firing Rates Ex Vivo.
(A) Spontaneous firing rates of VTA GABA neurons were measured using the cell-attached
configuration, and the whole-cell configuration was used to identify GABA neurons
electrophysiologically and histochemically upon termination of the recording. (B) VTA GABA
neurons displayed fast spontaneous firing rates (>7 Hz) and lack of Ih current. (C) Neurobiotinlabeled VTA neurons with these electrophysiological properties were immune-negative for tyrosine
hydroxylase (TH), consistent with a non-DA phenotype. (D) VTA GABA neurons from stressed rats
(red) showed a greater increase in firing rate following ethanol application (gray horizontal bar) than
did GABA neurons from the unstressed controls (black). **Significantly different from the control by
ANOVA with repeated measures, p < 0.01, n = 9 cells/group. (E) Glutamatergic receptor
antagonists (DNQX and AP5) did not prevent the enhanced firing rate of VTA GABA neurons from
stressed animals in response to ethanol. **Significantly different from the control by ANOVA with
repeated measures, p < 0.01, n = 6–7 cells/group. (F) GABAA receptor antagonist, picrotoxin,
prevented the ethanol-induced increase of GABA neuron firing rates after stress (red), and the firing
rate was similar to the unstressed controls (black), n = 7–12 cells/group. The basal firing of VTA
GABA neurons was not significantly different between control and stress groups (before ethanol):
11.1 ± 1.4 Hz versus 11.3 ± 1.3 Hz, p > 0.05, n = 9.
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Figure 2.6. Stress Promotes GABA-Mediated Excitation of GABA Neurons Ex Vivo.
(A) VTA GABA neurons were recorded in a cell-attached configuration before and after electrical
stimulation of GABAA receptor inputs. To isolate GABAA receptor inputs, we inhibited AMPA,
NMDA, and GABAB receptors with antagonists DNQX, AP5, and CGP55845, respectively. (B)
Representative GABA neuron recording from a control animal demonstrated decreased firing rate
in response to stimulation of GABAergic input (black). Similar stimulation enhanced the firing rate
of VTA GABA neurons from stressed animals (red). For display, the traces were filtered and
stimulus artifacts were removed. (C) Normalized mean changes in the firing rates of VTA GABA
neurons in response to stimulation for each treatment group. Values were averaged over 5 s
immediately following termination of the stimulation. In controls, GABAA receptor-mediated
increase in the firing rate was observed after slice incubation with corticosterone (blue).
Significantly different from the control by t test (*p < 0.05), n = 8–10 cells/group or (**p < 0.01), n =
6–8 cells/group.
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Figure 2.7. Stress Weakens Cl- Extrusion and Decreases the Function of KCC2 in the VTA.
(A) GABAergic input onto VTA GABA neurons was recorded using gramicidin perforated patches
at different holding potentials to measure stress-induced alterations in anion homeostasis. GABAA
IPSCs were evoked by electrical stimulation in the presence of DNQX, AP5, and CGP55845. (B)
Representative IPSCs recordings from control (black) and stressed (red) animals at the given
holding potentials. The IPSCs reverse direction at the EGABA. For display, the traces were filtered
and stimulus artifacts were removed. (C) VTA GABA neurons from stressed animals (red, **p <
0.01 by t test) demonstrated a significantly more positive EGABA value compared to neurons from
unstressed control animals (black square), n = 10 cells/group. (D) Cl- accumulation was estimated
by stimulating repetitive GABAA receptor input. Upon stimulation (20 Hz, Vh = 0 mV), a
representative GABA neuron from a control (black) animal demonstrated a minor depression of
IPSC amplitude compared to the significantly greater depression seen in a GABA neuron from a
stressed animal (red). (E) At 0 mV, VTA GABA neurons from stressed animals (red) demonstrated
a significantly higher rate of evoked IPSC amplitude depression compared to control animals
(black). **Significantly different from the control by F-test, p < 0.01, n = 10–17 cells/group. (F)
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Western blot analysis was conducted for total KCC2 and phosphorylated-S940 KCC2 with GAPDH
as a loading control. A representative western blot indicates no differences in total KCC2
expression after stress. However, stressed animals showed reduced expression of pS940 KCC2
relative to total KCC2 when compared to non-stressed controls. (G) Densiometric analysis revealed
a significant reduction in the ratio of pS940 KCC2 to total KCC2 protein in stressed animals
compared to non-stress controls (horizontal dashed line). *Significantly different from the control
by t test, p < 0.05, n = 10 animals/group. (H) Densiometric analysis revealed a significant reduction
in the ratio of pS940 KCC2 to total KCC2 protein in corticosterone-incubated slices from controls.
*Significantly different from the control by t test, p < 0.05, n = 16 animals/group.
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Figure 2.8. Stress and Corticosterone Do Not Alter Presynaptic GABA Release or Total KCC2
Expression in the VTA.
(A) Activity dependent synaptic depression was measured during whole-cell patch clamp
recordings under repetitive GABAA receptor input. Representative GABA neuron from control
(black) and stressed (red) demonstrated a similar depression in eIPSC amplitude when stimulated
at 20 Hz and clamped at -90 mV. (B) At -90 mV, VTA GABA neurons from control and stressed
animals showed no significant difference in rate of eIPSC amplitude depression (F = 2.6, p > 0.05,
n = 10-17). Amplitude values were averaged for five eIPSCs and shown as a percent of the first
five eIPSCs. (C) Densiometric analysis revealed no significant differences in total KCC2 expression
levels after stress (red bar graphs) or after corticosterone incubation of control slices (blue bar
graphs) (p > 0.05, n = 10-16 rats/group).
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Figure 2.9. KCC2 Activation Promotes Cl- Extrusion in Stressed Rats.
(A) At -90 mV, incubation of VTA slices with CLP257 (> 1 hour, 5 μM) produced no significant
difference in rate of eIPSC amplitude depression in VTA GABA neurons from control (black trace)
and stressed animals (red trace) (p > 0.05, n = 6-14 cells/group). The effect of stress without
CLP257 incubation is plotted for comparison (dotted red trace). Amplitude values were averaged
for five IPSCs and shown as a percent of the first five IPSCs. (B) At 0 mV, there was no longer a
difference in eIPSC amplitude suppression between control (black trace) and stressed animals (red
trace) after CLP257 incubation. The effect of stress in the absence of CLP257 is shown for
comparison (dotted red trace). (C) and (D) Similar effects on activity-dependent depression of
eIPSCs were observed following CLP290 incubation (> 1 hour, 10 μM) (p > 0.05, n = 11-12
cells/group).
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Figure 2.10. KCC2 Activation in the VTA Prevents Stress-Ethanol Interactions Ex Vivo and
In Vivo.
(A) Synaptic stimulation of GABAA receptor inputs onto patched VTA GABA neurons was used to
assess the effect of CLP290 incubation on Cl- homeostasis and GABA signaling mechanisms after
stress exposure. (B) When brain slices were incubated in the KCC2 activator, CLP290, EGABA was
hyperpolarized comparably in VTA GABA neurons from control (black) and stressed (red) animals.
The effect of stress exposure on EGABA in the absence of CLP290 is shown for comparison (open
red square), n = 6 cells/group. (C) Mean changes in the spontaneous firing rate of VTA GABA
neurons (as a % of basal) in response to repetitive stimulation (20 Hz, 1 s) after CLP290 incubation.
Values were averaged over 5 sec immediately following termination of stimulation. After CLP290
incubation (> 1 hour, 10 μM) repetitive stimulation of GABAA receptor inputs no longer enhanced
firing rate of VTA GABA neurons from stressed animals (red bar vs. black bar). The effect of stress
in the absence of CLP290 is shown for comparison (dotted red trace). (D) VTA DA neurons were
patched in cell-attached configuration to assess the effect of CLP290 incubation on DA neuron
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responses to ethanol after stress exposure. (E) After CLP290 incubation, ethanol-induced VTA DA
neuron firing was no longer attenuated after exposure to stress (red) and was similar to the
response of the unstressed controls (black). The effect of stress exposure and ethanol application
in the absence of CLP290 is shown for comparison (dotted red line), n = 10 cells/group. Note:
incubation of VTA slices with CLP290 (before ethanol) did not produce any significant alterations
in the mean basal firing rate of DA neurons between control and stress groups. (F) CLP290 was
infused bilaterally intra-VTA (40 mM at 0.5 mL/min) prior to the first ethanol self-administration
session in acutely stressed rats. (G) After CLP290 administration, stressed animals consumed
significantly less ethanol (blue) compared to vehicle-injected stressed animals (red). Ethanol
consumption in unstressed control rats is shown for comparison (dotted horizontal line).
*Significantly different from the VTA vehicle group by t test, p < 0.05, n = 12–13 rats/group. (H)
Bilateral VTA microinfusions of CLP290 were similarly distributed along the anterior/posterior axis.
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Abstract
Adolescent smoking is associated with pathological drinking later in life, but the biological
basis for this vulnerability is unknown. To examine how adolescent nicotine exposure
influences subsequent ethanol intake, nicotine was administered during adolescence or
adulthood, and responses to alcohol were measured 1 month later. We found that
adolescent, but not adult, nicotine exposure altered GABA signaling within the ventral
tegmental area (VTA) and led to a long-lasting enhancement of alcohol self-administration.
We detected depolarizing shifts in GABAA receptor reversal potentials arising from
impaired Cl- extrusion in VTA GABA neurons. Alterations in GABA signaling were
dependent on glucocorticoid receptor activation and were associated with attenuated
dopaminergic neuron responses to alcohol in the lateral VTA. Importantly, enhancing Clextrusion in adolescent nicotine-treated animals restored VTA GABA signaling and alcohol
self-administration to control levels. Taken together, this work suggests that adolescent
nicotine exposure increases the risk profile for increased alcohol drinking in adulthood.
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Introduction
Nearly 90% of smokers start smoking by the age of 18 (National Center for Chronic
Disease et al., 2012), and tobacco use is strongly predictive of pathological alcohol
consumption (Grant, 1998; Harrison & McKee, 2011). This association is thought to
originate in adolescence, with early tobacco exposure acting as a gateway for subsequent
alcohol use and abuse (Torabi et al., 1993; Cross et al., 2017). Adolescence is a
neurodevelopmental window marked by major reorganization of limbic brain regions
important for reward processing (Casey et al., 2008). Nicotine exposure may, therefore,
alter brain development to promote pathological drug use later in life. Evidence from
rodent models shows that exposure to nicotine during adolescence, but not postadolescence, is associated with enhanced drug reinforcement in adulthood (Adriani et al.,
2003; Lárraga et al., 2017). Although long-term alterations in brain function have been
reported following adolescent nicotine exposure (Counotte et al., 2009; Doura et al.,
2010), the specific neuroadaptations that give rise to excessive alcohol consumption in
adulthood remain unknown.
Our previous work suggested that nicotine-ethanol interactions could arise via altered
GABAA receptor (GABAAR) signaling within the ventral tegmental area (VTA) (Doyon et
al., 2013a). GABAARs are positively modulated by ethanol and are implicated in ethanol
reinforcement (Boyle et al., 1993; Rassnick et al., 1993a). The strength and polarity of
GABAAR signaling are predominantly dictated by cellular chloride ion (Cl-) gradients and
maintained by the K+, Cl- transporter, KCC2 (Doyon et al., 2016). Impaired KCC2 function
and intracellular Cl- accumulation leads to depolarizing shifts in the Cl- reversal potential
(EGABA) and compromised GABAAR-mediated inhibition (Hewitt et al., 2009; Ostroumov et
al., 2016). Within VTA GABA neurons, functional KCC2 downregulation and the
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consequent decreased GABAAR-mediated inhibition are thought to promote alcohol selfadministration following glucocorticoid receptor activation (Ostroumov et al., 2016).
Based on that previous work, we hypothesized that adolescent nicotine exposure
promoted ethanol consumption in adulthood via persistent adaptations in Cl- homeostasis.
We found that rats treated with nicotine as adolescents, but not those treated as adults,
showed elevated ethanol self-administration and excitatory shifts in GABAAR signaling a
month later that were dependent on glucocorticoid receptor activation. Adolescent nicotine
exposure impaired Cl- extrusion via KCC2 downregulation and altered mesolimbic
responses to ethanol. Enhancing Cl- extrusion in adolescent nicotine-treated rats returned
GABAergic inhibitory signaling to normal and returned alcohol consumption to control
levels. These results indicate that adolescent nicotine exposure produces long-lasting
alterations in Cl- homeostasis and GABAAR signaling and contributes to elevated ethanol
self-administration in adulthood.
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Methods and Materials
Animals
Male Long-Evans rats (Harlan-Envigo) were singly housed in a quiet temperature- and
humidity-controlled satellite facility under a 12-hr:12-hr light:dark cycle. Rats had food and
water available ad libitum in their home cages. All procedures were carried out in
compliance with guidelines specified by the Institutional Animal Care and Use Committee
at the University of Pennsylvania.
Drugs and Experimental Design
All drugs (Sigma-Aldrich, St. Louis, MO, USA) were dissolved in sterile saline unless
otherwise specified. Rats were administered daily injections of saline or nicotine tartrate
(0.4 mg/kg, freebase, i.p. injections) during adolescence (p28–p42), and responses to
ethanol were assessed in adulthood beginning 4 weeks later. The p28–p42 window
represents a conservative time frame within adolescence (Spear, 2000). A separate cohort
of animals was pretreated with RU486 (40 mg/kg, i.p. injections) 15 min prior to each
adolescent nicotine injection to examine the contribution of glucocorticoid receptor
signaling. Comparable injections were carried out in post-adolescent animals (>p60 or 300
g), and responses to ethanol were assessed 4 weeks post-nicotine exposure. Intra-VTA
microinfusions of CLP290 or vehicle occurred 30 min prior to ethanol self-administration
over 3 non-consecutive days. Animals that received vehicle infusions were
indistinguishable from non-surgerized controls and were thus combined. The intra-VTA
concentration of CLP290 was 50 µM delivered at 0.5 µL/min to 1 µL (Ostroumov et al.,
2016) at the following VTA coordinates (in millimeters relative to bregma): +5.7 anteriorposterior, +1.0 medial-lateral, −7.1 ventral to the skull surface (Paxinos & Watson, 1986).
A separate group of rats treated with 45 µM CLP290 before the first day of self73

administration were indistinguishable from the 50-µM treatment group, and these results
were thus combined.
Operant Ethanol Self-Administration
Standard operant chambers (Med Associates) were used for the self-administration
experiments. Illumination of an interior chamber light and presentation of a retractable
lever cued the start of each session. Depression of the lever triggered the entry of a
retractable drinking spout on the opposite side of the wall. Each lever press resulted in 15
s of access to the drinking spout (a fixed-ratio reinforcement schedule of 1). Animals
initially had restricted access to water overnight and were trained to press a lever for a
saccharin solution (0.125%, w/v). Once trained, the animals no longer had restricted
access to water, and their basal saccharin intake was monitored until intake appeared
stable for 3 consecutive days (one 60-min session per day). If the animals underwent
surgery, saccharin intake was re-established. The effects of nicotine or saline
pretreatment on 2%–4% ethanol self-administration were then measured (Ostroumov et
al., 2016). We previously confirmed that this self-administration protocol produces
pharmacologically relevant blood alcohol levels ranging from 40 to 160 mg/dL (Ostroumov
et al., 2016). In comparison, the legal limit of alcohol intoxication in humans is 80 mg/dL.
For 8% ethanol studies, initial ethanol fading (2%–8%) occurred over the first 8 days in a
saccharin solution (0.15%, w/v), and intake of 8% ethanol consumption was then
monitored for 7 consecutive days (Doyon et al., 2005). A separate cohort of animals
followed the same 8-day ethanol-fading procedure (2%–8%), but saccharin was then
gradually removed over 6 days. Intake of 8% ethanol without saccharin was subsequently
monitored for 7 consecutive days.

74

Ex Vivo Electrophysiology
Horizontal slices (230 µm) containing the VTA were cut (Leica Microsystems) from adult
Long-Evans rats in ice-cold, oxygenated (95% O2, 5% CO2), high-sucrose artificial
cerebrospinal fluid (ACSF) (in millimolar): 205.0 sucrose, 2.5 KCl, 21.4 NaHCO3, 1.2
NaH2PO4, 0.5 CaCl2, 7.5 MgCl2, and 11.1 dextrose. Immediately after cutting, slices
were transferred to normal ACSF buffer (in millimolar): 120.0 NaCl, 3.3 KCl, 25.0
NaHCO3, 1.2 NaH2PO4, 2.0 CaCl2, 1.0 MgCl2, 10.0 dextrose, and 20.0 sucrose. The
slices were constantly oxygenated (95% O2, 5%CO2) and maintained at 32°C in ACSF
for 40 min, then at room temperature for at least 60 min. For incubation experiments, slices
were bathed in CLP290 (10 µM) for an additional hour. To perform electrophysiological
recordings, slices were transferred to a holding chamber and perfused with normal ACSF
at a constant rate of 2–3 mL/min at 32°C. Patch electrodes made of thin-walled
borosilicate glass (1.12 mm inner diameter [ID], 1.5 mm outer diameter [OD]; World
Precision Instruments [WPI]) had resistances of 1.0–2.0 MΩ when filled with the internal
solution (in millimolar): 135.0 KCl, 12.0 NaCl, 2.0 Mg-ATP, 0.5 EGTA, 10.0 HEPES, and
0.3 Tris-GTP (pH 7.2–7.3).
For EGABA perforated-patch recordings, gramicidin was first dissolved in methanol to a
concentration of 10 mg/mL and then diluted in a pipette solution to a final concentration of
150 µg/mL. For synaptic stimulation recordings, a bipolar tungsten-stimulating electrode
(World Precision Instruments) was placed 100–150 µm away from the recording electrode.
To determine EGABA, evoked IPSCs were measured under voltage clamp at different
holding potentials. Amplitudes of IPSCs were plotted against voltage to estimate the
reversal potential. After each perforated-patch experiment, recordings were converted to
the whole-cell configuration, and Ih current was measured. When necessary, recordings
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were performed in the presence of DNQX, AP5, CGP55845, and tetrodotoxin (0.5 µM) to
isolate GABAergic currents.
VTA GABA neurons in the lateral VTA were identified by a combination of factors,
including small somata size, high firing rate (>7 Hz), and the lack of Ih current. Cells with
these properties were consistently tyrosine hydroxylase (TH) negative (> 95%) (Korotkova
et al., 2006; Ostroumov et al., 2016). Basal spontaneous firing rate of GABA neurons was
not altered after exposure to the nicotine treatment: 16 ± 3 Hz after nicotine and 14 ± 3 Hz
in control. In contrast, DA neurons were identified in the lateral VTA by their morphology
(>20 µm soma size), their low firing frequency (<5 Hz), and the presence of a large Ih
current, which, together, was shown to correlate (95%) with TH-positive cells using
immunocytochemistry approaches (Zhang et al., 2010; Doyon et al., 2013a; Ostroumov et
al., 2016). Basal spontaneous firing rate of DA neurons ex vivo was not altered after
exposure to the adolescent nicotine treatment: 1.9 ± 0.3 Hz after nicotine treatment and
1.6 ± 0.1 Hz in control. Spontaneous inhibitory postsynaptic currents onto DA neurons
were recorded in voltage-clamp mode in the whole-cell configuration. Synaptic GABAAR
inputs were isolated pharmacologically. To measure activity-dependent depression of
evoked IPSCs, whole-cell recordings were performed during repetitive stimulation (Hewitt
et al., 2009). The estimated GABA reversal was approximately −70 mV, and the internal
solution contained (in milllimolar): 123.0 K+-gluconate, 8.0 NaCl, 2.0 Mg-ATP, 0.2 EGTA,
10.0 HEPES, and 0.3 Tris-GTP (pH 7.2–7.3). Synaptic GABAAR input was isolated using
DNQX, AP5, and CGP55845. The liquid junction potential between the bath and the
pipette solutions was corrected.
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Western Blots
The VTA was harvested in horizontal brain slices from adult rats, and the VTA slices were
prepared as described previously in the Ex Vivo Electrophysiology section. Membrane
fractions were prepared using the Mem-PER Plus Membrane Protein Extraction Kit (Model
#89842; Thermo Scientific, Rockford, IL, USA). Samples (30 µg protein) in 2.5% 2mercaptoethanol were run through a 4%–15% Precast Protein Gel (#4561083; Bio-Rad).
The sample was transferred to nitrocellulose membrane (Bio-Rad). Primary antibodies
used were rabbit anti-KCC2 antibody at 1:400 (#07-432; Millipore, Temecula, CA, USA)
and mouse anti-GAPDH (glyceraldehyde 3-phosphate dehydrogenase) antibody
(#MAB374; Millipore) at 1:400. Secondary antibodies used were goat anti-rabbit
immunoglobulin (Ig)G secondary antibody (#T2191; Applied Biosystems, Foster City, CA,
USA) or goat anti-mouse IgG/IgM (#T2192, Applied Biosystems). All antibodies were
diluted in SignalBoost solution (#407207; EMD Millipore, Billerica, MA, USA). Membranes
were developed using Tropix CDP-Star solution (T2218; Applied Biosystems) for 5 min
and then scanned using the Protein Simple FluorChem R chemiluminescence detector
and analyzed using AlphaView SA software. The optical densities of KCC2-specific bands
were measured and normalized to the loading control GAPDH values.
To analyze KCC2 immunolabeling in the VTA, rats were perfused with PBS (Chemicon),
followed by 4% paraformaldehyde (Boston BioProducts). Brains were post-fixed for
additional 2 hr in 4% paraformaldehyde and then kept in 30% sucrose for 24–48 hr. VTA
sections were cut at 30 µm and processed with antibodies against KCC2 (1:500, Millipore,
#07-432) and TH (1:1,000, Millipore, #MAB318) or GAD-67 (1:150, Santa Cruz
Biotechnology, #sc-5602) overnight at 4°C. After washing in PBS, immunofluorescence
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reactions were visualized using secondary antibodies labeled with Alexa Fluor 488 or
Alexa Fluor 594 (1:1,000; Invitrogen) and confocal microscopy.
In Vivo Electrophysiology
Rats were anesthetized with isoflurane and implanted with a catheter in the jugular vein.
Animals were positioned on a stereotaxic apparatus, and burr holes were drilled into the
skull to accommodate recording and ground electrodes. Rat body temperature was
maintained throughout the experiment at 37°C using an isothermal pad. Glass electrodes
backfilled with 0.5 M Na+-acetate and 2% Chicago Sky Blue (5–15 MU) were positioned
in the lateral VTA (coordinates: 5.3–6.0 mm posterior from bregma, 0.8–1.4 mm lateral to
midline, and 7.5–8.5 mm ventral to brain surface). Electrical signals were filtered at 0.3–5
kHz. DA neurons in the lateral VTA were identified in vivo using established
electrophysiological and pharmacological criteria (Ostroumov et al., 2016). After 6–20 min
of stable baseline recording, we infused 0.3 g/kg of ethanol (by intravenous [i.v.] injection)
every 3 min to a final dose of 1.5 g/kg over 15 min. Drug-induced changes were detected
by the second infusion period and were comparable across all dose ranges (0.6–1.5
mg/kg). Following ethanol administration, the D2 receptor agonist quinpirole and the D2
receptor antagonist eticlopride were infused (i.v. injection, 0.25 mg/kg) to aid in the
identification of VTA DA neurons. Chicago Sky Blue injections were used to identify the
recording sites.
Statistical Analyses
An ANOVA with repeated measures (in SPSS for Windows) was used to analyze the daily
ethanol intake. Exponential fittings were compared by F test. For western blot analysis, a
paired t test was used to compare protein levels from saline- and nicotine-treated animals
that were run on the same gel. A two-tailed t test assuming equal variance was used to
78

assess differences between the mean GABA reversal potential, sIPSC frequency, ethanol
intake, and DA firing rate. Significance for all analyses was determined by p < 0.05.

79

Results
Adolescent Nicotine Increases Adult Ethanol Self-Administration
Adolescent rats were administered daily injections of saline or nicotine (0.4 mg/kg,
intraperitoneal [i.p.] injections) on post-natal day (p)28–p42, and ethanol selfadministration was measured approximately 1 month later (p70–p100; 1-hr session per
day) (Fig. 3.1A). Operant responses to saccharin were first established, followed by the
introduction of 2%–4% ethanol into the drinking solution (Ostroumov et al., 2016).
Saccharin consumption was measured 3 days immediately prior to ethanol exposure and
the average intake was not statistically different between adolescent nicotine-treated
animals (10 ± 1 mL) and adolescent saline controls (8 ± 1 mL): p > 0.05 n = 8, 10 rats per
group. Upon adding ethanol to the drinking solution, adolescent nicotine-treated animals
showed significantly increased self-administration compared to adolescent saline controls
(Fig. 3.1B): for group, F(1, 16) = 14.48, p < 0.01. Analysis of total fluid consumption also
revealed greater intake among adolescent nicotine-treated rats compared to controls: for
group, F(1, 16) = 14.69, p < 0.01. Mean ethanol intake across the first 7 days was 1.03 ±
0.05 g/kg for the nicotine-pretreated group and 0.75 ± 0.05 g/kg for the saline-pretreated
group (Fig. 3.1C): p < 0.01, n = 8, 10 rats per group.
Next, we examined self-administration of higher ethanol concentrations. The average
intake of 8% ethanol was significantly increased in the adolescent nicotine group
compared to adolescent saline controls (Fig. 3.1D): for nicotine, 1.83 ± 0.11 g/kg; for
saline, 1.30 ± 0.16 g/kg; p < 0.05; n = 9, 5 rats per group. To confirm the specificity of this
effect to ethanol, saccharin was removed, and the intake of 8% ethanol was measured.
Elevated drinking was observed in adolescent nicotine-treated animals compared to
saline-treated controls after the removal of saccharin (Fig. 3.1E): for nicotine, 0.88 ± 0.05
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g/kg; for saline, 0.60 ± 0.05 g/kg; p < 0.01, n = 11, 9 rats per group. The effects of
adolescent nicotine exposure persisted throughout the duration of self-administration
experiments (25 days), revealing long-lasting alterations in the acquisition and
maintenance of ethanol self-administration in adult animals.
Adult Nicotine Exposure Does Not Increase Adult Ethanol Self-Administration
To determine the effect of post-adolescent nicotine exposure on subsequent ethanol
consumption, young adult animals were administered comparable nicotine or saline
injections over a 2-week period (p60–p74). Self-administration was assessed in these
animals approximately 1 month later (Fig. 3.2A). Adult nicotine pretreatment failed to
increase daily ethanol self-administration compared to adult saline controls (Fig. 3.2B): for
group, F(1, 9) = 0.01, p > 0.05. The average intake in the adult nicotine group (0.76 ± 0.08
g/kg; Fig. 3.2C, gray bar) was not statistically different from that in adult saline controls
(0.68 ± 0.06 g/kg; Fig. 3.2C, black bar) or adolescent saline controls (0.71 ± 0.05 g/kg;
dotted line of Fig. 3.2C: p > 0.05, n = 9, 14, 9 rats per group). These results suggest that
adolescent, but not adult, nicotine exposure produces long-lasting elevations in
subsequent ethanol self-administration.
Adolescent Nicotine Alters GABA Transmission and Chloride Ion Homeostasis in the VTA
Enhanced ethanol self-administration has been previously associated with depolarizing
shifts in the GABAAR reversal potential (EGABA) of VTA GABA neurons (Ostroumov et al.,
2016). To examine whether adolescent nicotine exposure altered EGABA, midbrain slices
were prepared from adult rats treated with nicotine or saline during adolescence (Fig.
3.3A). Next, gramicidin perforated patch-clamp recordings were performed in VTA GABA
neurons to preserve the intracellular anion concentrations (Fig. 3.3B). We measured
GABAAR currents at different membrane potentials following electrical stimulation (Fig.
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3.3C). VTA GABA neurons from adult rats receiving adolescent nicotine showed a
significantly more depolarized EGABA value compared to saline-treated controls (Fig. 3.3C
and D): −66 ± 2 mV after nicotine (indicated in red) versus −87 ± 4 mV in controls (indicated
in black), n = 6, 7 cells per group, p < 0.01. Adolescent nicotine did not alter the membrane
resting potential (measured as zero holding current): −56 ± 2 mV after nicotine versus −61
± 3 mV in controls, n = 6, 7 cells per group, p > 0.05.
We previously showed that nicotine targets glucocorticoid receptors to alter GABAergic
signaling within the VTA (Doyon et al., 2013a). To examine whether glucocorticoid
receptor activation is necessary for adolescent nicotine to alter EGABA, adolescent animals
were injected with RU486 (40 mg/kg, i.p. injections) 15 min prior to injections with saline
or nicotine. Systemic injection of RU486 prior to nicotine prevented the adolescent
nicotine-mediated alterations in EGABA (Fig. 3.3D, blue): −84 ± 2 mV, n = 6 cells, p > 0.05.
These animals did not differ significantly from controls treated with RU486 and saline (data
not shown): −83 ± 4 mV, n = 6 cells, p > 0.05.
We next examined the effect of post-adolescent nicotine exposure on EGABA. Young adult
animals were administered nicotine or saline injections over a 2-week period (p60–p74),
and slice electrophysiology experiments were conducted approximately 1 month later. No
differences in EGABA were observed after adult nicotine exposure compared to adolescent
or adult saline-treated controls (Fig. 3.3D, gray): −87 ± 4 mV, n = 6 cells, p > 0.05.
Therefore, long-lasting adaptations in EGABA occur after adolescent, but not adult,
exposure to nicotine.
A depolarizing shift in EGABA reflects higher intracellular anion concentration and is often
mediated by a decrease in Cl- extrusion capacity. To test whether adolescent nicotine
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weakens Cl- extrusion in VTA GABA neurons, we applied repetitive GABAAR stimulation
during whole-cell recordings under a holding potential that favors Cl- influx (Vh = 0 mV).
Faster rates of inhibitory postsynaptic current (IPSC) amplitude reduction during repetitive
stimulation are indicative of impaired Cl- extrusion (Hewitt et al., 2009). Adolescent
nicotine-treated animals showed significantly faster rates of IPSC amplitude reduction
compared to adolescent saline controls (Fig. 3.3E and F): F(2;5) = 9.30, p < 0.05. No
differences in synaptic depression were observed between groups when the Cl- driving
force was outward (Vh = −90 mV; Fig. 3.3G). These data confirm that the differential
effects on short-term depression are derived from Cl- extrusion efficacy.
Adolescent Nicotine Downregulates KCC2 Expression
Reductions in Cl- extrusion capacity are often mediated by downregulation of the K+, Clcotransporter, KCC2 (Sarkar et al., 2011). To examine adolescent nicotine-induced
alterations in KCC2 protein expression, we performed western blot analysis using an
antibody against KCC2 protein. Immunoblots revealed two prominent bands
(approximately 140 and 270 kDa), indicating the presence of monomeric and dimeric
structures of KCC2 protein (Fig. 3.4A). A significant reduction in the expression of KCC2
was observed after adolescent nicotine pretreatment (Fig. 3.4A and B): 74% ± 6% for
monomer, 76% ± 6% for dimer, n = 12, p < 0.01. As predicted by our electrophysiological
results in Fig. 3.3, immunostaining revealed overlap between KCC2 and GAD67 protein,
confirming the presence of KCC2 protein in VTA GABA neurons (Fig. 3.4C).
In agreement with the literature (Taylor et al., 2016), immunolabeling analysis revealed
that KCC2 protein was not expressed in tyrosine hydroxylase (TH)-positive neurons in the
VTA (Fig. 3.5a), suggesting that DA neurons express another Cl- extrusion mechanism
(Gulacsi et al., 2003). Perforated patch recordings were performed to determine whether
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adolescent nicotine also altered EGABA in VTA dopaminergic (DA) neurons (Fig. 3.5B).
EGABA in VTA DA neurons from adult rats receiving adolescent nicotine were
indistinguishable from that in saline-treated controls (Fig. 3.5B): −76 ± 3 mV after nicotine
(indicated in red) versus −77 ± 2 mV in controls (indicated in black), n = 6 cells per group,
p > 0.05. In concert with the results of Figures 3.3. and 3.4, these data indicate that
adolescent nicotine exposure induces long-lasting alterations in VTA KCC2 expression,
Cl- homeostasis, and GABAAR signaling within VTA GABA neurons.
Adolescent Nicotine Increases Ethanol-Induced Inhibition of Dopamine Neurons Ex Vivo
VTA GABA transmission influences mesolimbic DA neuron activity and is modulated upon
exposure to ethanol (Theile et al., 2008; Tan et al., 2012). Depolarizing shifts in EGABA
within the VTA GABA neurons were previously associated with greater ethanol-induced
inhibition of lateral VTA DA neurons (Ostroumov et al., 2016). To determine whether
adolescent nicotine exposure altered ethanol-induced GABA release onto DA neurons,
we performed whole-cell patch-clamp recordings of VTA DA neurons and measured
spontaneous IPSCs (Fig. 3.6A and B). In control rats, bath-applied ethanol (50 mM)
produced a small increase in spontaneous IPSC (sIPSC) frequency (Fig. 3.6C and D):
114% ± 4% of basal (indicated in black), n = 8. In contrast, lateral VTA DA neurons from
rats treated with nicotine during adolescence showed significantly greater ethanol-induced
potentiation of sIPSC frequency compared to the control response (Fig. 3.6C and D): for
nicotine-treated rats, 177% ± 6% of basal, (indicated in red), n = 13, p < 0.01. No significant
differences in baseline sIPSC frequency were detected between saline and nicotine
groups: 4 ± 1 Hz in saline-treated rats versus 4 ± 1 Hz in nicotine-treated rats (p > 0.5).
Importantly, neither group showed alterations in sIPSC amplitude upon exposure to
ethanol (45 ± 5 pA in saline-treated versus 38 ± 6 pA in nicotine-treated rats, p > 0.05).
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An increase in the frequency, but not the amplitude, of sIPSCs suggests enhanced
presynaptic GABA release onto the DA neurons.
Adolescent Nicotine Attenuates Ethanol-Induced Dopamine Neuron Activity In Vivo
Ethanol application typically increases the firing of VTA DA neurons, and a more
depolarized EGABA in VTA GABA neurons has been shown to attenuate DA responses to
ethanol (Foddai et al., 2004; Ostroumov et al., 2016). We therefore hypothesized that
adolescent nicotine exposure would also attenuate adult ethanol-induced DA responses
from the lateral VTA in vivo (Fig. 3.6E). To test this, we first conducted in vivo single-unit
recordings of lateral VTA DA neurons in anesthetized adult rats. DA neurons were
recorded in the lateral VTA and were identified based on their electrophysiological and
pharmacological properties (see Methods and Materials). The spontaneous firing rate of
these VTA DA neurons was measured before and after intravenous infusion of ethanol
(0.3 mg/kg), and this dose was increased every 3 min until a final concentration of 1.5
mg/kg was achieved. Basal spontaneous firing rate of these DA neurons was not altered
after exposure to adolescent nicotine: 8.0 ± 0.7 Hz after nicotine and 7.4 ± 0.5 Hz in
control. Ethanol administration (0.6–1.5 mg/kg) induced a significant increase in the
spontaneous firing rate of lateral VTA DA neurons in saline-treated controls (Fig. 3.6F and
G, indicated in black): 124 ± 5% of basal, n = 17. In contrast, DA neurons from adolescent
nicotine-treated animals did not show significant increases in DA firing (Fig. 3.6F and G,
indicated in red): 98 ± 2% of basal, n = 7, p < 0.01. The VTA recording sites from
adolescent saline-treated (black) and adolescent nicotine-treated (red) rats were similar
across experiments (Fig. 3.6H). Taken together with our ex vivo electrophysiology results,
these data indicate that adolescent nicotine exposure produced long-lasting, circuit
adaptations in VTA DA neuron responses to ethanol.
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Restoring KCC2 Function Normalizes GABA Signaling and Alcohol Self-Administration
Intracellular Cl- accumulation can be reversed by enhancing Cl- extrusion with the KCC2
agonist CLP290 (CLP) (Gagnon et al., 2013; Ostroumov et al., 2016). To determine
whether CLP290 restored Cl- extrusion in VTA GABA neurons, we applied repetitive
GABAAR stimulation to slices incubated in CLP290 (>1 hr, 10 µM) under a holding
potential (Vh) of 0 mV to induce Cl- influx (Fig. 3.7A and B). Following CLP290 incubation,
the rates of IPSC amplitude reduction were indistinguishable between adolescent
nicotine-treated animals (indicated in red) and adolescent saline-treated controls
(indicated in black; Fig. 3.7C, p > 0.05).
Because CLP incubation prevented intracellular Cl- accumulation, we hypothesized that
CLP incubation would also prevent enhanced GABA release onto DA neurons in
adolescent nicotine-treated animals (Fig. 3.7D). Indeed, the nicotine-mediated
potentiation of the sIPSC frequency by ethanol was prevented by CLP290 incubation (Fig.
3.7E) (p > 0.05). The average sIPSC frequency induced by ethanol (relative to basal) was
123% ± 4% in adolescent nicotine-treated animals (Fig. 3.7E, red bar with CLP treatment)
and 123% ± 9% in saline-treated controls (Fig. 3.7E, black bar). These results indicate
that the effects of adolescent nicotine pretreatment on altered ethanol-induced GABA
network activity in the VTA could be reversed by CLP290.
Finally, we examined whether enhancing Cl- extrusion would prevent elevated ethanol
self-administration following adolescent nicotine exposure. Adolescent-treated rats
received bilateral intra-VTA infusions of CLP290 (1 µL, 50 µM) or vehicle prior to ethanol
self-administration on non-consecutive days (Fig. 3.8A and B, blue arrows). Compared to
adolescent nicotine-treated rats that received intra-VTA infusion of vehicle (Fig. 3.8A and
B, red), intra-VTA infusion of CLP290 significantly decreased daily ethanol consumption
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(Fig. 3.8A and B, blue): for group, F(1, 19) = 18.43, n = 9, 13 rats per group, p < 0.01.
Mean ethanol intake over 7 days was also significantly lower in rats (Fig. 3.8C) that
received infusions of CLP290 (0.79 ± 0.04 g/kg, blue bar), compared to animals that
received infusions of vehicle (1.04 ± 0.03 g/kg, red bar); n = 9, 13 rats per group, p < 0.01.
Bilateral VTA cannulation and vehicle infusions did not significantly alter ethanol
consumption in adolescent saline-treated controls compared to controls without surgery
(Fig. 3.8B and C, dotted gray lines): 0.75 ± 0.04 g/kg, n = 6, p > 0.05. In addition, intraVTA infusions of CLP290 did not significantly alter ethanol consumption in adolescent
saline-treated animals compared to vehicle infusions: 0.63 ± 0.05 g/kg, n = 5, p > 0.05.
Infusion sites were similarly distributed throughout the anterior/posterior axis of the VTA
(Fig. 3.8D).
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Discussion
Adolescent tobacco exposure is predictive of pathological drinking later in life (Jensen et
al., 2003; Riala et al., 2004), but the neuronal adaptations underlying this interaction have
not been well delineated. We demonstrated in rats that repeated exposure to nicotine
during adolescence, but not adulthood, promotes long-lasting increases in ethanol selfadministration. In VTA GABA neurons, adolescent nicotine treatment functionally
downregulated KCC2, attenuated Cl- extrusion, and caused a depolarizing shift in EGABA.
These alterations were associated with enhanced GABAergic inhibition of DA neurons in
the lateral VTA upon ethanol exposure and diminished DA responses to ethanol. Most
importantly, enhancing Cl- extrusion in adolescent nicotine-treated animals prevented
alterations in VTA GABA signaling and normalized ethanol self-administration to control
levels.
Adolescence is thought to be a critical period of neural development, and drug exposure
during this time is known to induce persistent neurobehavioral alterations (Chambers et
al., 2003; Spear, 2016). Here, we show that adolescent, but not adult, nicotine exposure
increases ethanol self-administration and induces depolarizing shifts in EGABA. These
findings support previous work suggesting that a unique vulnerability to nicotine may exist
during adolescence (Adriani et al., 2003; Counotte et al., 2009; Lárraga et al., 2017) and
point to differential regulation of GABAergic transmission as a factor mediating adolescent
vulnerability to substance use.
Within the VTA, GABAARs on GABA and DA neurons can show differential responses to
drugs of abuse (Green et al., 2010). We previously demonstrated that GABAAR signaling
onto VTA GABA neurons is positively modulated by ethanol and contributes to ethanol
88

reinforcement (Ostroumov et al., 2016). Depolarizing shifts in GABAAR signaling within
the VTA have been reported in adult animals under conditions of stress, drug dependence,
and withdrawal (Laviolette et al., 2004; Taylor et al., 2016), but our results demonstrate
that these adaptations can persist into adulthood following an adolescent drug exposure.
These long-lasting alterations in GABAAR signaling may, therefore, represent a
neurobiological mechanism by which adolescent nicotine exposure acts as a gateway for
subsequent alcohol use and abuse (Torabi et al., 1993; Chen et al., 2002; Cross et al.,
2017).
The strength of GABAergic inhibition is dynamically regulated in the adult nervous system
through changes in the transmembrane Cl- gradient (Doyon et al., 2016). We provide
evidence that changes in EGABA following adolescent nicotine treatment arise from
impaired Cl- extrusion and downregulation of the K+, Cl- transporter KCC2. This neuronspecific transporter is differentially expressed across development and differentially
regulated by environmental exposures (Williams et al., 1999). In mature neurons, KCC2
downregulation is known to occur in pathological conditions like epilepsy and chronic pain
(Kaila et al., 2014). More recently, KCC2 downregulation has also been observed in VTA
GABA neurons following acute stress and opiate withdrawal (Ostroumov et al., 2016;
Taylor et al., 2016). Thus, KCC2 is a key molecular target underlying changes in
GABAergic signaling across the CNS.
Our findings suggest the involvement of glucocorticoid receptors, which have previously
been shown to reduce KCC2 activity via S940 dephosphorylation (Ostroumov et al., 2016).
It is known that dephosphorylation at S940 precedes KCC2 internalization and decreased
membrane expression (Lee et al., 2007), which suggests that adolescent exposure to
nicotine more potently drives KCC2 downregulation compared to acute stress. Future
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work should examine the intermediate signaling molecules from glucocorticoid receptors
to changes in KCC2 expression, because these mechanisms may differ between
adolescent and adult populations.
Ethanol acts at multiple targets within the midbrain to elicit DA release, including
glutamatergic, GABAergic, and direct actions on DA neuron cell firing (Harris, 1999).
Downstream of the KCC2 and VTA GABA neuron alterations, there was increased
ethanol-induced inhibition of lateral VTA DA neurons and attenuated ethanol-induced DA
neuron firing from adolescent nicotine-treated animals. Our prior work demonstrated that
a blunted DA response to ethanol corresponded with impairment of Cl- homeostasis in the
VTA and increased ethanol self-administration (Ostroumov et al., 2016). Because DA
signaling is heterogeneous from its source in the midbrain to its targets throughout the
striatum and elsewhere (Lammel et al., 2012; Yang et al., 2018), the amplitude and
temporal DA signal response to ethanol throughout the nucleus accumbens, a principal
target region of the VTA important in ethanol reinforcement (Ikemoto et al., 1997), is not
anticipated to be homogeneous. Moreover, the finding that attenuated or intermediate DA
responses to ethanol and enhanced ethanol self-administration is consistent across
multiple studies (Brodie & Appel, 2000; Ramachandra et al., 2007; Doyon et al., 2013a;
Ostroumov et al., 2016) and illustrates how impaired Cl- extrusion can influence broader
mesolimbic responses to ethanol.
Direct modulation of KCC2 is a favored therapeutic strategy to restore GABAAR function
under conditions involving impaired Cl- transport (Gagnon et al., 2013). We showed that,
following adolescent nicotine exposure, elevated drinking in adulthood could be prevented
by intra-VTA infusion of the KCC2 agonist, CLP290. These results suggest that Clextrusion enhancers may serve as a therapeutic strategy to mitigate excessive alcohol
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consumption in smoking populations. Taken together, these results reveal that adolescent
nicotine exposure induces long-lasting alterations in mesolimbic responses to ethanol and
promotes ethanol consumption in adulthood. Thus, adolescent tobacco use may increase
the risk for excessive alcohol drinking in adulthood.
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Figures

Figure 3.1. Adolescent Nicotine Exposure Increases Adult Ethanol Self-Administration.
(A) Adolescent animals were administered daily injections of saline or nicotine from p28 to p42,
and adult ethanol self-administration was assessed beginning 4 weeks later. (B) Mean daily ethanol
intake for the first seven self-administration sessions. Adolescent nicotine-treated rats (red) showed
greater daily ethanol intake compared to saline-treated controls (black). **p < 0.01, significantly
different by ANOVA with repeated measures, n = 8, 10 rats per group. (C) Average intake of 2%–
4% ethanol with saccharin over the first seven self-administration sessions. Adolescent nicotinetreated rats showed greater ethanol intake compared to saline-treated controls. **p < 0.01,
significantly different by t test, n = 8, 10 rats per group. (D) Average intake of 8% ethanol with
saccharin over seven self-administration sessions was significantly elevated in adolescent nicotinetreated animals compared to saline-treated controls. *p < 0.05, significantly different by t test, n =
5, 8 rats per group. (E) After saccharin removal, intake of 8% ethanol over seven self-administration
sessions was significantly elevated in adolescent nicotine-treated animals compared to salinetreated controls. **p < 0.01, significantly different by t test, n = 9, 11 rats per group.
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Figure 3.2. Adult Nicotine Exposure Does Not Increase Adult Ethanol Self-Administration.
(A) Adult animals were administered daily injections of saline or nicotine (p60–p74), and ethanol
self-administration was assessed beginning 4 weeks later. (B) Mean daily ethanol intake for the
first seven self-administration sessions. No differences in ethanol consumption were observed
between adult nicotine-treated (gray) and saline-treated (black) groups, p > 0.05, n = 5, 7 rats per
group. Ethanol intake in adolescent saline-treated controls is shown for comparison (dotted line).
(C) Average intake of 2%–4% ethanol with saccharin over the first seven self-administration
sessions. No differences in ethanol consumption were observed between adult nicotine-treated
and saline-treated groups, p > 0.05, n = 5, 7 rats per group. Ethanol intake in adolescent saline
controls is shown for comparison (dotted horizontal line).
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Figure 3.3. Adolescent Nicotine Exposure Alters GABA Transmission and Cl- Homeostasis.
(A) Animals were administered saline or nicotine throughout adolescence (p28–p42), and in vitro
electrophysiology experiments were conducted beginning 4 weeks later. (B) GABAergic input onto
VTA GABA neurons was measured using gramicidin perforated-patch whole-cell recordings at
different holding potentials. GABAAR IPSCs were evoked by electrical stimulation in the presence
of glutamate and GABAB receptor antagonists. (C) Representative IPSCs recordings from salineand nicotine-treated animals at the given holding potentials (Vh). The IPSCs reverse direction at
the EGABA. For display, the traces were filtered, and stimulus artifacts were removed. (D) VTA GABA
neurons from adolescent nicotine-treated animals (red) demonstrated a significantly more positive
EGABA value compared to neurons from saline-treated control animals (black). No significant
differences in EGABA were observed if animals were pretreated with RU486 during adolescent
nicotine (blue) or if animals were treated with nicotine as adults (gray). **p < 0.01, significantly
different by t test, n = 6, 7 cells per group. (E) Cl- accumulation was estimated by stimulating
repetitive GABAAR input. Upon stimulation (20 Hz, Vh = 0 mV), a representative GABA neuron from
a saline-treated animal (black) demonstrated a minor depression of IPSC amplitude compared to
the significantly greater depression seen in a GABA neuron from a nicotine-treated animal (red).
(F) At 0 mV, VTA GABA neurons from nicotine-treated animals demonstrated a significantly higher
rate of evoked IPSC amplitude depression compared to saline-treated controls. **p < 0.01,
significantly different from the control by F test, n = 7, 9 cells per group. (G) At -90 mV, no
differences were observed in the rate of evoked amplitude depression in VTA GABA neurons from
nicotine-treated animals compared to saline-treated controls. p > 0.05, n = 7, 9 cells/group.
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Figure 3.4. Adolescent Nicotine Exposure Decreases KCC2 Expression in the VTA.
(A) Western blot analysis was conducted for KCC2 protein expression, with GAPDH as a loading
control. A representative western blot shows reduced expression of KCC2 in nicotine-treated
animals. (B) Densiometric analysis showed a significant reduction in KCC2 protein in nicotinetreated animals (red bars) compared to saline-treated controls (horizontal dashed line). **p < 0.01,
significantly different from the control by t test, n = 12 rats per group. (C) Immunostaining from a
VTA section revealed the presence of overlap between KCC2 and GAD67 right signals.
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Figure 3.5. VTA DA Neurons Lack KCC2 and Demonstrate No Change in Cl- Homeostasis
after Adolescent Nicotine Exposure.
(A) Immunostaining from a VTA section revealed lack of overlap between KCC2 and TH signals.
(B) GABAergic input onto VTA DA neurons was measured using gramicidin perforated-patch
recordings at different holding potentials. GABAAR IPSCs were evoked by electrical stimulation in
the presence of glutamate and GABAB receptor antagonists. No differences were detected in EGABA
values of VTA DA neurons from adolescent nicotine-treated animals compared to neurons from
saline-treated controls. p > 0.05, n = 6 cells/group.
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Figure 3.6. Adolescent Nicotine Exposure Increases Ethanol-Induced Inhibition of
Dopamine Neurons.
(A) Animals were administered saline or nicotine throughout adolescence (p28–p42), and in vitro
electrophysiology experiments were conducted beginning 4 weeks later. (B) Spontaneous
inhibitory postsynaptic currents (sIPSCs) onto VTA DA neurons were recorded using the wholecell patch-clamp configuration in the presence of glutamate receptor antagonists. (C)
Representative recordings of sIPSCs before and after ethanol administration in the adolescent
saline-treated (black) and adolescent nicotine-treated (red) animals. (D) Mean changes in the
sIPSC frequency after ethanol (50 mM) application in VTA DA neurons. DA neurons from nicotinetreated animals demonstrated a significantly increased ethanol-mediated sIPSC frequency
compared to neurons from saline-treated controls. **p < 0.01, significantly by t test, n = 8, 13 cells
per group. (E) Animals were administered saline or nicotine throughout adolescence (p28–p42),
and in vivo DA responses to ethanol were measured beginning 4 weeks later. (F) Representative
in vivo recordings from putative DA neurons before and after ethanol administration in the salineand nicotine-treated groups. No significant differences in the mean basal firing rate were detected.
(G) In saline-treated controls, ethanol increased the firing rate of putative DA neurons. In the
nicotine-treated group, ethanol failed to increase the firing rate of putative DA neurons. **p < 0.01,
significantly different from the control group by t test, n = 7, 19 rats per group. (H) Putative DA
neuron recording sites in the VTA from adolescent saline-treated (black) and nicotine-treated (red)
animals.
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Figure 3.7. Enhancing VTA Cl- Extrusion Ex Vivo Normalizes GABA Signaling in Adolescent
Nicotine-Treated Animals.
(A) Animals were exposed to saline or nicotine throughout adolescence (p28–p42), and effects of
CLP290 on GABAergic signaling were evaluated using slice electrophysiology 4 weeks later (p70–
p100). (B) The effect of CLP290 on Cl- accumulation was estimated by stimulating repetitive
GABAAR input and measuring eIPSC amplitude in VTA GABA neurons. (C) Following CLP290
incubation, no differences were observed in the rate of evoked amplitude depression in VTA GABA
neurons between saline-treated (black) and nicotine-treated (red) animals. n = 6, 9 cells per group.
(D) The effect of CLP290 on spontaneous inhibitory postsynaptic currents (sIPSCs) onto VTA DA
neurons were recorded using the whole-cell patch-clamp configuration in the presence of glutamate
receptor antagonists. (E) Following CLP290 incubation, no differences were observed between
saline-treated and nicotine-treated animals in the sIPSC frequency. n = 6, 5 cells per group.

99

Figure 3.8. Enhancing VTA Cl- Extrusion In Vivo Normalizes Ethanol Self-Administration in
Adolescent Nicotine-Treated Animals.
(A) Animals were exposed to saline or nicotine throughout adolescence (p28–p42), and the effects
of CLP290 on adult ethanol self-administration were measured. (B) Effects of CLP290 on mean
daily ethanol intake for the first seven self-administration sessions. Vehicle (red) or CLP290 (blue)
was locally infused bilaterally intra-VTA prior to ethanol self-administration on non-consecutive
days (blue arrows). Adolescent nicotine-treated animals that were also treated with CLP290
showed significantly reduced ethanol consumption compared to vehicle-treated controls. Ethanol
consumption in adolescent saline vehicle-treated control rats is shown for comparison (dotted line).
**p < 0.01, significantly different by ANOVA with repeated measures. (C) Effects of CLP290 on
mean ethanol intake over the first seven self-administration sessions. Adolescent nicotine-treated
animals that were also treated with CLP290 showed significantly reduced ethanol consumption
compared to vehicle-treated controls. Ethanol consumption in adolescent saline vehicle-treated
control rats is shown for comparison (dotted horizontal line). **p < 0.01, significantly different from
the VTA vehicle group by t test, n = 9, 13 rats per group. (D) No significant differences were
observed in CLP infusions sites from adolescent saline (black) and adolescent nicotine-treated
(red) animals.
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Abstract
Stress is known to alter GABAergic signaling in the ventral tegmental area (VTA), and this
inhibitory plasticity is associated with increased alcohol self-administration. In humans,
serotonin 2A receptor (5-HT2AR) agonists can treat stress- and alcohol-related disorders,
but the neural substrates are ill-defined. Thus, we reasoned that 5-HT2AR
pharmacotherapies may ameliorate the stress-induced dysregulated inhibitory VTA
circuitry that contributes to subsequent alcohol abuse. We found that acute stress
exposure in mice compromised GABA-mediated inhibition of VTA GABA neurons
corresponding with increased ethanol-induced GABAergic transmission. This stressinduced inhibitory plasticity was reversible by applying the 5-HT2AR agonist TCB-2 ex vivo
via functional enhancement of the potassium-chloride ion cotransporter KCC2. The
signaling pathway linking 5-HT2AR activation and normalization of KCC2 function was
dependent on protein kinase C signaling and phosphorylation of KCC2 at serine 940
(S940), as mutation of S940 to alanine prevented restoration of chloride ion transport
function by TCB-2. Through positive modulation of KCC2, TCB-2 also reduced elevated
ethanol-induced GABAergic signaling after stress exposure that has previously been
linked to increased ethanol consumption. Collectively, these findings provide mechanistic
insights into the therapeutic action of 5-HT2AR agonists at the neuronal and circuit levels
of brain reward circuitry.
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Introduction
Stress is commonly cited as a reason for initiation or escalation of alcohol use (Uhart &
Wand, 2009; Keyes et al., 2012). However, there remains a lack of treatments targeting
stress-subverted neural circuitry underlying this behavioral interaction. The midbrain
ventral tegmental area (VTA) is an important substrate of acute stress and alcohol
(ethanol) effects in the brain (Brodie et al., 1990; Saal et al., 2003; Niehaus et al., 2010).
Our prior work in rats, demonstrated that GABAAR signaling in VTA GABA neurons
undergoes stress-induced plasticity resulting in aberrant ethanol-induced excitation of
local GABA neurons (Ostroumov et al., 2016). Diminished GABA-mediated inhibition or
non-canonical excitation, reflected in a depolarized GABAAR reversal potential (EGABA),
arises from impaired chloride ion (Cl-) homeostasis maintained by the potassium-chloride
cotransporter, KCC2 (Kaila, 1994; Rivera et al., 1999; Coull et al., 2003; Doyon et al.,
2011; Kaila et al., 2014). Decreased functionality of KCC2 in the VTA contributes to
increased ethanol consumption (Ostroumov et al., 2016; Thomas et al., 2018), suggesting
that targeting this form of stress-induced neural plasticity can mitigate problem drinking.
Interestingly, serotonin 2A receptor (5-HT2AR) agonists demonstrate potential in human
patients as adjunctive pharmacotherapies for the treatment of neuropsychiatric disorders
including alcohol abuse and depression (Bogenschutz, 2013; Bogenschutz et al., 2015;
Carhart-Harris et al., 2016; Nichols et al., 2017; Nielson et al., 2018). For this reason, the
5-HT2AR might be critically involved in the relationship between stress and alcohol
drinking. However, the neural mechanisms linking 5-HT2AR activation to positive
therapeutic outcomes remains unclear (Vollenweider & Kometer, 2010). Promotion of
neuronal Cl- homeostasis, dictated by KCC2 in VTA GABA neurons, may underlie the
therapeutic success of 5-HT2AR agonists. Notably, TCB-2, a 5-HT2AR agonist (Fox et al.,
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2010), was shown to upregulate KCC2 function in spinal cord neurons following injury
(Bos et al., 2013; Dong et al., 2016; Sanchez-Brualla et al., 2018), indicating that 5-HT2AR
activation is one of a variety of mechanisms by which KCC2 can be modulated (Medina
et al., 2014; Mahadevan & Woodin, 2016). Furthermore, 5-HT2ARs and KCC2 are both
expressed in VTA GABA neurons and have both been implicated in the regulation of
inhibitory transmission in this brain area (Nocjar et al., 2002; Bankson & Yamamoto,
2004). Therefore, we hypothesized that activation of 5-HT2ARs in VTA GABA neurons
normalizes Cl- homeostasis after stress exposure by boosting KCC2 function and thereby
mitigates aberrant ethanol-induced GABAergic signaling that promotes increased ethanol
drinking (Ostroumov et al., 2016).
Indeed, we found that after stress exposure, ex vivo administration of TCB-2 promoted
recovery of Cl- homeostasis and returned VTA GABAergic circuitry to the pre-stress
condition. 5-HT2AR activation boosted stress-impaired KCC2 function via protein kinase C
signaling and phosphorylation of KCC2 at serine 940. At the circuit level, aberrant
GABAergic transmission in response to ethanol was prevented by 5-HT2AR activation.
These results indicate that VTA KCC2 upregulation is an important component of 5-HT2AR
agonist effects in the brain and suggest potential cellular and synaptic mechanisms that
underlie the therapeutic success of 5-HT2AR activation in treating stress- and alcoholrelated disorders.
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Methods and Materials
Animals
Adult, male, wildtype C57Bl/6J mice (8-16 weeks, The Jackson Laboratory) were used in
all studies, unless otherwise specified. Initially, mice arrived in the temperature- and
humidity-controlled vivarium facility group-housed (5 mice/cage) and were allowed to
acclimate to a reversed light/dark cycle (lights off: 10:00 am) for at least one week prior to
experimental manipulations. All home cages were provided with environmental
enrichment and ad libitum food and water access. All procedures were carried out in
compliance with guidelines specified by the Institutional Animal Care and Use Committee
at University of Pennsylvania.
S940A Mice
S940A knock-in mice were generously provided by the Moss Lab (Sackler School of
Graduate Biomedical Sciences, Tufts University, Boston, MA) (Silayeva et al., 2015).
Adult, S940A mice, raised on a C57 background and heterozygous for the point mutation
at S940 were used for electrophysiological recordings. S940A mice were maintained
under housing conditions described above. Genotypes were confirmed with PCR.
Wildtype C57 mice served as controls for experiments performed in S940A heterozygotes.
Drugs
The

5-HT2AR

agonist

(4-Bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamine

hydrobromide, TCB-2 (Tocris), was dissolved in deionized water for all experiments. The
5-HT2AR agonist 4-[2-[[(2-Hydroxyphenyl)methyl]amino]ethyl]-2,5-dimethoxybenzonitrile
hydrochloride (Jensen et al., 2017; Buchborn et al., 2018), 25CN-NBOH (Tocris), was
dissolved in dimethyl sulfoxide (DMSO). The 5-HT2AR antagonist, α-Phenyl-1-(2phenylethyl)-4-piperidinemethanol, MDL 11,939 (Tocris), was dissolved in DMSO. The
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PKC inhibitor, chelerythrine chloride (Tocris), was dissolved in deionized water. 190 proof
ethanol (Decon labs) was dissolved in aCSF for electrophysiological recordings.
Acute Restraint Stress
Acute restraint stress was performed using modified 50 mL Falcon tubes, with holes
created for breathing and tail exit. Stressed mice were subjected to 1 hr of immobilization,
which potently activates stress hormone signaling (Pitman et al., 1988), between 11 a.m.
and 3 p.m., 22-26 hr prior to experimentation. This timeframe was selected based on our
prior work (Ostroumov et al., 2016), in order to examine the prolonged effects of the acute
stress on neuronal signaling mechanisms in the VTA. Mice were removed from the home
cage and secured in the tube with a threaded cap. Restraint stress was performed for one
hour in all experiments. Unstressed, control animals remained in the home cage for the
duration of the one hour. Restraint stress resulted in vocalization, urination, and defecation
in the majority of animals (DeTurck & Vogel, 1982).
Slice Electrophysiology and Neuronal Identification
Electrophysiological recordings were performed as previously described (Ostroumov et
al., 2016; Thomas et al., 2018). Briefly, horizontal slices (230 µm) containing the VTA were
cut using a vibratome (Lecia Microsystems) in ice-cold, oxygenated (95% O2/5% CO2)
high-sucrose artificial cerebrospinal fluid (aCSF, in mM): 205.0 sucrose, 2.5 KCl, 21.4
NaHCO3, 1.2 NaH2PO4, 0.5 CaCl2, 7.5 MgCl2, 11.1 glucose. Upon cutting, slices were
immediately transferred to oxygenated (95% O2/5% CO2) standard aCSF for 40min at
32°C (in mM): 120.0 NaCl, 3.3 KCl, 25.0 NaHCO3, 1.2 NaH2PO4, 2.0 CaCl2, 1.0 MgCl2,
10.0 glucose, 20.0 sucrose. Following incubation, slices were kept at room temperature
for at least 1 hr and then transferred to a holding chamber for electrophysiological
recordings. During recordings, slices were perfused with standard aCSF at a constant flow
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rate of 2-3ml/min at 32°C. Thin-walled borosilicate glass (1.12mm ID, 1.5mm OD; WPI)
was used to make patch electrodes with resistances between 1.0-2.0 MW when filled with
internal solution. Unless otherwise specified, the internal solution contained (in mM): 135.0
KCl, 12.0 NaCl, 2.0 Mg-ATP, 0.5 EGTA, 10.0 HEPES, 0.3 Tris-GTP, pH 7.2-7.3. In all
experiments using 5-HT2AR agonists, slices were perfused with agonist-containing aCSF
solution for at least 10 min prior to recordings and for the duration of the experiment.
The firing rates of VTA GABA and DA neurons were recorded in cell-attached
configuration in voltage-follower (I=0) mode. To measure the effects of ethanol (50 mM,
Decon) on action potential firing in GABA neurons, stable firing was achieved for 6 min
followed by bath application of ethanol. Basal VTA GABA neuron firing rates did not differ
from the wildtype, untreated control group (16.5 ± 3.6 Hz) across experimental treatments
when analyzed by one-way ANOVA (p > 0.05). Repetitive synaptic stimulation recordings
in cell-attached configuration were performed with a bipolar tungsten stimulating electrode
(WPI), placed 50-100 µm from the patched neuron. Constant-current pulses were
delivered in trains of 20-Hz frequency, 1 s in duration, and 100-200 µA in amplitude. An
inter-stimulus interval of at least 1 min was used. GABAA receptor stimulation was isolated
using AMPA and NMDA-type glutamate receptor antagonists 6,7-dinitroquinoxaline-2,3dione (DNQX, 20 µM, Sigma Aldrich) and DL-2-amino-5-phosphonopentanoic acid (AP5,
50 µM, Tocris), respectively, as well as the GABAB receptor antagonist CGP55845 (1 µM,
Sigma Aldrich). After all cell-attached experiments, the patch configuration was converted
to whole-cell and the h current (Ih) was measured.
Perforated cell-attached recordings were performed to measure the GABA reversal
potential (EGABA). Gramicidin was first dissolved in methanol (10 mg/mL) and then diluted
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to a final concentration of 150 µg/mL in the internal solution. EGABA was estimated by
recording evoked inhibitory postsynaptic currents (eIPSCs) while voltage-clamping the
neuron at different holding potentials in the presence of DNQX, AP5, CGP55845, and
tetrodotoxin (0.5 µM, Abcam) dissolved in the perfusing aCSF. Vrest was estimated in I=0
current clamp mode. Upon completion of each EGABA measurement, perforated patches
were converted to the whole-cell configuration in order to record Ih.
Whole-cell recordings were performed in VTA DA neurons to measure spontaneous
IPSCs (sIPSCs) while holding the neuron at -60 mV. sIPSCs were isolated in the presence
of DNQX and AP5 dissolved in the perfusing aCSF. Following a 10-min baseline period,
ethanol (50 mM) was added to the aCSF for assessment of ethanol-induced changes in
sIPSCs relative to the pre-ethanol recording time. Basal sIPSC frequencies and
amplitudes did not significantly differ from the wildtype, untreated control group (3.9 ± 0.5
Hz; 29.6 ± 4.9 pA) between experiments by one-way ANOVA (p > 0.05). In VTA GABA
neurons, activity-dependent depression of eIPSCs was performed in whole-cell
configuration at both -90 mV (Cl- efflux) and 0 mV (Cl- influx) holding potentials with the
internal solution (in mM): 123.0 K+-gluconate, 8.0 NaCl, 2.0 Mg-ATP, 0.2 EGTA, 10.0
HEPES, 0.3 Tris-GTP, pH 7.2-7.3. The liquid junction potential between the patch pipette
and bath solution was corrected prior to recordings. Evoked IPSCs were isolated in the
presence of DNQX, AP5, and CGP55845 dissolved in the perfusing aCSF.
Neurons in the lateral VTA were identified by their morphological and electrophysiological
properties (Zhang et al., 2010; Ostroumov et al., 2016; Thomas et al., 2018). DA neurons
possess a large soma size (> 20 µm), low firing rate (1-5 Hz), and a prominent Ih. These
properties highly correlate with tyrosine hydroxylase (TH)-expressing neurons (Ostroumov
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et al., 2016). GABA neurons of the lateral VTA possess a small soma size (< 20 µm), high
firing rate (> 7 Hz), and lack Ih, corresponding with TH-negative neurons (Ostroumov et
al., 2016). A subset of neurons was used to validate these identification parameters by
backfilling patched neurons with neurobiotin and performing TH immunohistochemical
labeling. Patch pipettes contained 0.3% neurobiotin (Vector Laboratories) and slices were
fixed in 10% neutral formalin phosphate buffer for 12-24 hrs after completing recordings.
Following fixation, slices were incubated in blocking solution containing 3% normal goat
serum solution and 0.3% triton X-100 for 2 hrs prior to overnight incubation in primary
rabbit anti-TH (1:100; Millipore, AB152) at 4°C. Slices were then rinsed in PBS and
incubated in the secondary antibodies goat-anti rabbit AlexaFluor488 (1:1000,
ThermoFisher) and AMCA-conjugated streptavidin (1:1000, Jackson ImmunoResearch).
Western Blot Analysis
Bilateral VTA tissue punches (0.5 mm diameter; 230 µm thick) were collected from
horizontal brain slices prepared as described in the Slice Electrophysiology and Neuronal
Identification section. Whole cell lysates were prepared by homogenizing punched tissue
in 100 µL of ice-cold RIPA buffer (Boston BioProducts) containing phosphatase (1:250,
HALT, ThermoFisher) and protease (1:500, Sigma) inhibitors. Protein concentrations were
calculated using a Qubit fluorometer (ThermoFisher). Equalized protein samples were
prepared in 2.5% 2-mercaptoethanol, heated at 95°C for 4min and run on a 4-15% precast
protein gel (BioRad). Following electrophoresis, protein was transferred to nitrocellulose
membrane (BioRad) and blocked in 2.5% milk-containing TBS-T for 1 hr and then cut into
sections for separate probing of Total KCC2, phosphorylated S940, and GAPDH. The
primary antibodies were dissolved in SignalBoost primary solution (Millipore) at the
following concentrations: 1:1000 rabbit anti-KCC2 (Millipore, 07-432), 1:1000 rabbit anti110

Phospho-Ser940 KCC2 (PhosphoSolutions, p1551-940), or 1:300 mouse anti-GAPDH
(Millipore, MAB374). Following overnight incubation in primary antibodies at 4°C,
membranes were washed and incubated for 2 hr at room temperature in the secondary
antibodies dissolved in SignalBoost secondary solution: 1:5000 goat anti-rabbit IgG
(Applied Biosystems, T2191) or 1:5000 goat anti-mouse IgG/IgM (Applied Biosystems,
T2192). Membranes were then washed and prepared for chemiluminescent imaging in
Tropix CDP-Star solution (Applied Biosystems) for 5 min. Total KCC2, phosphorylated
S940, and GAPDH membranes were scanned concurrently with the Protein Simple
FluorChem R chemiluminescence detector and analyzed in ImageJ (NIH). Optical
densities of KCC2 and phosphorylated S940 KCC2 were measured and normalized to
GAPDH values. For display purposes, brightness and contrast of the example blot images
were adjusted for all blot sections simultaneously.
Immunohistochemistry
To analyze KCC2 immunolabeling in the VTA, an untreated wildtype mouse was perfused
with phosphate-buffered saline (PBS) (Millipore), followed by 10% formalin (Sigma
Aldrich). Brains were post-fixed for additional 24 hr in 10% formalin and then transferred
through a PBS-sucrose gradient for 24 hr each (10%, 20%, and 30%). VTA sections were
cut at 30 μm and probed with antibodies against KCC2 (1:500, Millipore, #07-432) and TH
(1:500, Millipore, #MAB318) overnight at 4°C. After washing in PBS, sections were
incubated in the secondary antibodies goat anti-rabbit AlexaFluor594 and goat anti-mouse
AlexaFluor488 (1:1,000; Invitrogen) for 3 hrs at room temperature. Immunofluorescent
images were obtained using confocal microscopy.
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Statistical Analyses
Two-way analysis of variance (ANOVA) with repeated measures (in SPSS for Windows)
was used to analyze GABA neuron firings rates in the presence of ethanol. To analyze
action potential firing rate changes following ethanol, the raw frequencies (in Hz) were
converted to a percentage of basal with the last three 2-min bins designated as the
baseline before ethanol application. One-way ANOVA was used to analyze mean changes
in sIPSC frequencies, as well as basal firing frequencies, sIPSC frequencies and
amplitudes, Vrest, and GGABA between groups (in GraphPad Prism8). For repetitively
evoked IPSC recordings, an F test for comparing fits was used (Origin 7.5). Unpaired twotailed t tests assuming equal variance were used to assess differences between EGABA
measurements and mean changes in GABA neuron firing in response to GABAergic input
stimulation (in Prism8). For western blot analysis, paired two-tailed t tests were used to
compare quantified protein levels between control and stressed littermates run on the
same gel (in Prism8). Reported values and plotted data represent the mean ± standard
error of the mean (SEM). The significance level for all analyses was set at p < 0.05.
Optogenetic identification of VTA neurons
Adult VGAT-Cre mice raised on a C57Bl/6J background (028862, The Jackson
Laboratory) were group-housed in a temperature- and humidity-controlled vivarium on a
reversed light/dark cycle (lights off: 10:00 a.m.). Intra-VTA viral injections were performed
for neuronal identification. Mice were anesthetized with isoflurane and burr holes were
drilled above the VTA (coordinates in mm from Bregma: A/P -3.25, M/L ±0.5, D/V -4.4).
An adeno-associated viral construct (AAV2) expressing channelrhodopsin (ChR2) and
enhanced yellow fluorescent protein (AAV2-DIO-ChR2-eYFP) was injected into the VTA
at a rate of 0.1 µL/min over the course of 10 min. Following viral injections, mice recovered
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for at least one week prior to slice recordings. During recordings, a Leica EL6000 compact
light source was controlled by an Axon Digidata 1550 (Molecular Devices) to trigger lightevoked changes in action potential firing.
Data Availability
All

raw

data

have

been

deposited

to
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Results
5-HT2AR activation restores chloride ion homeostasis in VTA GABA neurons of stressexposed mice
Adult mice were subjected to acute restraint stress 24hr before cutting midbrain slices to
examine the effect of stress on VTA Cl- homeostasis and GABAergic circuitry. Using
gramicidin perforated patch recordings to preserve the intracellular anion concentration,
EGABA was measured in VTA GABA neurons by evoking inhibitory post-synaptic currents
(eIPSCs) with electrical stimulation (Fig. 4.1A, B). Lateral VTA GABA neurons were
identified as previously reported (Ostroumov et al., 2016; Thomas et al., 2018). EGABA was
substantially depolarized in VTA GABA neurons of stressed mice relative to unstressed
control mice (Fig. 4.1C): -63.7 ± 2.5 mV (Stress, red data) versus -86.5 ± 1.2 mV (Control,
black data), n = 5, 6 cells/group respectively, p < 0.01 by unpaired, two-tailed t test, which
reinforces our prior findings in rats that stress alters the Cl- gradient in these neurons
(Ostroumov et al., 2016). Total synaptic GABAAR conductances and resting membrane
potentials were calculated for EGABA measurements and did not differ across experimental
conditions (Table 4.1).
In the spinal cord, agonist-mediated 5-HT2AR activation resulted in a hyperpolarizing shift
in EGABA in motoneurons from animals exposed to injury (Bos et al., 2013). VTA GABA
neurons also express 5-HT2ARs (Cornea-Hebert et al., 1999; Doherty & Pickel, 2000;
Nocjar et al., 2002); however, it remains unknown whether 5-HT2ARs can similarly regulate
EGABA in the VTA. To investigate, ex vivo slices containing the VTA were bathed in the 5HT2AR agonist TCB-2 (1 µM) (Fox et al., 2010; Bos et al., 2013) prior to and during
measurement of EGABA in VTA GABA neurons of stressed and control mice. In the
presence of TCB-2, EGABA was hyperpolarized back to the control potential in GABA
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neurons of stressed mice, and had no effect on controls (Fig. 4.1D, E): -88.8 ± 2.4 mV
(Stress+TCB-2, blue data), -87.9 ± 1.8 mV (Control+TCB-2, gray data), n = 4, 5 cells/group
respectively, p = 0.76 by unpaired, two-tailed t test, suggesting that TCB-2 can restore
normal Cl- homeostasis after stress.
EGABA is determined by the anion gradient (Kaila, 1994; Staley et al., 1995; Ben-Ari et al.,
2012). Depolarization of EGABA is indicative of intracellular Cl- accumulation following
GABAAR activation. To observe Cl- accumulation in slice, we applied repetitive GABAAR
stimulation during whole-cell recordings. VTA GABA neurons were clamped at a holding
potential (0 mV) that drives Cl- influx (Fig. 4.1F). Under these conditions, Cl- accumulation
results in reduced amplitudes of eIPSCs (Hewitt et al., 2009; Ostroumov et al., 2016;
Thomas et al., 2018). In VTA GABA neurons of stressed mice, we found that repetitive
stimulation reduced eIPSC amplitudes more than in controls. An exponential fit of the
eIPSC amplitudes revealed a significant difference in the rates of eIPSC depression
between stressed and control groups (Fig. 4.1G: F = 65.5, n = 9 cells/group, p < 0.01).
Next, we tested whether treatment with TCB-2 would prevent stress-induced Claccumulation. In the presence of TCB-2 (1 µM), repetitive GABAAR stimulation did not
produce substantial eIPSC depression in GABA neurons from stressed mice when
compared to controls (Fig. 4.1H, I: F = 0.12, n = 6 cells/group, p = 0.94), indicating that 5HT2AR activation can reverse stress-induced Cl- accumulation.
At a holding potential of -90 mV, Cl- effluxes via GABAARs and presynaptic rundown can
be observed independent of intracellular Cl- accumulation. Presynaptic rundown was
unchanged across all treatment groups (Fig. 4.3A-C), confirming that the effects of TCB2 in stressed animals occurred through postsynaptic normalization of Cl- extrusion.
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5-HT2AR activation normalizes VTA chloride ion homeostasis following stress exposure
via second messenger signaling and site-specific phosphorylation of KCC2
We previously revealed that stress-induced Cl- accumulation in VTA GABA neurons
resulted from functional downregulation of KCC2, which is expressed in non-dopaminergic
(DA) VTA neurons (Fig. 4.4A) (Taylor et al., 2016; Thomas et al., 2018). Post-translational
modifications, such as reduced phosphorylation at serine 940 (S940), can diminish the Clextrusion capacity of KCC2 (Kahle et al., 2013; Medina et al., 2014; Ostroumov et al.,
2016) or dynamically regulate the functional state of KCC2 (Medina et al., 2014;
Mahadevan & Woodin, 2016). Therefore, we investigated whether TCB-2 normalizes Clhomeostasis in VTA GABA neurons of stressed mice by initiating an intracellular pathway
that phosphorylates KCC2 at S940 (Fig. 4.2A). Using western blot analysis of VTA tissue
punches, we assessed changes in KCC2 protein levels in stressed and control mice (Fig.
4.2B). We found that stress diminished S940 phosphorylation (pS940) relative to controls
(Fig. 4.2C): 69.1 ± 12.2% (monomer) and 64.3 ± 12.6 % (dimer) of control, n = 8
mice/group, p = 0.02 (monomer) and p = 0.03 (dimer) by paired, two-tailed t test. In
separate groups of stressed and control mice, VTA slices were incubated in TCB-2 (1 µM)
for 20-30 min prior to sample preparation for immunoblotting. TCB-2 treatment increased
pS940 in stressed mice to the control level (Fig. 4.2D, E): 98.0 ± 20.3% (monomer) and
110.1 ± 17.5% (dimer) of control, n = 5 mice/group, p = 0.79 (monomer) and p = 0.61
(dimer) by paired, two-tailed t test. Total KCC2 protein was unchanged in stressed mice
relative to controls, with or without TCB-2 treatment (Fig. 4.4B-C). These findings
demonstrate

that

TCB-2

re-establishes

normal

phosphorylation at S940.
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KCC2

function

by

increasing

KCC2 function can be altered by kinase activity (Lee et al., 2007; Kahle et al., 2013) and
kinases are a common mechanism by which proteins are phosphorylated. Upon activation
by agonist, 5-HT2ARs engage the Gq-type G protein and modulate cellular function through
a number of effectors, including protein kinase C (PKC). Previously, PKC signaling has
been shown to phosphorylate KCC2 S940 (Lee et al., 2007), so we hypothesized that
TCB-2-mediated rescue of Cl- accumulation in the VTA GABA neurons of stressed mice
might occur via 5-HT2AR-induced PKC signaling. Therefore, in whole-cell configuration,
we recorded Cl- accumulation in VTA GABA neurons of stressed and control mice in the
presence of TCB-2 while also intracellularly dialyzing the PKC inhibitor chelerythrine (20
µM) (Liu & Chen, 2008; Bos et al., 2013) (Fig. 4.2F, light blue trace). Blocking intracellular
PKC function prevented TCB-2-mediated recovery of Cl- extrusion in VTA GABA neurons
of stressed mice (Fig. 4.2G, light blue data: F = 22.4, n = 7 cells/group, p < 0.01), indicating
that 5-HT2AR agonism leads to phosphorylation of KCC2 S940 by activating PKC
signaling. Importantly, chelerythrine did not alter presynaptic rundown in the presence of
TCB-2 (Fig. 4.3D).
Next, we examined whether reduced KCC2 S940 phosphorylation was sufficient to
dysregulate Cl- homeostasis. We also wanted to avoid any confounds that may have
arisen from off-target pharmacological effects in our mechanistic experiments. Therefore,
we used KCC2 transgenic mice in which S940 is mutated to alanine (S940A), rendering
the 940 site insensitive to kinase activity and impairing KCC2 transport activity (Silayeva
et al., 2015). We found that haplodeficiency of S940 phosphorylation in unstressed
heterozygous S940A mice resulted in depolarized EGABA in VTA GABA neurons (Fig.
4.2H), similar to the effects of stress in wild-type mice. This demonstrates that KCC2 S940
phosphorylation is indeed sufficient to cause the aberrant Cl- gradient observed after
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stress. Additionally, TCB-2 (1 µM) application during recordings did not correct this
depolarized EGABA (Fig. 4.2I): -57.7 ± 1.2 mV (S940A, purple data), -58.8 ± 1.2 mV
(S940A+TCB-2, navy data), n = 6, 5 cells/group respectively, p = 0.56 by unpaired, twotailed t test; further indicating that 5-HT2AR activation normalizes Cl- homeostasis in VTA
GABA neurons after stress via phosphorylation of KCC2 S940. Acute stress exposure in
S940A heterozygotes resulted in no additional depolarization in EGABA and was unaffected
by TCB-2 treatment (Fig. 4.2J): -59.5 ± 1.6 mV (S940A, dark red data), -55.3 ± 3.2 mV
(S940A+TCB-2, indigo data), n = 6, 4 cells/group respectively, p = 0.23 by unpaired, twotailed t test. The occlusion of this stress-induced plasticity suggests that KCC2 S940
phosphorylation is indeed the mechanism by which stress dysregulates Cl- homeostasis
in VTA GABA neurons.
5-HT2AR activation reverses aberrant GABA- and ethanol-induced firing of VTA GABA
neurons in stressed mice
In our previous work in rats, we showed that stress resulted in compromised GABAARmediated inhibition of VTA GABA neurons and even caused paradoxical GABAARmediated excitation (Ostroumov et al., 2016). We repeated those experiments in mice with
the additional hypothesis that because TCB-2 positively modulates KCC2 function, 5HT2AR activation would recover GABA-mediated inhibition in the VTA GABA neurons of
stressed mice. Thus, repetitive stimulation of GABAARs was performed during
spontaneous action potential firing of VTA GABA neurons ex vivo (Fig. 4.5A). GABAergic
inhibition of firing was observed in control mice (Fig. 4.5B), but as in our previous work,
VTA GABA neurons from stressed mice were resistant to GABAergic inhibition, instead
displaying paradoxical increased firing (Fig. 4.5B, C): 124.5 ± 8.9% (Stress, red) vs 80.9
± 4.0% (Control, black), n = 9 cells/group, p < 0.01 by unpaired, two-tailed t test. Changes
118

in firing rate were calculated for 1 s immediately following stimulation and normalized to
the pre-stimulation period. TCB-2 application (1 µM) normalized GABAAR-mediated
inhibition of VTA GABA neurons from stressed mice to control levels while having no
impact on those from control mice (Fig. 4.5D, E): 90.2 ± 7.4% (Stress+TCB-2, blue) vs
82.5 ± 7.5% (Control+TCB-2, gray), n = 6-7 cells/group, p = 0.48 by unpaired, two-tailed t
test, suggesting that 5-HT2AR activation corrects compromised GABAergic inhibition of
VTA GABA neurons.
Our previous work has also shown that the acute stress procedure we used resulted in an
aberrant increase in VTA GABA neuron firing in response to ethanol, leading to a
corresponding increase in ethanol-induced inhibitory drive to the VTA dopamine (DA)
neurons (Ostroumov et al., 2016). To first show that in mice, stress results in the same
irregular ethanol-induced inhibitory signaling in the VTA, we measured VTA GABA neuron
action potential firing in the presence of ethanol (Fig. 4.5F). Wash-in of ethanol (50 mM)
(Ostroumov et al., 2016; Thomas et al., 2018) onto control VTA slices resulted in a modest
increase in firing rates (Fig. 4.5G, black traces). In contrast, a substantially greater
increase in ethanol-induced firing was observed in VTA GABA neurons of stressed mice
(Fig. 4.5G, red traces). Normalizing to the pre-ethanol baseline period revealed a
significant difference between stressed (red data) and control (black data) firing in
response to ethanol (Fig. 4.5H): group x time, F(10,438) = 5.20, p < 0.01, n = 12, 10
cells/group, respectively.
Next, we hypothesized that by correcting KCC2 function, 5-HT2AR activation would restore
normal firing responses to ethanol. Slices were treated with TCB-2 (1 µM), which indeed
normalized VTA GABA neuron firing in response to ethanol in stressed mice (Fig. 4.5I,
blue traces). No significant difference was observed in normalized ethanol-induced firing
119

rates stressed (blue data) and control (gray data) groups in the presence of TCB-2 (Fig.
4.5J): group x time, F(10,19) = 0.48, p = 0.88, n = 7, 8 cells/group, respectively,
demonstrating that 5-HT2AR activation prevents stress-induced enhancement of VTA
GABA neuron firing in response to ethanol.
5-HT2AR activation in stressed mice rescues normal ethanol-induced GABAergic inhibitory
drive to VTA DA neurons
VTA GABA neurons influence ethanol-related behavior, in part, by modifying DA neuron
activity (Morikawa & Morrisett, 2010; Ostroumov et al., 2016; Nelson et al., 2018; Thomas
et al., 2018). We hypothesized that stress-induced KCC2 impairment in VTA GABA
neurons would correspond with enhanced inhibitory transmission onto DA neurons and
that this circuit adaptation could be reversed by activation of 5-HT2ARs. We performed
whole-cell voltage-clamp recordings in VTA DA neurons and monitored ethanol-induced
changes in inhibitory transmission (Fig. 4.6A). Lateral VTA DA neurons were identified as
previously reported (Zhang et al., 2010; Ostroumov et al., 2016; Thomas et al., 2018). In
control mice, spontaneous IPSC (sIPSC) frequency onto control DA neurons was
moderately increased from baseline in response to ethanol (50mM, Fig. 4.6B, black
traces). In stressed mice, sIPSC frequency was robustly increased relative to baseline in
response to ethanol and was significantly increased compared controls (Fig. 4.6B, red
traces). Similarly, in unstressed heterozygous S940A mice, sIPSC frequency was
substantially increased in response to ethanol compared to wildtype controls, indicating
that impaired KCC2 function is sufficient to cause aberrant inhibitory signaling to VTA DA
neurons. Mean changes in the normalized sIPSC frequency during ethanol wash-in were
significantly greater in the stressed and S940A groups relative to controls (Fig. 4.6C) by
one-way ANOVA: 116.5 ± 5.9% (Control, black data), 159.8 ± 10.0% (Stress, red data),
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and 160.63% ± 10.8% in the (S940A, purple data), F(2, 15) = 9.029, p < 0.01 (Dunnett’s
post-hoc test, ** p < 0.01), n = 7, 6, 5 cells/group, respectively. Bath-application of TCB-2
(1 µM) prevented the ethanol-induced increase in sIPSC frequency in stressed mice (Fig.
4.6D, blue traces). Importantly, co-application of the 5-HT2AR antagonist, MDL11,939 (2
µM) (Bos et al., 2013), blocked the effects of TCB-2 in stressed mice (Fig. 4.6E): 112.2 ±
2.7% (Control+TCB-2, gray data), 110.6 ± 3.2% in the (Stress+TCB-2, blue data), and
159.2 ± 5.5% (Stress+TCB-2+MDL11,939, orange data), F(2, 17) = 49.96, p < 0.01
(Dunnett’s post-hoc test, ** p < 0.01), n = 7, 7, 6 cells/group, respectively. Further
demonstrating the specificity of TCB-2 action at the 5-HT2AR, bath application of a lower
concentration of TCB-2 (0.1 µM) or a distinct 5-HT2AR agonist, 25CN-NBOH (1 µM),
comparably suppressed the enhanced ethanol-induced sIPSC frequency in VTA DA
neurons of stressed mice (Fig. 4.7).
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Discussion
Stress triggers neural plasticity that can promote addiction-related behaviors (Koob & Le
Moal, 2005; Ostroumov & Dani, 2018a). Here, we show that acute stress exposure in mice
disrupts chloride ion (Cl-) homeostasis in the VTA by impairing KCC2 function and thereby
altering midbrain GABAergic transmission in response to ethanol. Critically, these stressinduced alterations to VTA circuitry were pharmacologically reversible. Ex vivo
administration of the 5-HT2AR agonist TCB-2 was sufficient to restore Cl- homeostasis and
normalize GABAergic responses to ethanol. At the molecular level, recovery of KCC2
function by TCB-2 was dependent on both intact second messenger signaling and
phosphorylation of KCC2 S940. These data suggest that drugs, such as TCB-2, which
can normalize the functional state of KCC2 may be particularly effective in treating
conditions involving KCC2 impairment.
5-HT2AR agonist drugs are emerging as promising interventions for a number of
neuropsychiatric conditions, including alcohol dependence and stress-related disorders
(Bogenschutz et al., 2015; Bogenschutz & Johnson, 2016; Carhart-Harris et al., 2016;
Carhart-Harris & Goodwin, 2017). While the mechanisms underlying the therapeutic
outcomes associated with 5-HT2AR agonist treatment have remained unclear, evidence
suggested that circuitry adaptations in the ventral midbrain are important. For example,
the transition to escalating drug intake in rodents has been associated with inhibitionresistant VTA GABA neuron firing (Vargas-Perez et al., 2009; Nelson et al., 2018), and
intra-VTA infusion of a 5-HT2AR agonist can prevent such dependence-related transitions
(Vargas-Perez et al., 2017). We observed similar, irregular VTA GABA neuron firing in
response to GABAergic stimulation or ethanol application following acute stress exposure,
which were ameliorated by TCB-2. Our findings are also consistent with a proposed
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regulatory role of 5-HT2ARs on VTA GABAergic transmission (Bankson & Yamamoto,
2004), as TCB-2 mitigated the stress-induced increase in inhibitory drive onto DA neurons
in response to ethanol. Our previous work has also shown that correcting Cl- homeostasis
in the VTA decreases stress-induced ethanol self-administration (Ostroumov et al., 2016),
indicating that 5-HT2AR agonists may recruit similar mechanisms to achieve long-lasting
therapeutic effects.
A growing preclinical literature has implicated KCC2 impairment in drug abuse (Ben-Ari et
al., 2012; Ostroumov et al., 2016; Taylor et al., 2016; Thomas et al., 2018). KCC2
downregulation renders VTA GABA neurons less sensitive to, or even excited by, GABA
or GABA mimetics (Ostroumov et al., 2016; Thomas et al., 2018). Under basal conditions,
KCC2 deficiency does not overtly change GABAergic signaling, but repetitive GABAAR
stimulation or exposure to ethanol overwhelms the limited Cl- extrusion capacity of
impaired KCC2 following stress (Hewitt et al., 2009; Ostroumov & Dani, 2018a). This
explains why we observed no differences in baseline GABA neuron firing rates or sIPSCs
in DA neurons between stress and control groups. Dynamic in vivo regulation of KCC2
function occurs via post-translational changes along the C-terminal, cytoplasmic domain
(Kahle et al., 2013; Kaila et al., 2014). Among these, phosphorylation of S940 positively
modulates the transport function of KCC2 (Lee et al., 2007). While stress reduced the
functionality of KCC2 in the VTA, ex vivo activation of 5-HT2ARs normalized the functional
state of KCC2 by restoring phosphorylated S940 to the pre-stress level. To understand
how 5-HT2AR activation modulates KCC2 phosphorylation, we pharmacologically inhibited
PKC, which blocked the restorative effects of TCB-2. Additionally, we used a mouse with
a genetic mutation of the KCC2 S940 site to alanine. This KCC2 deficiency in S940A
heterozygous mice was also effective in preventing 5-HT2AR-mediated normalization of
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EGABA following acute stress exposure and recapitulated the effects of stress on ethanolinduced GABAergic transmission. These data suggest that stress-induced KCC2
impairment in VTA GABA neurons is mediated by PKC signaling and phosphorylation of
S940 induced by 5-HT2AR activation and that disruption of S940 phosphorylation is
sufficient to dysregulate GABA transmission in the VTA. Finally, while our results indicate
KCC2 impairment as the critical mediator of aberrant GABAergic signaling in the VTA
following stress, future work is needed to assess potential alterations in other transporters
involved in Cl- homeostasis, such as the Cl- importer NKCC1 (Kaila et al., 2014).
Negative motivational conditions, like stress, and reward states may converge in the VTA
to modulate KCC2 function, thereby altering GABA signaling and promoting maladaptive
behaviors (Ostroumov & Dani, 2018a). Our data implicate this VTA circuitry as an
important locus of 5-HT2AR agonist effects. Taken together, we provide mechanistic insight
into the therapeutic action of 5-HT2AR agonists through correction of stress-perturbed Clhomeostasis and inhibitory transmission in the ventral midbrain.
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Tables
Table 4.1. Electrophysiological parameters estimated during EGABA
recordings.
Wildtype
Control

S940A
Stress

Control

Stress

aCSF

TCB-2

aCSF

TCB-2

aCSF

TCB-2

aCSF

TCB-2

Vrest1
(mV)

-52.4
±
2.0

-50.1
±
1.8

-51.0
±
2.1

-48.8
±
1.5

-56.0
±
3.3

-57.1
±
3.2

-52.8
±
2.2

-56.3
±
2.5

GGABA2
(pS)

404.2
±
102.2

530.5
±
133.2

482.7
±
72.9

478.1
±
58.4

392.5
±
91.5

466.5
±
24.1

388.4
±
70.6

422.6
±
117.7

Abbreviations: aCSF, artificial cerebrospinal fluid; Vrest, resting membrane potential
at zero holding current (millivolts); GGABA, total synaptic GABAA receptor
conductance (picosiemens).

1. Vrest did not significantly differ across experimental conditions by one-way
ANOVA: F(7, 33) = 1.423, p = 0.23, n = 4-6 cells/group. Data presented as mean
± standard error of the mean.
2. GGABA did not significantly differ across experimental conditions by one-way
ANOVA: F(7, 33) = 0.3303, p = 0.93, n =4-6 cells/group. Data presented as
mean ± standard error of the mean.
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Figures

Figure 4.1. Ex vivo 5-HT2AR agonist treatment restores Cl- homeostasis in VTA GABA
neurons following stress exposure.
(A) GABAergic inputs were stimulated in VTA GABA neurons. Patched neurons were clamped at
different holding potentials to record EGABA or Cl- accumulation, which are both measures of Clhomeostasis. (B) Perforated patches were obtained to estimate EGABA in VTA GABA neurons from
a control and a stressed mouse at the given holding potentials; eIPSCs reverse direction at EGABA.
(C) Significantly depolarized EGABA was observed in VTA GABA neurons from stressed mice relative
to controls: n = 5-6 cells/group; ** p < 0.01. (D) Example EGABA recording from a stressed mouse in
the presence of the 5-HT2AR agonist TCB-2 (1 µM). (E) TCB-2 hyperpolarized EGABA in VTA GABA
neurons of stressed mice, which was indistinguishable from controls: n = 4-5 cells/group; p = 0.76.
(F) Whole-cell patches were obtained to estimate Cl- accumulation in VTA GABA neurons during
repetitive GABAAR stimulation (20 Hz, Vh = 0 mV). Example recording from a control mouse
revealed minor depression in eIPSC amplitudes. Heightened eIPSC depression was observed in a
VTA GABA neuron of a stressed mouse. (G) At 0 mV, VTA GABA neurons from stressed mice
demonstrated a significantly higher rate of eIPSC depression compared to controls: n = 9
cells/group; ** p < 0.01. (H) In the presence of TCB-2 (1 µM), repetitive eIPSCs in a VTA GABA
neuron of a stressed mouse revealed minor depression. (I) Decreases in eIPSC amplitudes in VTA
GABA neurons of stressed and control mice was not significantly different with TCB-2 treatment: n
= 6 cells/group; p = 0.94.
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Figure 4.2. 5-HT2AR activation normalizes stress-impaired Cl- homeostasis via intracellular
PKC signaling and phosphorylation of KCC2 S940.
(A) In VTA GABA neurons of stressed mice, we hypothesized that restoration of Cl- homeostasis
by TCB-2 occurs via 5-HT2AR activation and subsequent phosphorylation of KCC2 S940 as
illustrated. (B) Whole cell lysates of VTA tissue were probed for total KCC2 and phosphorylated
S940 (pS940), with GAPDH serving as the loading control. No difference in total KCC2 expression
was detected between groups. However, a substantial reduction in pS940 was observed between
stressed and control mice. (C) A significant decrease in the ratio of pS940 KCC2 to total KCC2 was
found in stress samples relative to controls (100% dashed line): n = 8 mice/group; * p = 0.02
(monomer), * p = 0.03 (dimer). (D) Example western blot of stressed and control VTA samples
incubated in TCB-2 (1 µM) prior to tissue punching. (E) No significant difference in the ratio of
pS940 KCC2 to total KCC2 was found in stress samples relative to controls (100% dashed line)
when exposed to TCB-2: n = 5 mice/group; p = 0.79 (monomer), p = 0.61 (dimer). (F) Claccumulation was estimated in VTA GABA neurons from stressed and control mice in the presence
of TCB-2 (1 µM) while intracellularly dialyzing the PKC inhibitor chelerythrine (20 µM). Under these
conditions, an example recording from a VTA GABA neuron in the stressed group demonstrated
rapid eIPSC depression when held at 0 mV. (G) Chelerythrine prevented the effect of TCB-2 on
eIPSC amplitude reduction in VTA GABA neurons from stressed mice when compared to the
control group: n = 7 cells/group; ** p < 0.01. Red dashed line represents the untreated stress group.
(H) In KCC2 S940A heterozygous mice, haplodeficiency of the S940 phosphorylation site produced
depolarized EGABA in a VTA GABA neuron, which was insensitive to bath-application of TCB-2. (I)
EGABA was comparably depolarized in VTA GABA neurons of unstressed S940A heterozygotes
between untreated or TCB-2-treated slices: n = 5-6 cells/group; p = 0.56. Dotted line represents
wildtype control EGABA. (J) Following stress exposure, EGABA remained depolarized in VTA GABA
neurons of S940A heterozygotes, comparable to that observed in unstressed S940A mice. TCB-2
did not significantly alter EGABA relative to untreated slices after stress exposure: n = 4-6 cells/group;
p = 0.23.
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Figure 4.3. Inhibitory presynaptic depression is comparable across experimental
conditions.
(A) Activity-dependent evoked inhibitory postsynaptic current (eIPSC) depression was measured
during whole-cell recordings at a holding potential of -90 mV, which drives Cl- out of the cell (i.e.,
inward positive current). Repetitive stimulation of GABA inputs at 20 Hz and -90 mV holding
potential revealed a similar, minor depression in eIPSC amplitudes in VTA GABA neurons from
control (black trace) and stressed (red trace) groups. (B) At -90mV, eIPSC depression did not differ
in VTA GABA neurons from stressed (red data) and unstressed, control (black data) mice: p = 0.97
by F test, n = 9 cells/group. (C) In the presence of TCB-2 (1 µM), eIPSC depression at -90 mV was
comparable in VTA GABA neurons from stressed (blue data) and control (gray data) mice: p = 0.99
by F test, n = 6 cells/group. (D) Intracellular PKC inhibition (chelerythrine, 20 µM) did not impact
the minor eIPSC depression during bath-application of TCB-2 (1 µM) in VTA GABA neurons from
stressed (light blue data) and control (gray data) mice: p = 0.54 by F test, n = 7 cells/group.
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Figure 4.4. KCC2 is absent from VTA dopamine neurons and total VTA KCC2 expression
was unchanged by stress exposure and TCB-2 incubation ex vivo.
(A) Immunostaining of a horizontal section containing the VTA showing lack of overlap between
tyrosine hydroxylase (TH, green) and KCC2 (red) signals. Arrows indicate the location of THpositive neurons. Arrowheads indicate the location of KCC2-positive neurons. VTA-adjacent
structures are labeled: MT = medial terminal nucleus of the accessory optic tract; ML = medial
lemniscus. (B) Western blot analysis of total KCC2 protein revealed no significant differences
between VTA tissue samples collected from stressed (red data) and unstressed, controls (dashed
line): p = 0.41 (monomer), p = 0.63 (dimer) by paired t test, n = 8 mice/group. (C) Following
incubation in TCB-2 (1µM), total KCC2 in VTA tissue samples from stressed mice (blue data) did
not differ from controls (100%, dashed line): p = 0.90 (monomer), p = 0.82 (dimer) by paired t test,
n = 5 mice/group.
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Figure 4.5. 5-HT2AR activation normalizes GABA- and ethanol-induced VTA GABA neuron
firing in stressed mice.
(A) Cell-attached recordings of VTA GABA neurons were performed to observe changes in
spontaneous action potential firing following electrical stimulation of GABAergic inputs. (B)
Representative recordings from control and stressed mice revealed distinct post-stimulation (20 Hz
Stim) firing patterns. The control cell displayed canonical GABA-mediated inhibition, while the
stress cell showed paradoxical excitation in response to stimulation. (C) When averaged over 1 s
following the end of stimulation, normalized firing in VTA GABA neurons from stressed mice
showed enhanced firing relative to the decrease in firing observed in controls: n = 9 cells/group; **
p < 0.01. (D) In the presence of TCB-2 (1 µM), a VTA GABA neuron from a stressed mouse
demonstrated GABA stimulation-induced decreased firing (i.e., restoration of GABAergic
inhibition). (E) VTA GABA neurons exposed to TCB-2 from stressed and control mice revealed
comparable GABA-mediated inhibition of firing: n = 6-7 cells/group; p = 0.48. (F) In a separate
experiment, cell-attached recordings of VTA GABA neurons were performed in the presence of
ethanol (50 mM) to observed changes in ethanol-induced firing rate. (G) Ethanol produced a
modest increase in firing of a control VTA GABA neuron relative to the baseline period, while a
stress GABA neuron displayed a substantially greater increase in firing rate in response to ethanol.
(H) We observed a significantly greater ethanol-induced increase in firing of GABA neurons from
stressed mice when compared to controls: n = 10-12 cells/group; ** p < 0.01. (I) TCB-2 application
(1 µM) to a stressed slice revealed a marginal increase in GABA neuron firing in response to
ethanol. (J) TCB-2 prevented the increased ethanol-induced firing in VTA GABA neurons from
stressed mice relative to controls: n = 7-8 cells/group; p = 0.88.
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Figure 4.6. TCB-2 rescues normal ethanol-induced inhibitory drive onto VTA DA neurons
following stress exposure.
(A) In whole-cell configuration, sIPSCs in VTA DA neurons were recorded while holding at -60 mV.
Changes in sIPSC frequency and amplitude were monitored in the presence of ethanol (50 mM).
(B) Example sIPSC recordings in VTA DA neurons demonstrated a robust enhancement of ethanolinduced sIPSC frequency in the stress group relative to controls. No differences in amplitude were
observed between groups. (C) Ethanol-induced sIPSC frequency, relative to baseline, was
significantly increased in the wildtype stressed and unstressed S940A groups when compared to
wildtype controls: n = 5-7 cells/group; ** p < 0.01. (D) TCB-2 (1 µM) decreased the sIPSC frequency
in response to ethanol in VTA DA neurons from stressed mice. TCB-2 did not impact sIPSC
amplitudes. (E) Ethanol-induced sIPSC frequency was reduced to the control level in VTA DA
neurons from stressed mice in the presence of TCB-2. Blockade of 5-HT2ARs with the antagonist
MDL11,393 (2 µM) prevented the effect of TCB-2 in the stressed group: n = 6-7 cells/group; ** p <
0.01.
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Figure 4.7. Stress-related enhancement of ethanol-induced sIPSC frequency in VTA DA
neurons is comparably reversed by TCB-2 and a distinct 5-HT2A receptor agonist, 25-CN
NBOH.
(A) Example sIPSC recording in a VTA DA neuron of a stressed mouse demonstrated a lack of
enhanced ethanol-induced sIPSC frequency in the presence of a lower concentration of TCB-2 (0.1
µM). No differences in amplitude were observed between groups. (B) Ethanol-induced sIPSC
frequency, relative to baseline, was not significantly increased in wildtype control or stressed
groups in the presence of 0.1 µM TCB-2: p = 0.73 by t test, n = 5-9 cells/group. Red dashed line
represents the untreated stress group. (C) A distinct 5-HT2A receptor agonist 25-CN NBOH (1 µM)
decreased the sIPSC frequency in response to ethanol in VTA DA neurons from stressed mice. 25CN NBOH did not significantly impact sIPSC amplitudes. (D) Ethanol-induced sIPSC frequency
was reduced to the control level in VTA DA neurons from stressed mice in the presence of 25-CN
NBOH: p = 0.63 by t test, n = 5-7 cells/group. Red dashed line represents the untreated stress
group.
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Abstract
Alcohol use disorder (AUD) is highly prevalent and contributes substantially to global
disease burden. Disruption of chloride ion (Cl-) homeostasis has been linked to a number
of neuropathic conditions, including drug dependence, yet targeted pharmacotherapies
are lacking. In this study, we tested the hypothesis that, like other drugs, alcohol abuse
impairs Cl- regulation in a key brain reward circuit, the ventral tegmental area (VTA), to
facilitate heavy alcohol drinking in mice. As a therapeutic intervention, we investigated
whether a serotonin 2A receptor (5-HT2AR) agonist can abrogate alcohol-induced
inhibitory plasticity and attenuate alcohol consumption. We performed ex vivo
electrophysiological recordings of mouse VTA GABA neurons to examine the effect of
acute alcohol injection and chronic ethanol drinking on midbrain Cl- homeostasis. A subset
of mice was administered the 5-HT2AR agonist TCB-2 to assess the impact of this drug on
ethanol consumption and on VTA inhibitory circuitry following alcohol exposure. We found
that alcohol exposure, by acute injection or intermittent drinking, impaired Cl- homeostasis
in VTA GABA neurons. Moreover, this form of inhibitory plasticity was correlated with the
amount of alcohol consumed. Systemic administration of the 5-HT2AR agonist TCB-2
normalized Cl- transport in the VTA and dose-dependently attenuated heavy alcohol
drinking. This study describes a profound, lasting effect of alcohol exposure on VTA
inhibitory circuity. Critically, we found that 5-HT2AR agonism targets and corrects this
aberrant plasticity linked to heavy alcohol consumption, providing novel insight into the
therapeutic action of 5-HT2AR agonist compounds for AUD.
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Introduction
Alcohol use disorder (AUD) is one of the most prevalent neuropsychiatric diseases
worldwide (Collins et al., 2011) and a leading cause of preventable mortality (Peacock et
al., 2018). In the United States alone, as many as sixteen million people suffer from AUD
(Lipari & Van Horn, 2013). Despite the continued health burden incurred by AUD and our
current understanding of underlying brain mechanisms, pharmacotherapies targeting
specific neural circuits impacted by and driving alcohol abuse are lacking.
Alcohol positively modulates inhibitory GABAA receptors (GABAARs) in the ventral
tegmental area (VTA) (Boyle et al., 1993; Rassnick et al., 1993a; Kumar et al., 2009), a
central hub of the brain’s reward circuitry that mediates the reinforcing effects of numerous
drugs of abuse, including alcohol (Koob & Volkow, 2010; You et al., 2018). Specifically,
prior drug or stress experience shifts GABAAR function from inhibition towards excitation
via dysregulation of the chloride ion (Cl-) gradient and thereby alters the effects of alcohol
on midbrain GABAergic signaling (Ostroumov & Dani, 2018a). Although reinforcement of
alcohol drinking has been classically linked to increased dopamine signaling arising in the
VTA (Brodie et al., 1990; Rassnick et al., 1993b), emerging evidence suggests that VTA
inhibitory circuit plasticity is a consequence of alcohol exposure (Melis et al., 2002; Nelson
et al., 2018) and Cl- dysregulation promotes heightened alcohol intake (Ostroumov et al.,
2016; Thomas et al., 2018). For this reason, leveraging pharmacological agents that can
normalize subverted midbrain Cl- homeostasis is a novel interventional approach to
treating AUD.
We recently showed that stress-related VTA inhibitory plasticity, in the form of disrupted
Cl- homeostasis, is corrected pharmacologically by 5-HT2A receptor (5-HT2AR) agonist
treatment ex vivo (Kimmey et al., 2019). Pilot studies reveal that 5-HT2AR agonist
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compounds are clinically efficacious for treating alcohol dependence (Bogenschutz, 2013;
Bogenschutz et al., 2015; Nielson et al., 2018), yet the neural mechanisms underlying
their therapeutic success remain obscure. Therefore, the major goal of this study was to
identify potential alcohol-related inhibitory circuit aberrations in the VTA that could be
pharmacologically targeted by in vivo 5-HT2AR agonist treatment. Indeed, we found that
withdrawal from alcohol exposure impaired Cl- transport in VTA GABA neurons. In vivo
administration of TCB-2 reversed the effect of alcohol on Cl- transport and reduced heavy
alcohol consumption in mice. Thus, our results suggest that 5-HT2AR agonist compounds
may normalize midbrain Cl- homeostasis to limit alcohol intake.
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Methods and Materials
Animals
Adult, male, wildtype C57Bl/6J mice (8-16 weeks of age, The Jackson Laboratory) were
used in all studies. Initially, mice arrived in the temperature- and humidity-controlled
vivarium facility group-housed (5 mice/cage) and were allowed to acclimate to a reversed
light/dark cycle (lights off: 10:00 am) for at least one week prior to experimentation. All
home cages were supplied with environmental enrichment and mice were given access
to food and water ad libitum.
Ethical Considerations
All experimental procedures were approved and carried out in compliance with guidelines
specified by the Institutional Animal Care and Use Committee at the University of
Pennsylvania.
Intermittent Two-Bottle Choice Ethanol Drinking
Mice were single-housed and acclimated to two bottle access by providing two 50 mL
sipper tubes in the home cage, placed on opposite sides of the cage. After one week of
acclimation, mice were given concurrent access to one bottle containing ethanol (Decon
Labs, King of Prussia, PA) dissolved in filtered water and a second bottle containing only
filtered water for 24 hr on alternating days. The ethanol dose was escalated over the first
week (Day 1, 3%; Day 2, 6%; Day 3, 10%) after which mice were maintained on either
10% ethanol or 20% ethanol. Bottles were weighed at the 24 hr timepoint and adjusted for
leakage (i.e. bottle weight minus solution loss from bottles placed in an empty cage). Mice
were weighed at the start of each drinking day. Alcohol consumption (g/kg body weight
over 24 hr: g/kg/24hr), total fluid consumption (g of total solution intake over 24 hr: g/24hr),
and ethanol preference (ethanol intake as a % of total intake over 24 hr: %/24hr) were
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calculated. Placement of the ethanol bottle was alternated (left versus right side of cage)
to control for side preference. Mice were given at least 4 weeks of intermittent ethanol
access prior to experimental endpoints.
Systemic Drug Administration
Prior to experiments involving peripheral (i.p.) drug injections, mice were habituated to
handling for i.p. drug administration with daily sham injections for 3 days. For groups
receiving ethanol injections, group-housed mice were randomly selected for acute
injection of either ethanol (1.5 g/kg of body weight, i.p.; 20% v/v in 0.9% saline) or an
equivalent volume of sterile 0.9% saline (Hospira, Lake Forest, IL) approximately 2-3 hr
after lights out. Tail marks were made to differentiate injected mice from naïve littermates.
24 hr after injection, mice were sacrificed for electrophysiological recordings, described
below. Subsets of ethanol-injected and ethanol-drinking mice were subsequently
administered the 5-HT2A receptor agonist TCB-2 (Tocris, Bio-Techne, Minneapolis, MN)
at the doses indicated, or an equivalent volume of 0.9% saline (i.p.). 22 hr after TCB-2 or
saline injection mice were either sacrificed for electrophysiological recordings or, for
ethanol-drinking groups, were given access to ethanol. This injection protocol was
followed for three consecutive drinking days in experiments testing the effects of TCB-2
on two-bottle choice ethanol consumption.
Ex Vivo Slice Electrophysiology
Electrophysiological recordings were performed as previously described (Ostroumov et
al., 2016; Thomas et al., 2018; Kimmey et al., 2019). Briefly, horizontal slices (230 µm)
containing the VTA were cut using a vibratome (Leica Microsystems, Buffalo Grove, IL) in
ice-cold, carbogenated (95% O2/5% CO2, Airgas, Philadelphia, PA) high-sucrose, reduced
Ca2+, elevated Mg2+ artificial cerebrospinal fluid (aCSF, in mM): 205.0 sucrose, 2.5 KCl,
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21.4 NaHCO3, 1.2 NaH2PO4, 0.5 CaCl2, 7.5 MgCl2, 11.1 glucose. Slices were immediately
transferred to carbogenated standard aCSF for 40min at 32°C (in mM): 120.0 NaCl, 3.3
KCl, 25.0 NaHCO3, 1.2 NaH2PO4, 2.0 CaCl2, 1.0 MgCl2, 10.0 glucose, 20.0 sucrose. After
incubation, slices were maintained at room temperature for at least 1 hr and then
transferred to a holding chamber for electrophysiological recordings. During recordings,
slices were perfused with standard aCSF at a constant flow rate of 2-3ml/min at 32°C.
Thin-walled borosilicate glass (1.12mm ID, 1.5mm OD; WPI, Sarasota, FL) was used to
make patch electrodes with resistances between 1.0-2.0 MW when filled with internal
solution.
In VTA GABA neurons, activity-dependent depression of evoked inhibitory postsynaptic
currents (eIPSCs) was recorded in whole-cell configuration at both -90 mV (Cl- efflux) and
0 mV (Cl- influx) holding potentials with the internal solution (in mM): 123.0 K+-gluconate,
8.0 NaCl, 2.0 Mg-ATP, 0.2 EGTA, 10.0 HEPES, 0.3 Tris-GTP, pH 7.2-7.3. The liquid
junction potential between the patch pipette and bath solution was corrected prior to
recordings. Repetitive synaptic stimulation was delivered with a bipolar tungsten
stimulating electrode (WPI), placed 50-100 µm from the patched neuron. Constant-current
amplitude and duration pulses were delivered in trains of 20 Hz frequency and 100-200
µA amplitudes. Evoked IPSCs were isolated in the presence of (DNQX, 20 µM, Sigma
Aldrich, St. Louis, MO), DL-2-amino-5-phosphonopentanoic acid (AP5, 50 µM, Tocris),
and the GABAB receptor antagonist CGP55845 (1 µM, Sigma Aldrich) dissolved in the
perfusing aCSF.
Perforated cell-attached recordings were performed to measure the GABA reversal
potential (EGABA) under physiological Cl- conditions. Gramicidin was first dissolved in
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methanol (10 mg/mL) and then diluted to a final concentration of 150 µg/mL in the internal
solution (in mM): 135.0 KCl, 12.0 NaCl, 2.0 Mg-ATP, 0.5 EGTA, 10.0 HEPES, 0.3 TrisGTP, pH 7.2-7.3. A high concentration of Cl- was added to the internal solution to allow
for rapid detection of perforated patch failure (i.e. conversion to whole-cell configuration).
EGABA was estimated by recording eIPSCs while voltage-clamping the neuron at different
holding potentials in the presence of DNQX, AP5, CGP55845, and tetrodotoxin (0.5 µM,
Abcam, Cambridge, MA) dissolved in the perfusing aCSF. The resting membrane potential
(Vrest) of each cell was estimated in I=0 pA current clamp mode and did not differ across
experimental conditions from the saline-injected, group-housed mice (-50.4 ± 4.5 mV; F(4,
20) = 0.5053, n = 4-6 cells/group, p = 0.7323 by one-way ANOVA). Total synaptic GABAAR
conductances (GGABA) were calculated for all EGABA measurements and did not differ across
experimental conditions from the saline-injected, group-housed mice (440.6 ± 157.9 pS;
F(4, 20) = 0.09681, n = 4-6 cells/group p = 0.9823 by one-way ANOVA). Upon completion
of each EGABA measurement, perforated patches were converted to the whole-cell
configuration to record Ih.
VTA GABA neurons in the lateral VTA were identified by their morphological and
electrophysiological properties (Zhang et al., 2010; Ostroumov et al., 2016; Kimmey et al.,
2019). These neurons possess a small soma size (< 20 µm), relatively high firing rate (>
7 Hz in I=0 pA cell-attached configuration), and lack a prominent h-current (Ih; < 150 pA
peak amplitude in whole-cell configuration). Putative lateral VTA GABA neurons with these
properties are consistently immuno-negative for tyrosine hydroxylase (Ostroumov et al.,
2016; Kimmey et al., 2019).
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Statistical Analyses
Data were analyzed using extra sum-of-squares F tests for non-linear fit comparisons,
unpaired, two-tailed t tests, one-way analysis of variance (ANOVA) with Dunnett’s posthoc multiple comparisons test, two-way ANOVA, and bivariate correlations. All datasets
were normally distributed and are presented as mean ± SEM. Statistical analyses were
performed using Prism8 software (GraphPad, San Diego, CA), with significance level set
at alpha = 0.05.
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Results
Ethanol exposure dysregulates Cl- homeostasis in VTA GABA neurons
Adult mice received an acute injection of alcohol (ethanol, EtOH; 1.5 g/kg, i.p.) 24 hr prior
to cutting midbrain slices to examine the impact of ethanol exposure on inhibitory circuitry
in the ventral tegmental area (VTA; Fig. 5.1A). Lateral VTA GABA neurons were identified
based on previously-reported electrophysiological parameters (Zhang et al., 2010;
Ostroumov et al., 2016; Thomas et al., 2018; Kimmey et al., 2019).
Chloride ion (Cl-) dysregulation has been reported in VTA GABA neurons following drug
and stress exposures (Ostroumov et al., 2016; Taylor et al., 2016; Thomas et al., 2018;
Kimmey et al., 2019) and is readily observable ex vivo with synaptic stimulation of
GABAARs (Hewitt et al., 2009; Ferrini et al., 2013; Ostroumov et al., 2016; Thomas et al.,
2018; Kimmey et al., 2019). During whole-cell recordings in VTA GABA neurons of salineor ethanol-treated mice, repetitive GABA stimulation was applied to afferent terminals
while holding the patched neuron at 0 mV or -90 mV, to drive Cl- influx or efflux,
respectively. Under these conditions, evoked inhibitory postsynaptic current (eIPSC)
depression reflects both presynaptic rundown and postsynaptic Cl- accumulation (Hewitt
et al., 2009). At 0 mV, a VTA GABA neuron from an ethanol-injected mouse (Fig. 5.1B,
top red trace) demonstrated greater eIPSC amplitude depression than a saline-injected
control (Fig. 5.1B, top black trace). A significant difference in eIPSC depression at 0 mV
between the control and ethanol groups was revealed by non-linear fit comparison of the
normalized eIPSC amplitudes (Fig. 5.1C): F(3, 79) = 15.33, n = 8 cells (4 mice) in the
Control group and 9 cells (5 mice) in the EtOH group, ****p < 0.0001 by extra sum-ofsquares F test. At -90 mV, eIPSC amplitude depression was comparable between control
and ethanol groups (Fig. 5.1B, bottom traces). Non-linear fit comparison of the normalized
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eIPSC amplitudes during repetitive stimulation showed no difference between the control
and ethanol groups (Fig. 5.1D): F(3, 79) = 0.2427, n = 8 cells (4 mice) in the Control group
and 9 cells (5 mice) in the EtOH group, p = 0.8663 by extra sum-of-squares F test. These
data indicate that the enhanced eIPSC depression at 0 mV was due to postsynaptic Claccumulation and not presynaptic neurotransmitter rundown.
Deficits in postsynaptic transport that lead to Cl- accumulation has been linked to a shift in
the function of GABAARs from inhibition towards excitation (Kaila, 1994; Coull et al., 2003;
Doyon et al., 2011). Therefore, we used gramicidin perforated patch recordings to
preserve the intracellular anion concentration in VTA GABA neurons of ethanol-exposed
mice or saline-injected controls, to measure the physiological GABAAR reversal potential
(EGABA) with electrical synaptic stimulation. EGABA was substantially depolarized 24 hr after
acute ethanol injection (Fig. 5.1E, red traces) relative to saline-injected control mice (Fig.
5.1E, black traces): -65.4 ± 3.2 mV (EtOH, closed red circles) versus -84.5 ± 3.3 mV
(Control, closed black circles), n = 6 cells (3 mice: EtOH group) and 4 cells (4 mice: Control
group), **p < 0.01 by unpaired, two-tailed t test (Fig. 5.1F). These data reinforce the
conclusion that ethanol exposure disrupts Cl- homeostasis in VTA GABA neurons.
In vivo administration of the 5-HT2A receptor agonist TCB-2 restores Cl- homeostasis in
VTA GABA neurons following ethanol exposure
Prior work demonstrated that correcting mechanisms linked to Cl- transport dysregulation
in the VTA is sufficient to reduce elevated ethanol self-administration (Ostroumov et al.,
2016; Thomas et al., 2018). For this reason, serotonin 2A receptor (5-HT2AR) agonists are
of particular interest as activation of 5-HT2ARs has been shown to reverse dysregulated
Cl- homeostasis by upregulating KCC2 function (Bos et al., 2013; Dong et al., 2016;
Sanchez-Brualla et al., 2018; Kimmey et al., 2019). However, the mechanism by which 5145

HT2AR agonists achieve successful therapeutic outcomes for AUD remains unknown. To
address this, we built on our previous work, which showed that ex vivo application of the
5-HT2AR agonist TCB-2 to midbrain slice preparations was sufficient to normalize Clhomeostasis following acute stress exposure (Kimmey et al., 2019). Here, mice were
administered ethanol injections (1.5 g/kg, i.p.) 2hr prior to in vivo administration of TCB-2
(1.0 mg/kg, i.p.), then VTA-containing slices were prepared from injected mice 24 hr later
(Fig. 5.2A).
Among mice injected with ethanol, TCB-2 reversed repetitive stimulation-induced Claccumulation in VTA GABA neurons when measured in whole-cell configuration at 0 mV
(Fig. 5.2B, left blue trace). Non-linear fit comparison revealed that EtOH and Control mice,
when treated with TCB-2, expressed similar rates of eIPSC depression at 0 mV (Fig.
5.2C): F(3, 49) = 0.8757, n = 5 cells (3 mice: Control group, closed gray circles) and 6
cells (3 mice: EtOH group, closed blue circles), p = 0.4601 by extra sum-of-squares F test.
Likewise, eIPSC amplitude depression was unchanged by TCB-2 treatment when holding
a VTA GABA neuron at -90 mV (Fig. 5.2B, right blue trace). EtOH and Control rates of
eIPSC amplitude depression also did not significantly differ at -90 mV following TCB-2
treatment (Fig. 5.2D): F(3, 49) = 0.5756, n = 5 cells (3 mice: Control group, closed gray
circles) and 6 cells (3 mice: EtOH group, closed blue circles), p = 0.6338 by extra sum-ofsquares F test. These results confirm and extend our prior work, that 5-HT2AR activation
in the VTA is sufficient to normalize postsynaptic Cl- transport after ethanol exposure
(Kimmey et al., 2019).
In agreement with the effect we observed following acute ethanol exposure, a mouse
drinking 20% ethanol for more than 4 weeks followed by administration of TCB-2 (1.0
mg/kg, i.p.) demonstrated comparable restoration of Cl- homeostasis as reflected in a
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hyperpolarized EGABA (Fig. 5.2E, blue traces). Relative to saccharin-drinking, ethanolnaïve Control mice (closed dark gray squares), ethanol-injected (closed blue circles) and
ethanol-drinking mice (close blue diamonds) treated with TCB-2 expressed equivalent
hyperpolarized EGABA in VTA GABA neurons (Fig. 5.2F): -89.6 ± 2.9 mV (EtOH+TCB-2,
blue data) versus -90.1 ± 1.2 mV (Control, dark gray data), n = 5 cells (EtOH injection, 2
cells, 1 mouse; EtOH drinking, 3 cells, 2 mice) in the EtOH group and 4 cells (Saccharin,
2 mice) in the Control group, p = 0.8992 by unpaired two-tailed t test. Collectively, these
data provide evidence that Cl- homeostasis in VTA GABA neurons can be
pharmacologically corrected via peripheral 5-HT2AR agonist treatment, which may
underlie, at least in part, the therapeutic potential of 5-HT2AR agonist compounds for AUD
treatment.
Protracted ethanol consumption dose-dependently depolarizes EGABA in VTA GABA
neurons and reveals distinct ethanol-preferring groups
The intermittent two-bottle choice behavioral paradigm is commonly used in mice to elicit
high levels of ethanol intake over a protracted time course (Ron & Barak, 2016). Bouts of
24-hr ethanol drinking were alternated with days of abstinence (two water bottles) as the
ethanol concentration was increased (Fig. 5.3A). This procedure was done in two cohorts
of mice, 10% ethanol maintenance (open red diamonds, n = 10 mice) and 20% ethanol
maintenance (closed red diamonds, n = 28 mice) and demonstrated that 20% ethanol
maintenance elicits higher levels of ethanol consumption over time (Fig. 5.3A): RM twoway ANOVA revealed a significant group-by-time interaction [F(5, 180) = 4.322, ***p =
0.001], as well as significant main effects of time [F(2.527, 90.97) = 65.10, ***p < 0.0001]
and group [F(1, 36) = 4.178, *p < 0.05]. Following the fourth drinking week, subsets of
mice maintained on 10% and 20% ethanol were used for EGABA measurements in VTA
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GABA neurons (Fig. 5.3B). We found that the amount of ethanol consumed over 24 hr
correlated with the measured value of EGABA, such that higher ethanol consumption
corresponded with a more depolarized EGABA estimate (Fig. 5.3B): Pearson R2 = 0.9835,
****p < 0.0001 by bivariate correlation (dotted gray line = regression trend line; solid gray
lines = 95% confidence interval). Thus, individual ethanol intake corresponds with the
integrity of Cl- homeostasis in the VTA.
Because mice will consume substantially more ethanol when given access to a 20%
solution (Fig. 5.3A), subsequent behavioral experiments were performed in mice
maintained at 20% ethanol, which our data suggest will result in the largest difference in
EGABA between ethanol-naïve and ethanol-drinking groups. Within the 20% EtOH group,
we observed that mice cluster into two preference categories according to their 24 hr
ethanol consumption behavior: less than (low, down-facing red triangles, n = 8 mice) or
greater than (high, up-facing red triangles, n = 20 mice) 50% preference for the ethanolcontaining bottle. Mean Week 4 ethanol consumption strongly correlated with ethanol
preference (Fig. 5.3C): Pearson R2 = 0.5975, ****p < 0.0001 by bivariate correlation
(dotted gray line = regression trend line; solid gray lines = 95% confidence interval).
Low and High ethanol-preferring mice demonstrated significantly different levels of ethanol
consumption [Fig. 5.3D: 7.6 ± 0.4 g/kg/24hr (Low) versus 14.6 ± 0.7 g/kg/24hr (High),
****p < 0.0001 by unpaired, two-tailed t test] and ethanol preference [Fig. 5.3E: 38.8 ± 2.6
%/24hr (Low) versus 61.9 ± 1.2 %/24hr (High), ****p < 0.0001 by unpaired, two-tailed t
test], with no difference observed in total fluid consumption [Fig. 5.3F: 3.8 ± 0.2 g/24hr
(Low) versus 4.1 ± 0.1 g/24hr (High), p = 0.1513 by unpaired, two-tailed t test]. Collectively,
these results suggest that changes in VTA GABA neuron EGABA may predict ethanol
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consumption patterns in mice, but was not measured in low and high preference mice in
this study. For these reasons, targeting disrupted VTA Cl- homeostasis represents a novel
therapeutic avenue for limiting ethanol consumption.
In vivo TCB-2 administration dose-dependently attenuates ethanol consumption in high
ethanol-preferring mice
5-HT2AR agonist drugs, which include the classical hallucinogens, are emerging as
efficacious therapeutics for several drug-related disorders, including AUD, and may
reduce drinking through restoration of midbrain Cl- homeostasis (Kimmey et al., 2019). To
test whether 5-HT2A receptor agonist treatment reduces 24-hr ethanol drinking behavior in
the two-bottle choice paradigm, mice maintained at 20% ethanol for > 4 weeks were
administered the 5-HT2AR agonist TCB-2 (0-1.0 mg/kg, i.p.). Over the course of three
consecutive drinking days, TCB-2 was injected 2 hr after removal of the ethanol bottle
during the abstinence period, 22 hr prior to replacement of the ethanol bottle (Fig. 5.4A).
This treatment strategy was selected to observe the lasting effects of TCB-2 administration
on ethanol consumption, independent of potential somatic effects of TCB-2 that have been
previously reported (Fox et al., 2010). Among Low ethanol-preferring mice, described
above, TCB-2 (1.0 mg/kg, blue data), failed to alter ethanol consumption [Fig. 5.4B: 8.9 ±
1.1 g/kg/24hr (0 mg/kg) versus 9.8 ± 1.4 g/kg/24hr (1.0 mg/kg), n = 5 mice/group, p =
0.6466 by unpaired, two-tailed t test] or ethanol preference [Fig. 5.4C: 41.2 ± 4.1 %/24hr
(0 mg/kg) versus 44.9 ± 4.2 %/24hr (1.0 mg/kg), n = 5 mice/group, p = 0.5503 by unpaired,
two-tailed t test] when compared to the saline-treated (0 mg/kg TCB-2, gray data) group.
In contrast, TCB-2 treatment dose-dependently decreased ethanol consumption in High
ethanol-preferring mice (Fig. 5.4D): F (2, 22) = 10.62, n = 10, 6, and 9 mice in the 0 (gray
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data, 15.9 ± 0.9 g/kg/24hr), 0.1 (cyan data, 12.3 ± 1.3 g/kg/24hr), and 1.0 (blue data, 10.3
± 0.7 g/kg/24hr) mg/kg TCB-2 groups respectively, ***p < 0.001 by one-way ANOVA;
Dunnett’s post-hoc multiple comparison test revealed significant differences between the
0 and 0.1 mg/kg TCB-2 groups (*p < 0.05) and between the 0 and 1.0 mg/kg TCB-2 groups
(***p < 0.001). Similarly, 1.0 mg/kg TCB-2 reduced ethanol preference in High ethanolpreferring mice relative to saline-treated controls (Fig. 5.4E): F (2, 22) = 11.91, n = 10, 6,
and 9 mice in the 0 (gray data, 65.2 ± 1.7 %/24hr), 0.1 (cyan data, 59.3 ± 2.5 %/24hr), and
1.0 (blue data, 49.7 ± 2.9 %/24hr) mg/kg TCB-2 groups respectively, ***p < 0.001 by oneway ANOVA; Dunnett’s post-hoc multiple comparison test revealed a significant difference
between the 0 and 1.0 mg/kg TCB-2 groups (***p < 0.001), but not the 0 and 0.1 mg/kg
groups (p = 0.1956).
Finally, TCB-2 at the highest dose tested (1.0 mg/kg, blue data), decreased total fluid
consumption in High ethanol-preferring mice relative to vehicle treatment (Fig. 5.4F): n =
10 and 9 mice in the 0 (gray data, 4.0 ± 0.1 g/24hr) and 1.0 (blue data, 3.5 ± 0.1 g/24hr)
mg/kg TCB-2 groups respectively, **p < 0.01 by unpaired, two-tailed t test. For clarity, we
also show that the reduction in total fluid consumption among TCB-2-treated mice is not
due to a global decrease in fluid intake, rather through selective attenuation of ethanol
consumption (open portion of bars) relative to water consumption (closed portion of bars).
TCB-2 did not alter intermittent consumption of water or 0.2% saccharin in separate
groups of mice (Fig. 5.5A, B). Collectively, these data demonstrate that 5-HT2AR agonist
treatment reduces ethanol consumption and preference among high ethanol-preferring
mice.
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Discussion
In this study, using ex vivo patch clamp electrophysiology, we found that acute
experimenter-administered alcohol injection or chronic, volitional alcohol drinking
produced a robust deficit in Cl- homeostasis in VTA GABA neurons. This form of inhibitory
plasticity was corrected by systemic administration of a 5-HT2AR agonist following alcohol
exposure. Concomitantly, 5-HT2AR agonist treatment reduced alcohol intake and
preference under an intermittent access schedule, only among mice with a high (>50%)
preference for alcohol. Collectively, our results suggest that VTA Cl- transport
dysregulation facilitates increased alcohol consumption and is a substrate for the
therapeutic effects of 5-HT2AR activation in vivo.
Our results agree with a body of work that suggests that GABAergic signaling within the
brain’s reward circuitry, originating in the VTA, plays an important role in continued alcohol
taking and seeking (Chester & Cunningham, 2002; Kumar et al., 2009). In ex vivo slice
preparations, alcohol application increases the frequency of spontaneous inhibitory postsynaptic currents (sIPSCs) in VTA DA neurons of alcohol-naïve mice (Theile et al., 2008;
2009), which occurs in parallel with increased DA transmission (Brodie et al., 1990;
Gonzales et al., 2004; Theile et al., 2011). Following acute in vivo alcohol administration,
inhibitory synapses onto VTA DA neurons demonstrate a long-lasting (>1 week) enhanced
frequency of sIPSCs during withdrawal (Melis et al., 2002), indicating that the effects of
alcohol on inhibitory circuitry are exacerbated in the absence of the drug. The prolonged
change in GABA transmission arising from acute alcohol injection corresponds with an
increase in subsequent alcohol drinking behavior in mice (Melis et al., 2002). Similarly,
protracted withdrawal from alcohol drinking in adolescent rats was shown to enhance
sIPSC frequency onto VTA DA neurons and reduce tonic DA concentrations in the nucleus
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accumbens (Schindler et al., 2016). In contrast, phasic VTA DA neuron signaling is
enhanced by prior alcohol experience (Spoelder et al., 2015) and increases in GABA
neuron activity accompanying reward presentation (Cohen et al., 2012) are predicted to
promote phasic DA neuron firing that facilitates drug reward learning (Morozova et al.,
2016). These studies demonstrate that GABAergic transmission in the VTA is potently
altered by alcohol in a manner that may drive heightened alcohol consumption.
Importantly, correcting mechanisms underlying this form of inhibitory plasticity represents
a novel therapeutic avenue for limiting alcohol abuse.
VTA GABA neurons, a local source of inhibitory input onto VTA DA neurons, display
impaired GABAAR function following acute or chronic alcohol exposure that parallels the
changes in alcohol-induced GABA signaling onto DA neurons (Nelson et al., 2018). This
suggests that alcohol subverts VTA inhibitory signaling through changes in VTA GABA
neurons. We have previously shown that shifts in GABAAR signaling in VTA GABA
neurons is sufficient to heighten alcohol self-administration in rats (Ostroumov et al., 2016;
Thomas et al., 2018). For example, prior acute stress or nicotine exposures, which are
common risk factors for subsequent alcohol abuse in humans (McKee et al., 2007; Uhart
& Wand, 2009; Keyes et al., 2012; Doyon et al., 2013b; Noori et al., 2014), robustly
depolarize EGABA in VTA GABA neurons and promote alcohol-induced GABA release onto
VTA DA neurons (Doyon et al., 2013a; Ostroumov et al., 2016; Thomas et al., 2018;
Kimmey et al., 2019). A shift in EGABA indicates that homeostatic mechanisms regulating
chloride ion (Cl-) concentrations across the plasma membrane of VTA GABA neurons has
been altered (Kaila, 1994; Coull et al., 2003; Doyon et al., 2011; Ferrini et al., 2013; Doyon
et al., 2016). At the molecular level, stress- and nicotine-induced inhibitory plasticity in
VTA GABA neurons manifest as downregulation of the neuron-specific K+-Cl152

cotransporter KCC2 (Ostroumov et al., 2016; Thomas et al., 2018; Kimmey et al., 2019),
which normally maintains a low intracellular Cl- concentration (Kaila et al., 2014). Like
acute stress or nicotine, we observed postsynaptic Cl- accumulation and depolarized
EGABA in VTA GABA neurons after alcohol exposure. The present data, and the extant
literature, demonstrate that disparate forms of experience influence midbrain Clhomeostasis and provides mechanistic insight into factors promoting alcohol
consumption.
Critically, midbrain Cl- transport dysregulation, mediated by KCC2 in VTA GABA neurons
(Taylor et al., 2016; Thomas et al., 2018; Kimmey et al., 2019), can be pharmacologically
reversed to reduce alcohol consumption (Ostroumov et al., 2016; Thomas et al., 2018).
Current pharmacological agents designed to directly target KCC2 hypofunction remain
untested in humans (Ben-Ari et al., 2012; Gagnon et al., 2013). Alternatively, a growing
body of work links 5-HT2AR activation with indirect upregulation of KCC2 function (Bos et
al., 2013; Dong et al., 2016; Mahadevan & Woodin, 2016; Sanchez-Brualla et al., 2018;
Kimmey et al., 2019). 5-HT2AR agonists, largely composed of classical hallucinogens, are
emerging as promising therapeutics for a range of neuropsychiatric disorders in humans,
including alcohol dependence; however, the mechanisms underlying the positive
therapeutic outcomes associated with 5-HT2AR agonist treatment remain unclear (CarhartHarris & Goodwin, 2017; Nichols et al., 2017). Our prior work demonstrated that KCC2
hypofunction is reversed by ex vivo application of the 5-HT2AR agonist TCB-2 (Kimmey et
al., 2019). Consistent with that finding, here, we show that peripheral administration of
TCB-2, a selective 5-HT2AR agonist, mitigated alcohol-induced dysregulation of midbrain
Cl- homeostasis. Moreover, we find that 5-HT2AR activation dose-dependently attenuates
heavy alcohol consumption and preference in mice, consistent with a recent report on the
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effects of the 5-HT2AR agonist DOI on alcohol drinking in mice (Oppong-Damoah et al.,
2019). This effect was observed only among mice with a high (>50%) preference for
alcohol, which our ex vivo electrophysiological data predict will derive the greatest benefit
from 5-HT2AR activation on midbrain inhibitory circuitry (i.e. greater intake corresponded
with more depolarized EGABA, Fig. 5.3B). This hypothesis is in line with prior work detailing
individual differences in alcohol drinking behavior and corresponding disparities in
midbrain circuitry (Juarez et al., 2017). Nevertheless, more work is needed to establish
whether the degree of VTA Cl- transport dysregulation, as reflected in the value of EGABA,
is predictive of alcohol intake.
Interrogating the neural circuits impacted by alcohol experience reveals novel targets for
therapeutic intervention in AUD. To this end, we show that midbrain inhibitory Clhomeostasis undergoes alcohol withdrawal-induced impairment. 5-HT2AR agonists can
attenuate alcohol abuse in humans and our data suggest that correction of VTA Clhomeostasis may an important mechanism engaged by 5-HT2AR activation to reduce
heavy alcohol drinking.
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Figures

Figure 5.1. Ethanol exposure disrupts Cl- homeostasis in the VTA.
(A) Mice were acutely injected with ethanol (1.5 g/kg, i.p.) 24 hr prior to preparation of VTAcontaining midbrain slices. VTA GABA neurons were patched and clamped at different holding
potentials during electrical synaptic stimulation of GABAAR inputs to evoked inhibitory postsynaptic
currents (eIPSCs) and thereby measure the integrity of Cl- homeostasis following ethanol exposure.
(B) VTA GABA neurons were patched in whole-cell configuration to set a tonic Cl- load during
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repetitive GABAAR stimulation while holding the neuron at 0 mV and -90 mV to drive Cl- influx or
efflux, respectively. At 0 mV, a VTA GABA neuron from an ethanol-treated mouse exhibited
heightened eIPSC depression (top red trace) when compared to a saline-treated control mouse
(top black trace). Rates of eIPSC amplitude depression were comparable between a saline(bottom black trace) and an ethanol-treated (bottom red trace) mouse at -90 mV. (C) At 0 mV, VTA
GABA neurons from ethanol-injected mice demonstrated a significantly higher rate of eIPSC
amplitude depression compared to saline-treated controls: extra sum-of-squares F test, F(3, 79) =
15.33; ****p < 0.0001; n = 8-9 cells/group. (D) Decreases in eIPSC amplitudes in VTA GABA
neurons of ethanol- and saline-treated mice were not significantly different at -90 mV: n = 8-9
cells/group; p = 0.8663. (E) Gramicidin perforated patches were obtained in VTA GABA neurons
of saline- and ethanol-treated mice to estimate EGABA under physiological Cl- concentrations. Single
electrical stimuli were delivered to the slice at the given holding potentials and the resulting eIPSCs
reverse direction at EGABA. Example recordings in VTA GABA neurons from saline- (black traces)
and ethanol-injected (red traces) mice revealed a substantial depolarization of EGABA following
ethanol exposure. (F) Ethanol injection resulted in significant depolarization of EGABA when
compared to saline-treated controls: t test, n = 4-6 cells/group, **p < 0.01.
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Figure 5.2. In vivo administration of a 5-HT2AR agonist reverses ethanol-induced Cldysregulation in VTA GABA neurons.
(A) Previously, ex vivo application of the 5-HT2AR agonist TCB-2 was shown to enhance Cl- export
from VTA GABA neurons following acute stress exposure. We hypothesized that ethanol-induced
Cl- dysregulation would be similarly restored by in vivo administration of TCB-2. In these
experiments, TCB-2 (1.0 mg/kg, i.p.) was administered 2 hr after ethanol. (B) Following ethanol
(1.5 g/kg, i.p.), mice administered TCB-2 demonstrated no substantial eIPSC amplitude depression
during repetitive GABAAR stimulation in VTA GABA neurons at 0 mV (top blue trace). Likewise,
eIPSC amplitude depression was unaffected at -90 mV (bottom blue trace). (C) At 0 mV, VTA
GABA neurons from ethanol- and TCB-2-injected mice demonstrated no significant differences in
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eIPSC amplitude depression relative to saline- and TCB-2-injected control mice: extra sum-ofsquares F test, F(3, 49) = 0.8757, n = 5-6 cells/group, p = 0.4601. Red dashed line represents the
ethanol-only group. (D) Repetitive synaptic GABAAR stimulation in VTA GABA neurons of TCB-2treated mice from both saline- and ethanol-injected groups revealed comparable eIPSC amplitude
depression at -90 mV: extra sum-of-squares F test, F(3, 49) = 0.5756, n = 5-6 cells/group, p =
0.6338. (E) A gramicidin perforated-patch recording from an ethanol- and TCB-2-injected mouse
revealed a hyperpolarized EGABA (blue traces), equivalent to that observed in ethanol naïve mice.
(F) TCB-2 injection reversed the ethanol-induced depolarization of EGABA in VTA GABA neurons,
hyperpolarizing EGABA to the control potential: t test, n = 4-5 cells/group, p = 0.8992. Red dashed
line represents the ethanol-only group.
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Figure 5.3. Protracted ethanol drinking depolarizes EGABA and reveals low and high ethanol
preference.
(A) Single-housed mice were given intermittent 24-hr access to two drinking bottles, one containing
ethanol and the other containing water, alternating with days of water only. During Week 1, the %
ethanol in solution was increased and beginning with the second week, mice were maintained at
either 10% or 20% ethanol through Week 4 of intermittent drinking, after which electrophysiological
or pharmacological studies were performed. Mice maintained on 20% EtOH (n = 28) drank
significantly more than 10% EtOH-drinking mice (n = 10) over time: significant group-by-time effect,
***p = 0.001. (B) A subset of mice was sacrificed after the fourth week of ethanol (10% EtOH, n =
5 mice; 20% EtOH, n = 1 mouse) or 0.2% saccharin drinking (EtOH naïve, n = 4 mice) for ex vivo
EGABA measurements in VTA GABA neurons. The amount of ethanol consumed over 24 hr
correlated with the value of EGABA for a given mouse: Pearson R2 = 0.9835 ****p < 0.0001. (C)
Among 20% EtOH drinkers, mice largely segregated into two major preference groups by Week 4
of intermittent ethanol drinking: Low EtOH Preference (n = 8 mice) and High EtOH Preference (n =
20 mice). In agreement with this observation, 24-hr ethanol consumption was positively correlated
with 24-hr ethanol preference: t test, ****p < 0.0001. (D) Direct comparison of 24-hr ethanol
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consumption between Low and High ethanol-preferring mice revealed a highly significant difference
between groups: t test, ****p < 0.0001. (E) 24-hr ethanol preference was also highly significantly
different between Low and High ethanol-preferring groups: t test, ****p < 0.0001. (F) Total fluid
consumption, calculated as the sum of the adjusted ethanol and water bottle weights at the 24 hr
timepoint, did not differ between the Low and High ethanol-preferring groups: t test, p = 0.1513.
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Figure 5.4. In vivo administration of TCB-2 dose-dependently attenuates ethanol
consumption among high preference mice.
(A) A subset of mice maintained on intermittent access to 20% ethanol was treated with the 5HT2AR agonist TCB-2 (0-1.0 mg/kg, i.p.) 2 hr following taking the 24-hr drinking measurement for
three consecutive drinking days. The resulting data was averaged over the injection period. (B)
Low ethanol-preferring mice showed no change in 24-hr ethanol consumption after TCB-2
treatment (1.0 mg/kg) when compared to saline-treated (0 mg/kg) controls: t test, n = 5 mice/group,
p = 0.6466. (C) TCB-2 (1.0 mg/kg) did not significantly alter 24-hr ethanol preference relative to
saline-treated controls among low ethanol-preferring mice: t test, n = 5 mice/group, p = 0.5503. (D)
Among high ethanol-preferring mice, TCB-2 (0, 0.1, 1.0 mg/kg) dose-dependently attenuated 24hr ethanol consumption when compared to saline-treated mice: one-way ANOVA, F(2, 22) = 10.62,
n = 10 (0 mg/kg), 6 (0.1 mg/kg), and 9 (1.0 mg/kg) mice/group, ***p < 0.001; Dunnett’s post-hoc
multiple comparison test, *p < 0.05 (0 vs 0.1), ***p < 0.001 (0 vs 1.0). (E) 24-hr ethanol preference
was significantly reduced by TCB-2 (1.0 mg/kg) relative to saline-treated control mice in the high
ethanol-preferring group: one-way ANOVA, F (2,22) = 11.91, n = 10 (0 mg/kg), 6 (0.1 mg/kg), and
9 (1.0 mg/kg) mice/group, ***p < 0.001; Dunnett’s post-hoc multiple comparison test, p = 0.1956 (0
vs 0.1), ***p < 0.001 (0 vs 1.0). (F) TCB-2 (1.0 mg/kg) significantly reduced total fluid consumption
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when compared to saline-injected controls in the high ethanol-preferring group: t test, n = 10 (0
mg/kg), 9 (1.0 mg/kg) mice/group, p < 0.01). Consumption of ethanol (open portion of bars) was
decreased, while water intake (filled portion of bars), was increased by TCB-2.
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Figure 5.5. TCB-2 does not affect consumption of water or 0.2% saccharin solution.
(A) A subset of mice maintained on intermittent access to water only or 0.2% saccharin dissolved
in water was treated with the 5-HT2AR agonist TCB-2 (0 or 1.0 mg/kg, i.p.) 2 hr following taking the
24-hr drinking measurement for three consecutive drinking days. The resulting data was averaged
over the injection period. (B) TCB-2 (1.0 mg/kg) did not significantly reduce total fluid consumption
when compared to saline-injected controls in the water-only drinking group: unpaired two-tailed t
test, n = 7 (0 mg/kg), 11 (1.0 mg/kg) mice/group, p = 0.3158). (C) Similarly, TCB-2 (1.0 mg/kg) did
not alter total fluid consumption when compared to saline-treated controls in the 0.2% saccharin
drinking group: unpaired two-tailed t test, n = 7 (0 mg/kg), 11 (1.0 mg/kg) mice/group, p = 0.9664).
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CHAPTER 6
The Role of Midbrain Chloride Ion Dysregulation and Escalated Alcohol Consumption:
General Discussion and Future Directions
Blake A. Kimmey
Overview
Alcohol is one of humanity’s oldest and most widely used psychoactive substances (Room
et al., 2005). Alcohol drinking is reinforcing and can lead to harmful alcohol use (Koob et
al., 1994). Excessive consumption of alcohol is linked to hundreds of short- and long-term
health consequences, including injury to self and others, organ insult and failure, as well
as the development of one of the most prevalent neuropsychiatric diseases globally,
alcohol use disorder (AUD) (WHO, 2018).
Studies of human alcohol drinking behavior have revealed a number of risk factors
associated with alcohol misuse. Among these, stressful life experiences and nicotine use
are highly prevalent in modern society and are positively associated with increased alcohol
consumption (Anthony & Echeagaray-Wagner, 2000; Keyes et al., 2011). Like alcohol,
stress hormones and nicotine exert diverse effects on mesolimbic dopamine (DA) pathway
function that can promote behavioral reinforcement (Piazza et al., 1993; Corrigall et al.,
1994; Gatto et al., 1994; Rodd-Henricks et al., 2000), suggesting, that convergent
mechanisms resulting from stress or drug exposure in reward-related circuitry provoke
escalated alcohol self-administration. In agreement with this hypothesis, the ventral
tegmental area (VTA), a central hub of the mesolimbic DA pathway, displays inhibitory
GABA plasticity arising from both stress and drugs of abuse (Ostroumov & Dani, 2018a).
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For this reason, the central hypothesis of this dissertation was that changes in alcoholinduced inhibitory GABA signaling in the VTA contribute to excessive alcohol drinking
behavior in rodents.
Experimental Evidence for the Role of Chloride Ion Dysregulation in Escalated
Alcohol Consumption
In Chapter 2, stress hormone signaling was found to alter both the behavioral and
neurobiological responses to alcohol in rats. Drug-naïve animals subjected to acute
restraint stress displayed elevated alcohol intake compared to non-stressed control
animals when examined the next day. This lasting effect of stress on alcohol-related
behavior correlated with diminished excitation of DA neurons by alcohol in tandem with
enhanced alcohol-induced inhibitory GABA release onto DA neurons. Correspondingly,
VTA GABA neurons, a source of GABA input onto DA neurons in the VTA, demonstrated
paradoxical excitatory GABAA receptor (GABAAR) function following stress exposure
mediated by compromised function of the potassium-chloride cotransporter KCC2.
Critically, this stress hormone-induced molecular adaptation was causally linked to the
increased alcohol self-administration behavior observed in stressed rats; pharmacological
upregulation of KCC2 in the VTA prevented escalated alcohol intake.
Like stress, the results presented in Chapter 3 revealed that adolescent nicotine exposure
prompts a long-lasting propensity for increased alcohol self-administration in rats. The
effects of adolescent nicotine treatment on adult VTA inhibitory circuitry were similar to
those observed after acute stress in adult rats. Indeed, adolescent nicotine treated animals
showed blunted DA neuron action potential firing in response to alcohol administration in
adulthood, corresponding with disrupted chloride ion (Cl-) homeostasis and decreased
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KCC2 expression in VTA GABA neurons. Importantly, the dysregulated midbrain inhibitory
circuitry and elevated alcohol self-administration resulting from adolescent nicotine
exposure were pharmacologically reversible through direct VTA application of a KCC2
activating compound.
Although these results revealed KCC2 hypofunction as a novel interventional target for
excessive alcohol intake, selective KCC2 activator drugs have only recently been
synthesized and thus are untested in human populations (Gagnon et al., 2013). However,
KCC2 upregulation is achievable through diverse endogenous signaling mechanisms
(Medina et al., 2014). For example, activation of the serotonin 2A receptor (5-HT2AR) was
previously shown to enhance KCC2 function in spinal motoneurons of injured rodents
through second-messenger signaling (Bos et al., 2013). Chapter 4 presents data
illustrating this receptor-transporter interaction in VTA GABA neurons. In addition to
recapitulating the findings of Chapter 2 in mice, the fourth chapter mechanistically showed
that 5-HT2AR activation in VTA GABA neurons is sufficient to reverse stress-induced
downregulation of KCC2 function via PKC-mediated phosphorylation of KCC2.
Recruitment of 5-HT2AR signaling also prevented stress-related aberrations in alcoholinduced inhibitory transmission that was linked to increased alcohol self-administration in
Chapter 2.
The results of Chapter 4 provided novel insight into the therapeutic action of the
hallucinogenic 5-HT2AR agonists currently being tested in humans for a range of
neuropsychiatric conditions, including AUD (Bogenschutz et al., 2015; Bogenschutz &
Johnson, 2016; Carhart-Harris et al., 2016). We hypothesized that, like stress and nicotine
exposures, alcohol use perturbs Cl- transport function in the midbrain to facilitate ongoing
escalated alcohol consumption. Moreover, we predicted that this molecular adaptation
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would be mitigated by 5-HT2AR activation. Thus, in Chapter 5, it was found 5-HT2AR
agonist treatment reversed alcohol-induced Cl- transport dysregulation in VTA GABA
neurons and selectively attenuated alcohol self-administration in heavy drinking mice.
These results suggest that disruption of VTA Cl- homeostasis can regulate individual
alcohol-drinking behavior and points to the therapeutic capacity of 5-HT2AR agonist drugs
to target this maladaptive midbrain circuit plasticity to limit alcohol intake among humans
at risk for harmful alcohol use.
Midbrain Chloride Ion Dysregulation and Mesolimbic Dopamine Function
Release of DA in the nucleus accumbens (NAc) is a consequence of alcohol ingestion
and this phenomenon is thought to mediate the positive reinforcing effects of drugs of
abuse in general (Berke & Hyman, 2000; Grace, 2000; Weiss & Porrino, 2002; Gonzales
et al., 2004; Stuber et al., 2012). However, increasing evidence suggests that blunted or
attenuated DA neuron responses to alcohol correlate with elevated drinking in rodents
(Brodie & Appel, 2000; Ramachandra et al., 2007; Juarez et al., 2017). In line with these
studies, the results presented herein reveal that prior exposure to acute stress in
adulthood (Chapter 2) or protracted nicotine in adolescence (Chapter 3) attenuates the
acute effect of alcohol on mesolimbic DA signaling while enhancing GABA transmission
in the VTA to drive increased alcohol self-administration.
The association between attenuated drug-induced dopamine responses and increased
addictive behaviors is consistent across different species and multiple drugs of abuse,
including alcohol, nicotine, cocaine, and marijuana (Martinez et al., 2007; Lack et al., 2008;
Audrain-McGovern et al., 2012; Wang et al., 2012; Doyon et al., 2013a; Volkow et al.,
2014; Twining et al., 2015; Buchel et al., 2017). From the work presented in this
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dissertation, it is hypothesized that diminished DA neuron activity in response to rewards
is a result of heightened midbrain GABA signaling. VTA GABA neurons are critically
involved in reward prediction (Cohen et al., 2012) and likely modulate the sign and
magnitude of DA neuron responses to stimuli based on their expectancy; surprising
rewards eliciting large increases in DA neuron firing rates and anticipated rewards
producing weaker DA neuron activation (Hollerman & Schultz, 1998). In this way, blunted
DA signaling may reflect a decrease in tonic DA release that is elicited by reward receipt,
while phasic DA responses to salient, drug-related stimuli that may drive addictive-like
behaviors are enhanced (Wanat et al., 2009; Steinberg et al., 2013; Tolu et al., 2013;
Morozova et al., 2016; Schindler et al., 2016; Kruse et al., 2017). Nevertheless,
experimental evidence characterizing and probing the importance of blunted DA signaling
in alcohol self-administration behavior is lacking.
At the circuit level both stress and nicotine increased alcohol-induced sIPSC frequency
onto VTA dopamine (DA) neurons, which corresponded with blunted DA neuron firing in
response to alcohol. This change in inhibitory transmission was linked to enhanced
alcohol-related excitability of local VTA GABA neurons. Under basal conditions, alcohol
positively modulates GABAARs on VTA GABA neurons to promote inhibition of this cell
type in vivo (Gallegos et al., 1999; Stobbs et al., 2004; Ludlow et al., 2009; Steffensen et
al., 2009; Steffensen et al., 2011). However, VTA GABA neuron responses to alcohol
undergo considerable adaptation following chronic alcohol exposure, shifting from
inhibition to excitation (Gallegos et al., 1999; Nelson et al., 2018). This suggests that
plasticity in GABAAR function in VTA GABA neurons is a consequence of stress, nicotine,
or alcohol experience within the mesolimbic DA pathway circuitry that facilitates the
development of alcohol abuse. However, because DA signaling was not causally linked to
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drinking in this dissertation, it is possible that VTA GABA transmission promotes drinking
through modulation of DAergic or non-DAergic pathways.
KCC2 Regulates Cl- Homeostasis in VTA GABA Neurons
The majority of mature neurons in the brain contain a low intracellular Cl- concentration
relative to the extracellular space, which establishes the GABAAR reversal potential
(EGABA) as hyperpolarizing in the context of the resting membrane potential of the neuron.
Consequently, GABAAR activation results in an inward Cl- flux that decreases the
likelihood of action potential firing. Through recruitment of glucocorticoid receptor
signaling, stress and nicotine shifted GABAAR function from inhibition towards excitation
selectively in VTA GABA neurons. This paradoxical GABAAR function arose from
diminished chloride ion (Cl-) export activity of the potassium-chloride cotransporter KCC2,
which was then causally linked to the increased alcohol self-administration. Thus, the
experiments presented herein identified KCC2 as a critical regulator of mesolimbic DA
pathway responses to alcohol at synaptic, cellular, circuit, and behavioral levels of
investigation.
KCC2 is a neuron-specific Cl- exporter expressed broadly throughout the brain and spinal
cord (Payne et al., 1996; Payne, 1997; Williams et al., 1999; Karadsheh & Delpire, 2001).
Immunostaining results in rats and mice revealed that KCC2 is expressed primarily in nonDA neurons in the VTA, in agreement with the literature (Gulacsi et al., 2003; Taylor et al.,
2016). In VTA GABA neurons of drug- and experience-naïve adult rodents, the Cl- export
function of KCC2 maintains the low intracellular Cl- concentration, or large transmembrane
Cl- gradient, that is essential to this inhibitory GABAAR function (Fig. 6.1, left panel)
(Chamma et al., 2012; Kahle et al., 2013; Kaila et al., 2014).
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Independently, adult stress, alcohol, or adolescent nicotine exposures all caused
diminution of the transmembrane Cl- gradient in VTA GABA neurons associated with
deficits in KCC2-mediated Cl- export. Reductions in KCC2 function result in intracellular
Cl- accumulation, which shifts the reversal potential of GABAARs to depolarized levels that
can contribute to an increased probability of action potential generation when GABA or a
GABA mimetic (e.g. alcohol) binds to the receptor (Fig. 6.1, right panel) (Raimondo, 2017).
The influence of Cl- gradient disturbances can be profound, as modest increases in
intracellular Cl- concentration promote neuronal action potential firing (Saraga et al.,
2008). During development, or in some pathological conditions that cause severe
decrements in KCC2 function, this form of excitatory GABAAR function dominates (BenAri, 2002; Kaila et al., 2014). Correspondingly, in adult rodents exposed to stress or
nicotine, reduced KCC2 function and excitatory GABAAR signaling promoted VTA GABA
neuron action potential firing upon alcohol exposure to thereby influence broader circuit
function and behavior.
Western blot data suggested that KCC2 downregulation following environmental exposure
is a uniform phenomenon across VTA subregions (Chapters 2 and 3), although all
electrophysiological studies were conducted exclusively in the lateral VTA. Much remains
unknown regarding VTA subpopulations that may be enriched in KCC2 (e.g. glutamate
and GABA neurons) and whether functional deficits in KCC2-mediated Cl- extrusion exert
comparable effects on DA neuron activity throughout the VTA (Ostroumov & Dani, 2018b).
For example, caudal VTA DA neurons have been linked to the reinforcing effects of alcohol
(Rodd et al., 2005) and demonstrate larger increases in activity in response to alcohol
relative to DA neurons in rostral and lateral subregions (Brodie et al., 1990; Mrejeru et al.,
2015). This raises the possibility that the magnitude of the effects observed in this
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dissertation may have been more pronounced if experiments were performed within
caudal VTA subregions. For these reasons, future work is needed to delineate potential
heterogeneity in KCC2 adaptations in the VTA and determine how such changes relate to
alcohol-induced DA signaling and alcohol self-administration.
Modulation of KCC2 Function as a Novel Therapeutic Intervention for Alcohol Abuse
Collectively, this body of work describes a previously unrecognized form of inhibitory
plasticity within the VTA that contributes to escalated alcohol consumption. By targeting
and increasing the function of KCC2, the underlying cause of subverted alcohol signaling
in the VTA, these data inform novel avenues of research in the development of
pharmacotherapies for alcohol abuse and AUD.
Cl- extrusion enhancers that target KCC2 were recently developed (e.g. CLP290), but
have only been applied in preclinical experiments for rescue of wildtype KCC2 expression
in animals experiencing hyperalgesia or traumatic brain injury (Gagnon et al., 2013; Ferrini
et al., 2017; Lizhnyak et al., 2019). Using CLP290 in alcohol self-administering rodents, it
was found that increasing Cl- extrusion locally in the VTA reduced alcohol intake in
stressed and adolescent nicotine-treated animals. Thus, these are the first studies
demonstrating the efficacy of VTA infusions of CLP290 in regulating drug selfadministration. Because KCC2 is found strictly in the brain and spinal cord and CLP290
is a prodrug with extended bioavailability (Gagnon et al., 2013), it has been proposed that
such compounds have therapeutic potential in humans. Further work is needed to
examine the potential role KCC2 hypofunction in other drug addictions, the safety profile
of CLP290, and establish the efficacy of Cl- extrusion enhancement in vulnerable human
populations.
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Indirect upregulation of KCC2 function via post-translational modification offers another
promising avenue for pharmacotherapy research. Under basal conditions, KCC2 is
modulated by a number of intracellular mechanisms (Medina et al., 2014). These include
transcription factors, kinases, phosphatases, and ions (e.g. zinc). In particular, C-terminal
phosphorylation at the serine residue at position 940 (S940) is highly implicated in cellsurface stability of KCC2 and internalization of the transporter (Kahle et al., 2013). Bidirectional regulation of S940 phosphorylation is mediated by protein kinase C (PKC) and
protein phosphatase 1 (PP1). Accordingly, phosphorylation at S940 by PKC contributes
to membrane stabilization and increased transport function whereas dephosphorylation
by PP1 contributes to diminished Cl- export function, membrane destabilization, and
endocytosis (Lee et al., 2007; Lee et al., 2011).
An expanding literature links PKC-dependent regulation of KCC2 to endogenous signaling
mechanisms, including activity-dependent attenuation of KCC2 function (Fiumelli et al.,
2005), tonic activation of the KCC2 by group I metabotropic glutamate receptors ((Banke
& Gegelashvili, 2008), and activation of the KCC2 by 5-HT2AR stimulation (Bos et al.,
2013). Although first reported in spinal cord injury and neuropathic pain models (Bos et
al., 2013; Dong et al., 2016; Sanchez-Brualla et al., 2018), it was found that 5-HT2AR
activation also enhanced deficient KCC2 function in VTA GABA neurons ex vivo after
acute stress exposure (Chapter 4). This positive modulation of KCC2 was achieved
through PKC signaling and site-specific phosphorylation of KCC2 at S940. Similar results
were obtained with in vivo administration of the 5-HT2AR agonist TCB-2 following acute or
chronic alcohol exposure (Chapter 5).
Recent preclinical studies demonstrate the protective effects of both peripheral and intraVTA administration 5-HT2AR agonists against drug abuse (Vargas-Perez et al., 2017;
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Oppong-Damoah et al., 2019). However, the molecular mechanisms underlying these
behavioral effects of 5-HT2AR agonists have not been identified. The work presented in
this dissertation sheds light on one important mechanism by which 5-HT2AR agonism may
produce successful therapeutic outcomes: the recovery of wildtype KCC2 function in the
midbrain.
Although labeled a Schedule 1 substance (i.e. deemed of high abuse potential with no
accepted medical use) under the United States Controlled Substance Act, psilocybin, a
naturally occurring 5-HT2AR agonist in numerous species of mushrooms, can be safely
administered in humans (Johnson et al., 2008; Nichols et al., 2017) with positive
therapeutic outcomes, including reduction of harmful alcohol use (Bogenschutz et al.,
2015). Therefore, future work is needed to further characterize the neural substrates of 5HT2AR agonist compounds that contribute to their clinical success. In this way, novel
pharmacotherapeutic targets will be identified, such as KCC2, and lead to further
understanding of plasticity mechanisms within the brain reward circuitry.
Concluding Remarks
The mesolimbic DA pathway is a critical actuator of alcohol reinforcement. Stress and
drugs of abuse promote harmful alcohol use through plasticity in this brain reward circuitry.
Similar to stress itself, exposure to and withdrawal from nicotine or alcohol serve as
separate activators of the body’s stress response, promoting release of glucocorticoids
that modulate neural function (Ellis, 1966; Tabakoff et al., 1978; Rivier et al., 1984). In this
way, glucocorticoids play a general role in the development of drug addiction behavior,
including compulsive alcohol drinking (Vendruscolo et al., 2012).
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The findings presented in this dissertation link stress- and nicotine-related glucocorticoid
signaling in the VTA to subsequent increased alcohol self-administration. At the molecular
level, the circuit and behavioral impact of prior stress or nicotine exposure on the
pharmacological effects of alcohol converged on disrupted Cl- homeostasis in the VTA
and KCC2 hypofunction in GABA neurons. Despite this crucial discovery, much remains
unknown about the neuronal, neuroendocrine, neurotransmitter, genetic, and epigenetic
processes that may be engaged by glucocorticoids, nicotine, and alcohol to reduce KCC2
function and expression over short and long timescales. Therefore, a major focus of work
extending from this thesis will investigate the mechanistic underpinnings of downregulated
KCC2 and its role in neuropsychiatric disorders in general.
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Figures

Figure 6.1. KCC2 Regulates Cl- Homeostasis in VTA GABA Neurons.
(Left) Under basal conditions, Cl- homeostasis in VTA GABA neurons is intact. This is due to
unimpaired KCC2 transport function. KCC2 rapidly exports Cl- when GABAARs are bound by GABA
and opened, even during repetitive stimulation of GABAARs. The high rapidity of this process
maintains a low intracellular Cl- concentration and, thus, a large transmembrane Cl- gradient that
is essential to hyperpolarizing GABAAR function in mature neurons. Phosphorylation of KCC2 at
S940 (indicated by P) is a critical regulator of KCC2 function. Fully functional KCC2 displays robust
phosphorylation at S940. (Right) Following acute stress in adulthood or chronic adolescent nicotine
exposure, KCC2 in VTA GABA neurons demonstrates compromised Cl- export function. This is
manifested as decreased phosphorylation of KCC2 at S940 or decreased total protein expression
in the plasma membrane. Under these conditions the transmembrane Cl- gradient diminishes, due
to an elevated intracellular Cl- concentration, which results in a depolarizing shift in the reversal
potential of GABAARs. Thus, VTA KCC2 hypofunction and the consequent dysregulation of Clhomeostasis, produces aberrant alcohol-mediated excitation of GABA neurons and promotes
escalated alcohol self-administration behavior.
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APPENDIX
Slicing Protocol for Electrophysiology Experiments
I.

Stock solution preparation: (usually in the 4° fridge made already ; use stock
within two weeks of making – ask if can use/if not make beforehand)
- 10X Sucrose Cutting Solution:
o Makes 500mL
o Typically used when cutting slices from adult rodent brains or when long,
cell-attached recordings need to be done
o Will be added to the working sucrose cutting solution daily
o Store at +4°C
o Dissolve the following in DI (Milli-Q) water:

-

[Final] in 1X
solution

MW

g/500mL of 10x
solution

KCl

2.5mM

74.55

0.9325

NaH2PO4

1.2mM

137.99

0.8275

NaHCO3

21.4mM

84.01

9.0

10X aCSF Recording Solution:
o Makes 1L
o Will be added to the working aCSF solution daily
o Store at +4°C
o Dissolve the following in DI (Milli-Q) water:
[Final] in 1X
solution

MW

g/1L of 10x
solution

NaCl

120mM

58.44

70.13

KCl

3.3mM

74.55

2.46

NaH2PO4

1.2mM

137.99

1.66
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II. Daily working solution preparation: (make fresh every time need to use – rinse
graduated cylinders with MilliQ water)
***Make sure water bath is on before starting - 32-33°C for slice recovery
-

1X Sucrose Cutting Solution:
o Makes 250mL [for two mice=500 mL]
o 1st – fill glass graduated cylinder (labeled E-phys) to ~190mL with DI
(Milli-Q) water [for two mice=fill cylinder with 400 mL E-pod H2O] ; have
smaller graduate cylinder with extra water to wash down weigh boats
used for salts below
o 2rd – Place graduated cylinder on hot plate with stir bar – stirring at ~level
6 speed)
o 3rd – add 25mL of the 10X sucrose stock solution [for two mice=50 mL];
use some water from smaller graduated cylinder to wash remaining
solution off walls of cylinder
o 3rd – dissolve the following in this solution and bring to 250mL with DI
(Milli-Q) water [for two mice=500 mL]:
[Final] in
1X
solution

MW or
[Stock]

g OR
mL/250mL
of 1x
solution
(1 mouse)

D+ Glucose

11.1mM

180.2

0.5g

Sucrose

205mM

342.3

17.5g

7.5mM

1M

1.873mL

0.5mM

1M

0.125mL

MgCl2
(Stored @
+4°C) =
neuroprotective
CaCl2
(Stored @
+4°C) = cells
need this
o
o

o
-

g OR
mL/500mL
of 1x
solution
(2 mice)
1.0 g
35 g

3.746 mL

0.250mL
(250 uL)

4th – After stirring, pour cutting solution into 500 mL bottle
5th – oxygenate with carbogen (95%O2/5%CO2) for at least 15min (yellow
part of glass pipette down – so produces bubbles – at 10 psi; turn gas
pressure colored long side of knob up for ‘on’; never long side of knob left
or right because blocks pressure downstream of that)
6th – freeze in ‘Cutting Solution’ bottle at -80°C for ~33-35min

1X aCSF Recording Solution (use when sucrose cutting solution is needed):
o Makes 1L (1,000 mL) [for 2 mice can do 500 mLs instead]
o 1st – fill graduated cylinder to ~800mL with DI (Milli-Q) water
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o

o

o
o
o
o
o

2nd – add 100mL of the 10X aCSF stock solution (w/ stir rod on hot plate)
[During this waiting time: rinse vibratome tools w/ MilliQ water; wipe
down chamber and put this with its lid at -20 fridge so cools down; clean
vibratome before using]
3rd – dissolve the following in this solution (weigh out each and rinse
weigh boat with water in small graduated cylinder) and bring to 1L with DI
(Milli-Q) water:
[Final] in 1X
solution

MW or [Stock]

g OR mL/1L of
1x solution

NaHCO3

25mM

84.01

2.1g

Glucose

10mM

180.2

1.8g

Sucrose

20mM

342.3

6.85g

MgCl2
(Stored @ +4°C)

1mM

1M

1mL

CaCl2
(Stored @ +4°C)

2mM

1M

2mL

4th – Pour aCSF 1x Recording Solution from graduated cylinder to 1 L
bottle
5th - oxygenate with carbogen (95%O2/5%CO2) for at least 15min prior to
recording (does not have to be in ice)
6th – pour ~200mL of this solution into the incubation beaker (picture in
following pages – in beakers w/ mesh), provide with carbogen
(95%O2/5%CO2), [& turn on] and place in a water bath set to ~32-33°C
7th – place “lids” (weigh boat cut flat) on beakers [to avoid things falling
into solution and to avoid evaporation]
8th – Now ready to switch on vibratome (‘on’ button at back right corner of
machine) [ go to these notes]

III. Equipment:
-

Preparing equipment and the vibratome for slicing:
o Prepare daily working solutions first; the following steps can be performed
while the cutting solution freezes
o Vibratome setup:
§ Get a new razor blade for cutting; remove the paper covering and
wipe clean with 95% ethanol to remove any adhesive, oil, or
residue; rinse with DI water after
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•

-

-

-

Break the blade in half (by bending up the side) – one half
will go to the vibratome (tightened into the blade holder),
the other will be held in a pair of hemostats for hemisecting
the slices
§ Turn on the vibratome and set up the vibracheck equipment
(connect cord to VC panel on left back corner):
Tools you will need for brain
1) Small surgical scissors
7
2) Large surgical scissors
3) Surgical spatula
4) Razor blade
5) Rongeurs
6) Serological pipette (for frozen cutting solution)
7) Vetbond tissue super glue
8) Double-edged razor blade
9) Black body bag
Tools you will need for slicing
1) Paintbrush
2) Transfer pipette
3) Hemostat with half of the cutting razor blade
a. Use this for hemisecting slices
4) Hex screwdriver for manipulating the blade holder
Additional equipment needed for slicing
1) Glass petri dish- flat side with square paper towel cut piece
2) Small (25mL) beaker
w/ oxygen tubing

A

IV. Slice Prep:
1. Dissection: cut head, pull skin forward with razor blade, cut back of brainstem, cut
sides of bone; use scissors to cut through middle of skull; remove skull with forceps;
carefully scoop out brain (tools needed for dissection in Figure A of page 5)
2. Put brain in bubbly beaker
3. Put plastic clear clip (we want the tube from the blue pressure knob to be connected
to the plastic clip that goes into the vibratome)
4. Put drop of glue in the center of the black circle platform
5. Put brain in petri dish (dorsal side up)
6. Using the razor blade, do two coronal cuts in the front and back of the brain and then
turn brain in ventral side up
7. Use film strip to get brain and lift up and put on the glue in the black platform
8. Pour Cutting Solution (away from the brain) into the chamber (w/ some ice)
9. Vibratome panel: Press down button ; turn razor blade down; bring platform up; and
leave a few sec . to cool in icy solution; to stop press ‘pause’
10. Use vacuum to suck up any excess pieces of glue, if needed
11. To align the brain: turn the wheel and nudge down with the paint brush
12. Can speed up to 0.5 for cutting the sections using ‘Cont cut’ – only if you are sure
that you are not close to the VTA
13. When get close to VTA (see U red smile), decrease speed down to 0.14
14. collect ~2-3 slices for VTA using transfer pipet : Will punch from slice where see
hump for medial lemniscus & “frown – or upside down U” on slice
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15. Use paint brush to nudge slices off razor blade
16. Transfer slices to beaker (mesh beaker that is outside of water bath sitting on the
bench) for mouse #1
17. When done collecting slices, put the beaker back in the water bath and leave for 40
mins (while collect sections for next mouse)
18. Clean everything with MilliQ water and turn off panel settings so blinking light turns
off
19. Take out plastic clip
20. Scrape off brain from glue with the razor on the hemostatic scissor
21. Dry black platform with paper towel
22. Put body bag in freezer
23. Remove platform from ice water and dump in sink – rinse with MilliQ water & dry
inside of black chamber (put plastic lid on when dumping icy water in white
surrounding chamber)
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Western Blot Protocol
Sample Prep
Before receiving samples:
1. Make permeabilization solution (500uL) [this volume is good for 4 samples]
a. 492.5 uL permeabilization buffer, in a pink-tape box on the top shelf of the
big freezer
(-20°C) labeled Mem-Perm Plus, aliquots are labeled with a
P.
b. 2.5 uL protease inhibitor (1:200), from big freezer, can re-use (mark with
sharpie when thawed)
c. 5 uL HALT phosphatase inhibitor (1:100), from small fridge, brown tube in
red basket.
2. Make solubilization solution (500uL) – Save on ice for Membrane Prep step below
a. 492.5 uL solubilization buffer, from small fridge, on door shelf
b. 2.5 uL protease inhibitor (1:200)
c. 5 uL HALT phosphatase inhibitor (1:100)
3. Label Eppendorf tubes (e.g. C1, C2 (control), T1, T2 (treatment)) then add 100 uL
of permeabilization solution to each tube
a. Keep sample tubes on ice
***Punches collected from VTA – Slices prepared first as they are normally for
physiology***
After receiving samples:
1. Use 1 mL syringe, found above vibratome, with 26 gauge needle (27 gauge used
for smaller punch diameters, e.g. 0.5mm), across from the ice machine, to suck up
the tissue sample and solution, repeat until sample is well homogenized (not >1min
off ice)
a. Break up sample with needle, but be careful not to poke through Eppendorf
tube.
b. Be careful not to lose the sample in the needle, don’t draw it up too far.
c. Put homogenized sample on ice until all samples are ready for further
processing
d. Keep protein samples on ice or at 4 °C for all remaining steps
2. Once tissue is broken up for all samples, place tubes on rack and put on nutator
(in clear door fridge at 4 °C) for 10 minutes
a. Turn on centrifuge and select “fast cool”, wipe away condensation
3. Spin down sample at 4 °C in large centrifuge for 15 minutes at 16,000 g
a. The “ * “ indicates g’s on the centrifuge, instead of rpm
b. Put tubes in same orientation so finding pellet is easy
Whole Cell (cytosol) Prep:
4. Prepare cytosol Eppendorf tubes while the samples are spinning in the centrifuge
(e.g. CT1, CC1, etc.) with date on the side
5. Transfer supernatant into cytosol tubes immediately after spin is complete; Save
pellet
6. Store cytosol samples at -80 °C (or proceed to Quantification)
Membrane Prep:
1. Add solubilization solution (prepared earlier) to pellet from Whole Cell Prep (100
uL)
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2.
3.
4.
5.

Pipette solution 6-8 times to mix the pellet
Place sample on nutator (in 4 °C fridge) for 30 minutes
Centrifuge for 15 minutes at 4 °C and 16,000 g
While waiting, label Eppendorf tubes, 3 aliquots of each sample, 12 total tubes.
Each with date and sample label (e.g. MC1,MT1, etc)
6. Make 2 aliquots of 30 uL of each sample, one with 35 uL (extra is for Qubit)
a. Easiest method is to first remove all 100 uL of supernatant from spun tubes
and aliquot the second and third tubes from the first tube
b. Mark the tube with 35 uL for easy identification later
7. Discard pellet
8. Store at -80 °C (or proceed to Quantification)
Protein Quantification & Equalization
Sample dilution and Standard Prep:
1. Thaw protein samples stored at -80 °C on ice (this will likely require 15+ min)
2. Make 1:10 dilutions of samples with DI water (e.g. 5 uL sample, 45 uL water)
a. E-POD water is required (NOT Milli-Q)
b. Vortex lightly, return diluted samples to ice
3. Prepare Qubit protein solution – make this solution after protein sample dilutions
have been prepared
a. In a Falcon tube:
i. add 200 uL protein buffer, found on the shelf behind the parafilm,
for each sample, then add an extra 800 uL for the 3 standards (plus
extra)
(E.g. for 4 samples, use 1.6 mL total)
ii. Add 1 uL red protein dye, found on rack near protein buffer, for each
sample, plus 4 for standards and extra
(E.g. for 4 samples, use 8 uL total)
iii. Vortex lightly, and place on nutator for 1-2 min to ensure complete
mixing
4. Prepare Qubit tubes as follows at room temperature (200uL total volume per tube):
a. For samples, add 195 uL of protein buffer + dye into Qubit tubes, then 5 uL
of diluted samples – Bubbles in the solution will prevent accurate readings!
b. For standards, add 190 uL of protein buffer + dye, then 10 uL of standard
#1 (0), #2 (200), and #3 (400) to their respective tubes
i. Standards should be prepared within 10 min of the samples (per
manufacturer)
ii. When preparing many samples, it is recommended to prepare 2
sets of standards to avoid the possibility that the first set of
standards are incorrect
c. Vortex Qubit tubes right after adding sample - be extra careful to keep track
of each
i. Do this carefully so as to not splash the solution into the tubes’ caps
– if this happens, re-prepare the tube
d. DO NOT label the tubes as this will interfere with Qubit reading
i. Can stick a piece of tape along one row of the tube rack, next to the
Qubit tubes you prepared, and write sample IDs on the tape
e. Wait 15 minutes with tubes at room temperature
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Qubit setup and quantification:
5. On Qubit, use Protein Quantification setting
a. Set new calibration with standards
6. Follow instructions on the Qubit; Standards must be re-run if you see an error
7. Calculate concentration for each sample – after initial reading, scroll to calculate
concentration and enter volume of sample (5 uL) to obtain a reading in ug/mL
Sample Equalization (see table on next page for examples of the following
calculations):
8. Calculate corrected concentration from dilution values from Qubit – divide by 100
to obtain ug/uL (since the sample is already diluted 1:10)
9. Calculate the amount of sample needed to obtain 90 ug (i.e. 90/corrected Qubit
value)
10. Subtract the calculated value from step 9 from 30 to obtain the amount of
solubilization buffer needed to make 30 uL of sample + sol. Buffer
a. Prepare solubilization buffer as described under Sample Prep on page 1
11. 30 ul of loading dye (βME+Dye) goes in each sample to obtain a total of 60 uL per
sample
a. βME+Dye stock = 975 uL 2X Laemmli sample buffer + 25 uL βMercaptoethanol
b. Samples are prepared with enough volume for 3 lanes, we use two 20 uL
(30 ug) aliquots per sample per gel, the leftover is saved in the big freezer
Preparing Samples for Gel Electrophoresis
1. Proceed directly from Equalization step, making sure calculations are completed
2. Set heat block to 95 °C
3. When preparing samples using calculations above, add loading buffer first
(βME+Dye), then solubilization buffer, then protein sample last
a. βME+Dye found in Jordan’s Western Box at -20 °C (see bottom of previous
page for instructions for making new stock)
4. Prepare 1L of 1x SDS running buffer (900 mL E-POD water + 100 mL 10x
SDS/running buffer)
a. Adding the running buffer to the water prevents bubbles
b. This should be made at least 10min prior to preparing the gel box to allow
complete mixing
5. Use BioRad Mini-Protean TGX Pre-Cast Gels (4-15%, bottom is more dense)
a. Gently slide lane divider comb from the gel, careful not to disturb lanes
b. Remove green tape from bottom of gel, place gel into gel running box
(“rabbit ears” of gel holder point up and lanes reading left to right)
i. Match red electrode with red tape on side of gel box
ii. For 1 gel, make sure the buffer dam is inserted correctly
c. Fill surrounding area of gel box to line on gel holder, then fill the gel holder
reservoir
i. Running buffer must reach top of the gap in the gel holder to ensure
correct running conditions – otherwise an error appears on the
power supply.
6. Place samples in heat block at 95 °C for 3-5 minutes (4 minutes works well) to
denature protein
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a. After removing samples from heat block, allow to cool for 1-2 min, vortex
well and spin samples quickly in mini centrifuge (2x 5sec pulses)
7. Fix/straighten wells with pipette by blowing ~100 uL of running buffer into them –
make sure lane dividers are even – recommended to do this several times to
ensure the wells are clean
Loading & Running Gel
8. Add 10 uL of ladder to lanes 1 and 6 – pipette solution very slowly to ensure an
accurate volume
9. Add 20 uL of samples to remaining lanes
a. Samples should be close to or at room temperature
b. First sample goes in lanes 2 and 7, next sample in 3 and 8, etc.
c. Keep track of lane assignments in notebook (see next page for illustration)
d. Pipette slowly into wells to prevent sample loss and contamination of
neighboring wells
10. Store remainder of equalized/denatured samples in box in freezer (-20 °C)
11. Plug in the running box, set to 100 V and press run
a. Look for bubbles to appear in gel holder box and ensure no errors appear
on power supply due to insufficient running buffer volume
12. Run gel for 1 – 1.5 hours or until dye front (blue dye in each well) just passes the
black reference line on the gel casing

T2

C2

T1

C1

Ladder

T2

C2

T1

C1

Ladder

Example Gel Lane Assignments (samples are run in duplicate on 2 halves of the gel to
allow for simultaneous probing of total and phosphorylated forms of the same protein)
Lane
Lane
Lane
Lane
Lane
Lane
Lane
Lane
Lane
Lane
1
2
3
4
5
6
7
8
9
10

Gel Transfer to Membrane
Protein Transfer:
1. With ~30 minutes remaining for gel electrophoresis, make transfer buffer (in the
following order): 1) 200 mL methanol, 2) EPOD DI water to 960 mL, 3) 40 mL
SDS/running buffer (add last)
a. Add 800-900 mL of transfer buffer to a glass pyrex dish and the remainder
in a pipette box for the gel to equalize in transfer buffer after the run is
complete
b. An additional 500 mL of solution is needed depending on the tank that is
used for transfer
2. Cut a 2.5 x 3.5 piece of nitrocellulose membrane (use filter paper to estimate size)
– nitrocellulose found in big roll in bottom cabinet – be careful not to expose
membrane
3. Use 2 pieces of Whatman paper the same size as the nitrocellulose and re-use
sponges – soak all 5 things in transfer buffer in large Pyrex container
a. Sponges, Whatman paper, and nitrocellulose membrane can be prestacked
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4. As the dye front passes the black indicator line on the bottom of the gel casing,
stop power supply, open gel with green prier tool at locations on the gel casing
marked with arrowheads
5. Place gel in transfer buffer for approximately 2 minutes
6. Prepare the transfer sandwich: sponge, Whatman paper, nitrocellulose, gel,
Whatman paper, sponge
a. Keep track of which side has nitrocellulose in front of gel
b. Try to avoid air bubbles by placing the nitrocellulose on the gel underwater
7. Roll over the sandwich with a broken pipette to remove bubbles
8. Place sandwich in black/white holder with the gel below the nitrocellulose (gel
closer to black, nitrocellulose closer to white – protein transfers from blackàred
(white) side (+à-) – See illustration below
9. Put black side of holder next to black part of box, red next to white
10. Fill transfer box completely with additional transfer buffer (extra solution may be
needed)
[ Black Electrode (+) ]
--------------------Black surface of transfer stack holder----------------------------------------------------------Sponge-------------------------------------------------------------------------Whatman Paper---------------------------------------------------------------------------Gel----------------------------------------------------------------------Nitrocellulose Membrane--------------------------------------------------------------Whatman Paper------------------------------------------------------------------------Sponge-----------------------------------------------------------White surface of transfer stack holder-------------------[ Red Electrode (-) ]
11. Place the whole transfer box in an ice bucket, fully bury it in ice and run at 100 V
for 30 minutes
a. During transfer, make milk solution (2.5g milk powder +50 mL TBS-T) for
membrane blocking (see below) – put on room temperature nutator to
thoroughly homogenize
b. TBS-T solution (890 mL E-POD di H20 + 10 mL 10% Tween + 100 mL 10X
TBS)
Membrane Immunoprobing
Day 1:
1. After the transfer, place nitrocellulose membrane in TBS to remove methanol (2
quick washes in recycled pipette tip boxes will suffice)
a. While in the first TBS wash, cut the one of the top corners of the
nitrocellulose with the protein side up to mark the correct orientation
b. *Use ladder to determine which side is the top – ladder will be spread out
on top and bunched together on bottom because gel is 4à15%
2. Place nitrocellulose protein side up in plastic top of pipette tip holder, add milk
solution, place on shaker at room temperature for 1 hour
3. Following blocking, wash the blot in TBS-T for 10min to remove excess milk
solution prior to primary antibody incubation
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4. During TBS-T wash, Cut three plastic sleeves for the 3 sections of the blot to be
incubated with primary antibody (1 for Total KCC2, 1 for phopho-KCC2 and 1 for
loading control)
5. At the end of the TBS-T wash, place plastic wrap on glass surface and sandwich
nitrocellulose within plastic wrap
a. Cut nitrocellulose in half horizontally using ruler and razor blade – cut at 72
kD along red lines, then cut an upper corner of bottom piece to mark correct
orientation
i. Cut the top portion in half so that each side has a ladder.
ii. *Don’t leave nitrocellulose dry, leave in milk to keep it moist when
not using it/after finishing the cuts
6. Place blot pieces in cut bags and use impulse sealer to close all but one side of
the bag (2 seals per side works well to prevent leaks; wait ~5 sec after each seal
to ensure the bag won’t rip)
7. 1° Antibodies (choose either GAPDH or Β-actin as the loading control):
a. Phospho-KCC2 is 1:1000 found in big freezer (rabbit)
i. 2.5 uL into 2.5 mL primary antibody solution
b. Total KCC2 is 1:1000 found in big freezer (rabbit)
i. 2.5 uL into 2.5 mL primary antibody solution
ii. For incubation bags, Phospho-KCC2 goes in one of the top-half
blots; Total KCC2 for the other top-half blot (These bands will be in
this portion of the blot with the more spread out ladder); make note
of which blot receives which antibody
c. GAPDH is 1:300 found in small fridge (mouse)
i. 16.7 uL GAPDH in 5 mL primary antibody solution
d. Β-actin is 1:1000 found in big freezer (mouse)
i. 5 uL Β-actin in 5 mL primary antibody solution
ii. Loading control antibody will go with the large bottom half of the blot
8. Remove air bubbles by gently sliding bubbles toward the opening in the bag
a. Once the air bubbles are sufficiently removed (some small bubbles may
remain) seal the final opening of the bag (again, 2 seals work well)
9. Incubate bags with blots/antibodies in 4 °C fridge on nutator overnight; or on RT
nutator for 1.5 hours (overnight preferred)
Day 2:
10. If desired, collect antibodies in 15 mL falcon tubes directly from the incubation bags
for subsequent re-use (stored at 4 °C)
11. Wash 3 x 10 minutes with 20+ mL (enough to submerge it) TBS-T (TBS/Tween)
on shaker in plastic top of pipette tip holder
12. During the final TBS-T wash, prepare bags for 2° antibody incubation and 2°
antibodies
13. 2° Antibodies:
a. Dilute 1:5000 uL of antibody for corresponding animal (mouse, rabbit, etc.
– stored in fridge) with secondary antibody solution
i. i.e. 5 uL in 5 mL secondary antibody solution
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ii. Phospho-KCC2 and Total KCC2 are rabbit
iii. GAPDH and B-actin are mouse
iv. Use most recent antibodies
b. Don’t leave antibody outside of fridge for very long, take it out right before
you need it)
14. Put nitrocellulose in plastic sleeve, seal, fill with corresponding antibody solution,
remove air bubbles, place on RT rocker for 2 hours (can cover with foil if desired)
15. Wash 2 x 10 minutes with 20+ mL TBS-T on shaker in plastic top of pipette tip
holder
16. Wash 2 x 10 minutes with 20+ mL TBS
Membrane Imaging
1. During the final TBS wash on Day 2 of Immunoprobing
a. Prepare Dilute Assay Buffer– Make two falcon tubes with 5 mL of 10x
Assay Buffer (small fridge) and 45 mL DI water (1:10) – place on room temp
nutator to mix thoroughly
2. Place nitrocellulose in plastic top of pipette holder, wash 5 minutes with each
Assay Buffer dilution (2 washes total)
3. Incubate 5 minutes in 4 mL CDP Star/NitroBlock (small fridge)
a. For 3 sections, pipette one 2 mL drop (for bottom half of blot) and two 1mL
drops (for each top-half blot) on plastic sleeve sitting on glass block
b. Place nitrocellulose on puddles protein side down
c. Slowly lay it down so developer solution spreads, move around
4. Before moving nitrocellulose, slosh it around in developer solution then rearrange
all of the blot pieces into their original shape inside a new plastic sleeve with protein
side up
a. Remove air bubbles, wait 15 minutes to 1 hour (no need to seal sleeve);
15 minutes is usually sufficient
5. Develop using Chemi Imager
a. In Darkroom
i. Manually select exposure time (15 sec, 30 sec, 1 min, or 5 min)
ii. No need to change any other parameters
iii. Press Expose
b. When imagining has completed, insert USB drive and copy blot image to
this drive
i. The imager software will create a new folder for each blot image
with 8-bit and 16-bit versions of the image
6. Blot can now be retained in TBS solution and kept at 4 °C if additional
immunoprobing is desired
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Immunohistochemistry Protocol
Perfusion and Brain Preparation:
1. Prepare the perfusion area
a. Grate for blood flow
b. Butterfly needle
c. Surgical tools: scissors large (flat on bottom) and small, clawed forceps, curved
hemostat, rongeurs, flat-tipped spatula
2. Perform a cardiovascular perfusion/s and collect brain/s in 10% buffered formalin
a. Inject 0.1mL of ketamine solution
b. Clean line with 95% ethanol before/after each procedure
c. Use the orange pipette box for blood/formalin collection
d. Open chest cavity, insert needle in right ventricle and then snip left atrium
e. Solution flow rate is 15.0 on the pump – run 10mL minimum of 1xPBS then 10%
formalin
3. Keep the brain/s in formalin for 24 hours. After that, increase sucrose levels before
freezing in OCT, followed by cryostat slicing
a. Change to 10% sucrose in PBS for 24 h
b. Change to 20% sucrose in PBS for 24 h
c. Change to 30% sucrose in PBS for 24 h
Immunohistochemistry:
1. Post Slicing PBS Rinses: Choose which wells you are going to stain and wash with
750 µL of PBS per well at least twice more for ~10 minutes each on the orbital shaker
(30-45rpm). Do 3-5 PBS washes for 10 minutes each on orbital shaker (45).
-1 ml of PBS in each well (suck out solution and put in 1 ml – for each well, then
shaker à round 1)
2. Blocking Solution: During the last PBS wash, prepare an ice bucket. Obtain Normal
Goat Serum (NGS) (found in the -20°C freezer in Mariella’s lab), PBS & 20% Triton X
(in PBS).
a. Prepare blocking with 3% NGS, 0.3 % Triton X in PBS.
b. Sample calculation: 10 wells X 300µL each = 3000µL total
i. 3000µL*0.03 = 90µL NGS
ii. 3000µL*0.003*5= 45µL Triton X
iii. 3000µL – 90µL – 45µL = 2865µL PBS
PBS= total volume (i.e. 3000) – NGS ad Triton X components – i.e. 3000135 = 2865
iv. When the washing is complete, remove the PBS from the wells and replace
with blocking solution. Cover and place on orbital shaker for 2 hours at
room temperature (45rpm).
3. Primary Antibody Solution - Calculations:
a. Prepare a new blocking solution on ice leaving space for primary antibodies
b. Calculate primary antibody concentrations. The concentrations that work well are:
rGAD67 1 µL:150 µL
mGFP 1 µL:1000 µL
mKCC2 1 µL:300 µL
rKCC2 1 µL:500 µL
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chMAP2 1µL:2000 µL
mnKCC1 1 µL:200 µL
chNueN 1 µL:1000 µL
mTH 1 µL:500µL
rTH 1 µL:1000µL
rpKCC2 1 µL:100 µL
rcfos 1 µL:1000 µL
gpVGAT 1 µL:500 µL
mTH 1 µL:1000µL
c. Sample calculation: 10 wells X 300µL each = 3000µL total
i. 3000µL solution*1µL rKCC2/500µL solution = 6µL rabbit KCC2
ii. 3000µL solution*1µL mTH/500µL solution = 6µL mouse TH
iii. 3000µL – 6µL – 6µL = 2988 µL blocking
iv. 3000µL*0.03 = 90µL NGS
v. 3000µL*0.003*5= 45µL Triton X
vi. 3000µL – 90µL – 45µL = 2865µL PBS
2865 (from above) – total antibody solution added to blocking: i.e. 2865 – 12 = 2853
4. Primary Antibody Solution - Incubation: When there is about 20 minutes left of
blocking, begin to prepare the primary antibody solutions in their respective
concentrations in new blocking solution (or prepare a stock in the beginning of the
procedure to save time).
a. Remove the blocking solution from the wells and replace with the primary antibody
solution, using ~300µL per well.
b. Cover and place on the orbital shaker in the 4°C fridge for the night.
5. Post Primary Washes: This starts on Day 2 (12-16 hours roughly)
a. Suck out antibody solution from each well and then add 1 ml PBS per well
b. Wash three times with PBS for 10 minutes each (using the shaker in the fridge,
can’t adjust rpm here, whatever it is on is fine)
6. Secondary Antibody Solution:
a. During the last PBS wash, begin to prepare blocking solution for secondary
antibodies on ice. All secondary antibodies can be found in the -20°C freezer in
the orange box on the top shelf of the freezer in Mariella’s lab. The concentrations
I used for all secondary antibodies were 1µL: 1000 µL.
gt anti-rb (405)
gt anti-gp (647)
gt anti-ms (488)
*Make sure to keep the ambient light to a minimum (use tin foil).
b. Remove PBS from all wells (suck up with 1 ml pipette) before adding 300 µL of
secondary antibody solution per well.
c. To reduce light exposure, cover in tin foil and place on orbital shaker at room
temperature (on the bench) @ 45rpm for 3 hours (just 1 incubation).
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7. Post Secondary Washes: After 3 hours, suck up secondary solution and then add 1
ml PBS per well. Place on the orbital shaker in the 4°C fridge between each wash for
10 minutes. Repeat 3x for 3 PBS washes.
8. Mount and coverslip slides for fluorescence microscopy
a. Label glass slides with sharpie. I usually include animal ID, date, well #, virus type,
antibodies with wavelength. (Example: MT28, 5/30/17, well #8, KCC2-eGFP,
KCC2 – 594, TH – 647)
b. Fill petri dish with PBS, transfer slices (transfer pipette) one well only at a time to
petri dish. Use a paintbrush to mount slices to prelabeled slides (so 2 slices per
well = 2 slices on each slide).
c. Carefully remove excess PBS with kimwipe by dabbing it on paper towel (make
sure slice isn’t too close to edge)
d. Place slide in black box on bench to dry for 5 minutes. While that slide is in the
box, can start mounting the next slide.
e. After removing the slide from the black box shake it to remove any remaining PBS
(slices should look a little damp).
f. Apply a drop of vectashield to each slice and a little one in the middle. Now can
apply coverslip (angle it down slowly from one end).
g. Once coverslip is on, make sure don’t see any bubbles on slides (if do, press gently
next to the slice with finger to move bubble off of slice).
h. Put the now coverslipped slide back into the black box to cure for at least one hour.
i. Store slides in slide box in freezer (where intracellular is)
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